Double fortified salt composition containing iron and iodine and process for the preparation thereof

THERAPEUTIC COMPOSITIONS

An oral composition, suitable as a hypoglycemic agent, includes an isolate from the leaves of Gymnema sylvestre, having a specified molecular weight. The isolate has a molecular weight at least about 3000 Daltons as determined by molecular weight cut-off filtration. Glucose metabolism in a human Patient can be regulated by dosage forms that contain the aforesaid isolate from the leaves of Gymnema sylvestre, in combination with a non-metabolizable, water- swellable polysaccharide such as the exudate of Sterculia urens, and a water- soluble polysaccharide such as guar gum. Optionally, the present oral compositions can include a physiologically acceptable calcium source, a physiologically acceptable metal carbonate salt, a physiologically acceptable chromium salt, and/or a physiologically acceptable vanadium compound. In addition, antioxidants such as ascorbic acid, cholecalciferol, d-.alpha.- tocopherol, the carotenoids, lycopene, lutein, and the like, can be included as well. The present ...

COMPOSITION FOR ACCELERATING CALCIUM ABSORPTION

A composition for accelerating calcium absorption which contains a less absorbable L-form aldonic acid, a salt thereof, or a less absorbable L-form aldonolactone; and a food or beverage which contains L-arabonic acid, a salt thereof, or L-arabonolactone. Also provided is a process for producing L- arabono-.gamma.-lactone crystals, characterized by dissolving L-arabonic acid in an organic solvent and crystallizing the lactone from the solution. Thus, a food or medicine effective in the prevention or treatment of osteoporosis can be provided.

METHOD FOR IMPROVING BONE MINERALIZATION

The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced mineralization results in the production of a higher peak bone mass and correspondingly lowers the incidence of osteoporosis.

COMPOSITIONS AND METHODS FOR NUTRITION SUPPLEMENTATION

CARBOHYDRATE AND ELECTROLYTE REPLACEMENT COMPOSITION

The present invention discloses novel compositions and methods. These compositions and methods may be used to attenuate or reverse the effects of dehydration or other adverse effects of exercise, heat or other activity which causes bodily fluid loss. The novel compositions comprise carbohydrates, electrolytes and water along with flavoring agents.

DIETARY SUPPLEMENT

A dietary supplement for treating or preventing prostate disease and/or vascular disease including saw palmetto, d-alpha tocopherol, d-gamma tocopherol, d- delta tocopherol, d-beta tocopherol, selenium, lycopene, zinc, folic acid, vitamin B12, and vitamin B6, each in a therapeutically effective amount.

MINERAL FORTIFICATION SYSTEMS FOR ADDING MINERALS TO BOTTLED, POTABLE LIQUIDS

A mineral-fortification system that has a bottle cap, a pouch and a pouch opener. A powder is contained within the pouch, and the powder contains at least one mineral and a redox modulating compound. When the cap is secured onto the opening of a bottle containing a liquid and when the pouch opener is activated, the powder is released from the pouch and mixes with the liquid to form a mineral fortified liquid composition that is fortified with at least one mineral and has a pH between about 2.5 and 9.5. Moreover, the mineral fortified liquid composition has a redox potential that satisfies the following equation:0 ~ RP - (A - B*pH). In this equation RP is the redox potential in millivolts of the mineral-containing liquid composition, pH is the pH of the mineral-containing liquid composition, A is 400 and B is 20. The mineral is preferably selected from calcium, iron, zinc, copper, manganese, iodine, magnesium, and mixtures of these. Moreover, the mineral-fortified liquid composition may ...

CALCIUM CONTAINING SOY PROTEIN ISOLATE COMPOSITION

The present invention is directed to a calcium containing vegetable protein containing composition, Comprising; a calcium containing protein material containing at least 90% protein by weight, dry basis, said protein material having a dry basis degree of hydrolysis of from about 1.8% up to about 4.0%, a dry basis calcium content of from 0.10% up to about 0.6%, a dry basis density of from about 0.28 up to about 0.48 g/cc, a pH of from about 6.9 up to about 7.7, and a particle size wherein not more than 10% of the particles are retained on a 30 mesh screen. The present invention is also directed to a calcium containing vegetable protein based beverage composition, comprising; a liquid and a calcium containing hydrolyzed soy protein isolate containing at least 90% protein by weight, dry basis, said protein material having a degree of hydrolysis of from about 1.8% up to about 4.0%, a percent calcium of from about 0.15 up to about 0.60, a density of from about 0.15 up to about 0.48 grams per ...

FORMULATION FOR MENOPAUSAL WOMEN

The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from symptoms associated with menopause, as well as prophylactic effects, and methods for using same.

COMPOSITION CONTAINING OMEGA-3 FATTY ACIDS AND OMEGA-6 FATTY ACIDS

... ²²²The invention relates to a composition containing omega-3 fatty acids and ²omega-6 fatty acids, which comprises zinc compounds, preferably in the form of ²zinc sulfate, especially for use in the treatment of dry eye symptom.² ...

MINERAL COMPOSITION

The present invention relates to a mineral composition, characterized in that the mineral composition comprises 100 parts by weight of a metal salt having a solubility product in water at 25.degree.C of 1.0 x 10-7 or less and 0.5 to 50 parts by weight of an emulsifier having an HLB of 6 to 10, wherein the metal salt comprises fine particles having an average particle size of 0.05 to 1 .mu.m.

DRINKS USING SEAWATER AND METHOD FOR PRODUCING THE SAME

A process for producing a drink which comprises desalting seawater to thereby seperate into water and a concentrate containing sufficient amounts of essential minerals (magnesium, calcium, iron, etc.) and vitamins, and then adding to the water the concentrate per se or essential mineral components (water-soluble magnesium, calcium, iron, etc.) separately obtained from concentrated seawater; and health-promoting drinks obtained by this method.

NUTRITIONAL COMPOSITIONS

The present inventors discovered that the onset of galactosamine hepatopathy is suppressed by nutritional compositions comprising as essential ingredients: whey protein hydrolysates; lecithin and oils and fats high in oleic acid, which are able to improve the lipid metabolism; and palatinose having an insulin-sparing effect. Furthermore, the whey protein hydrolysate included in the nutritional compositions was found to suppress endotoxin-induced TNF-a and interleukin 6 (IL-6) production in macrophages.

MATRIX-FORMING COMPOSITION CONTAINING PECTIN

One aspect of the present invention relates to a liquid edible composition with a pH of more than 6, a viscosity below 600 mPas at a shear rate of 100s-1 and 20 ~C, and a viscosity of at least 125 % of the aforementioned viscosity at a pH below 5 and a temperature of 37 ~C, the composition comprising at least 0.05 wt. % of pectin having a degree of methoxylation between 2 and 50 and/or of alginate; at least 5 mg calcium per 100 ml; and at least 0.1 wt. % indigestible oligosaccharide having a degree of polymerisation between 2 and 60. Another aspect of the invention relates to a method for the treatment or prevention of overweight or obesity in mammals, said method comprising the enteral administration to a mammal of an effective amount of the aforementioned composition.

PRODUCT AND METHOD TO REDUCE STRESS INDUCED IMMUNE SUPPRESSION

In its broadest aspect, the present invention is directed to the discovery of immunonutritional products that are useful in reducing the immunological system suppression that results from stress. The stress may be in the form of physical exertion, mental exhaustion, disease states and the like. In one embodiment, the invention relates to a nutritional composition comprising a structured glyceride component and an antioxidant system. This nutritional composition has been shown to be highly effective in reducing immune system down regulation or dysregulation as a result of stress.

COMPOSITIONS FOR IMPROVING BREAST HEALTH IN WOMEN

... ²²²Disclosed are compositions and corresponding methods for treating fibrocystic ²breast disease or other breast-related disease or condition. The compositions ²comprise, per serving or dose, from zero to about 400 ~g selenium, from about ²100 mg to about 6000 mg gamma linolenic acid, and about 0.15mg to about 5 mg ²iodine, with nutritional embodiments further comprising one or more of ²protein, fat, carbohydrate, vitamins, and minerals and providing from about 50 ²to about 1000 kcal of energy per severing or dose. Also disclosed are in-vitro ²studies showing that certain combinations of gamma linolenic acid, iodine, ²and/or selenium may 1) inhibit breast cancer or fibrocystic cell ²proliferation, 2) reinforce the function of tight junctions of endothelial ²cells and of mammary epithelial cells in estrogen-sensitive conditions, and 3) ²reduce the risk of vascular invasion by breast cancer cells.² ...

COMPOSITION FOR PROMOTING OSTEOGENESIS AND INCREASING BONE MINERAL CONTENT

METHOD FOR PRODUCING AN IRON SULFATE-BASED PHOSPHATE ADSORBENT

NUTRITIONAL SUPPLEMENT FOR ADOLESCENTS

A multinutrient nutritional supplement is provided that is designed to be most effective in optimizing health, increasing the immunity and decreasing the instances and severity of infection particularly among adolescents.

REHYDRATING FORMULATION

The present invention relates to an aqueous formulation for combating dehydration comprising a low concentration of galactose and a source of sodium ions which is particularly effective in children (e.g. infants). The dehydration is typically a symptom of severe diarrhoea.

NUTRITIOUS COMPOSITIONS AND FOOD COMPONENTS

The invention describes a nutritional composition containing selenium, colostrum and whey. Composition can be used alone or in combination with food or drink.

INFANT FORMULA CONTAINING PARTIALLY HYDROLYZED ISOLATED SOY PROTEIN WITH A REDUCED PHYTATE CONTENT

Nutritional formulas are provided which comprise isolated soy protein wherein the isolated soy protein has a phytate content of 100 mg per liter or less; and the isolated soy protein has a degree of hydrolysis between 5 and 20%.

METHODS OF FORTIFYING PROCESS CHEESE AND PRODUCTS THEREOF

Methods are provided for making nutrient fortified foods, and particularly methods of fortifying process cheeses with magnesium and the resulting magnesium- fortified process cheese products. These methods allow significant amounts of nutrient supplements, such as minerals and/or vitamins, to be delivered per serving of food product without adversely affecting functionality or product quality. These magnesium--fortified process cheeses also may be produced with increased salty flavor without increased sodium content, or maintain salty flavor at reduced sodium content, without need for potassium saft substitutes. Foods fortified by the disclosed methods retain their desired functionality and sensory properties such as textures, mouthfeel, flavor, and the like.

AIDING OF COGNITIVE FUNCTION

The invention provides the use of a bioavailable iron compound and a bioavailable zinc compound in a weight ratio of at least 2:1, and at least one B vitamin, in the manufacture of an edible composition, for use in aiding the cognitive development or cognitive performance of humans having an age of up to 18 years.

TRADITIONAL SNACKS HAVING BALANCED NUTRITIONAL PROFILES

Appealing traditional nutritious snacks and mixes from which consumers can prepare appealing traditional nutritious snacks are disclosed. These snacks and mixes offer an alternative to appealing but unhealthy snacks. The nutritious snacks of the present invention are traditional in form, provide a balanced mix of an amino acid source, fat, and carbohydrates and typically have an appeal similar to that of unhealthy snacks of similar form. Thus, the snacks and snack mixes of the present invention resolve the dilemma that consumers are currently faced with - healthy eating or enjoying what you eat. Processes for making and methods of using appealing traditional nutritious snacks and mixes from which consumers can prepare appealing traditional nutritious snacks are also disclosed.

CARBOHYDRATE MODIFYING AGENT AND DRINKS CONTAINING THE MODIFYING AGENT

The present invention provides a composition that modulates the rate of sugar absorption and/or metabolism in a subject to whom the composition is administered. The composition includes active soluble fiber, one or more polyphenolic compounds, and a source of amino acids. The composition may be used dry in formulating foodstuffs and beverages. In a preferred embodiment, the composition is a component of a finished beverage, such as a carbonated soft drink.

COMPOSITION CONTAINING OMEGA-3 FATTY ACIDS AND OMEGA-6 FATTY ACIDS

DUAL VISCOSITY FIBER SYSTEM AND USES THEREOF

The present invention relates generally to a method of blunting the postprandial glycemic response to a meal by feeding a dual induced viscosity fiber system. The first component of the induced viscosity fiber system is soluble fiber. The second component of the induced viscosity fiber system is water-insoluble, acid-soluble multivalent cations. The third component of the induced viscosity fiber system in lightly hydrolyzed starch. The fiber system will typically be incorporated into a meal replacement nutritional. The present invention also refers to a method of delivering soluble fiber to diabetics and to persons needing to lose weight. Additionally, the invention refers to a method of promoting the feeling of fullness and satiety by feeding a nutritional product containing the induced viscosity fiber system.

COMPOSITIONS AND KITS COMPRISING A DEFINED BORON COMPOUND, METHODS OF THEIR PREPARATION, AND USE AND ADMINISTRATION THEREOF

The present disclosure is directed to compositions containing boron which are useful for a variety of purposes, including enhancing bone health, alleviating arthritis, pain, and inflammation, and producing other beneficial health effects. The disclosure is further directed to methods of preparing such compositions, methods of using (including administering) the compositions, and kits comprising the compositions. The compositions have a pH which is at least about 2 pH units less than the pKa of the boron compound.

CALCIUM SORBEFACIENTS AND PROCESS FOR PRODUCING THE SAME

Calcium sorbefacients which are produced by subjecting a vegetable protein at least to a treatment for removing phytic acid salts with an anion exchange resin and a deamidation treatment with a weakly acidic cation exchange resin. Thus, calcium sorbefacients which are widely applicable and excellent in processing properties can be obtained.

NUTRITIONALLY COMPLETE LOW PH ENTERAL FORMULA

This invention is directed to a low pH nutritional formula that contains high levels of macronutrients, vitamins and minerals. The pH of the enteral formula is from about 3.0-4.6 and delivers at least 25 % of the RDI for selected vitamins and minerals in a 237 ml. serving. The enteral formula uses a stabilizing system comprising a high methoxy pectin to stabilize the protein and a unique process to produce the formula.

PREPARATION FOR THE PREVENTION AND/OR TREATMENT OF VASCULAR DISORDERS

The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions: fraction a) long chain polyunsaturated fatty acids; fraction b) phospholipids, which fraction contains at least two different phospholipids selected from the group consisting of phosphatidylserine; phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine. fraction c) compounds which are a factor in methionine metabolism, which fraction contains at least one member selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium and zinc.

USE OF CARBOHYDRATE SOURCE TO LIMIT WEIGHT GAIN IN CATS

A process is provided for limiting weight gain in cats. The process includes feeding the cat a pet food composition that includes a source of protein, a source of fat, and a source of carbohydrates from a grain source that excludes rice. Use of the preferred low glycemic index grain sources that comprise a blend of corn and sorghum; a blend of corn, sorghum, and barley; or a blend of corn, soghum, and oats, has the effect of decreasing the postprandial blood glucose and insulin response of the cat as compared to when feeding a rice- based diet. The result is that the animal becomes satiated and voluntarily decreases its intake of food, causing less weight gain. This effect is even more marked when the composition is fed to male cats.

COMPOSITION COMPRISING MICRONUTRIENTS IN COMBINATION WITH PREBIOTICS, PROBIOTICS, AND/OR SYNBIOTICS

A composition useful for enhancing general immunity is disclosed. The composition includes one or more micronu- trients, one or more compounds selected from the group of a prebiotic, probiotic. and synbiotic, and lipid-based or carbohydrate-based excipient. Use of this composition to enhance general immunity of the composition is provided. A method of enhancing the general immunity of a mammal is provided, comprising the steps of removing a composition comprising micro-encapsulated micronutrient granules, a substance selected from the group of a prebiotic, probiotic or synbiotic, and a pharmaceutically acceptable excipient selected from the group of a lipid-based excipient and a carbohydrate-based excipient from packaging material; adding a therapeu- tically effective amount of said composition to a food, and administering the food to said mammal.

FOOD ADDITIVE FOR SUPPLYING MINERAL SUBSTANCES

The invention relates to a food additive as a concentrated additive for supplying the human metabolism with mineral substances. The mineral substances are components of a salt-hydrate melt in an ionised form, and the salt-hydrate melt is a salt-water system, whereby the water content corresponds to the co- ordination number of the most hydrated ion.

CALCIUM CARBONATE GRANULATION

Highly compactable granulations and methods for preparing highly compactable granulations are disclosed. More particularly, highly compactable calcium carbonate granulations are disclosed. The granulations comprise powdered materials such as calcium carbonate that have small median particle sizes. The disclosed granulations are useful in pharmaceutical and nutraceutical tableting and provide smaller tablet size upon compression than previously available.

POLYMER CONTROLLED INDUCED VISCOSITY FIBER SYSTEM AND USES THEREOF

The present invention relates generally to a method of blunting the postprandial glycemic response in a human by feeding an induced viscosity fiber system together with lightly hydrolyzed starch. The invention also relates to an induced viscosity fiber system and the liquid products that incorporate the induced viscosity fiber system. Further, the invention relates to a method of incorporating soluble fiber into a liquid product without the typical negative organoleptic or physical stability issues. The invention also relates to a method of inducing the feeling of fullness and satiety by feeding the induced viscosity fiber system.

NUTRITIONALLY COMPLETE LOW PH ENTERAL FORMULA

This invention is directed to a low pH nutritional formula that contains high levels of macronutrients, vitamins and minerals. The pH of the enteral formula is from about 3.0-4.6 and delivers at least 25 % of the RDI for selected vitamins and minerals in a 237 ml. serving. The enteral formula uses a stabilizing system comprising a high methoxy pectin to stabilize the protein and a unique process to produce the formula.

ANTI-PROLIFERATIVE COMPOSITION

Non-estrogen-dependent hyperproliferation of cells in animals or humans can be prevented or treated by means of a pharmaceutical or nutritional composition containing a combination of at least three components from: a) two or more inhibitors of the G1/S phase of the cell cycle; and b) two or more inhibitors of the G2/M phase of the cell cycle; and c) two or more inhibitors of protein tyrosine kinase activity. Especially, component a) comprises two or more compounds selected from flavanolignans, carotenoids and isoflavone; component b) comprises two or more compounds selected from flavanolignans, hydroxylated stilbenes, isoflavones and apigenin; and component c) comprises two or more compounds selected from flavanolignans and isoflavones.

VITAMIN COMPATIBLE MICRONUTRIENT SUPPLEMENT

In general, this invention relates to a micronutrient supplement that can be used in food or in animal feeds and to a method fo enhancing the growth of animals using the micronutrient. The micronutrient supplement includes a basic salt of an essential metal. The essential metal can be formulated as a pharmaceutically acceptable basic salt that includes a divalent or trivalent cation of an essential metal, a pharmaceutically acceptable anion and a hydroxyl moiety. Representative essential metals for use in this invention include: Magnesium, calcium, iron, manganese, zinc, copper, cobalt, iron and chromium. When provided as a metal salt, the essential metal is highly bioavailable to enhance the survivability, growth, health and/or reproductivity of animals. The micronutrient supplement can be administered to animals either as a single supplement or admixed with other nutrients or feeds.

НАПИТОК НА ОСНОВЕ МОЛОКА И СПОСОБ ЕГО ПОЛУЧЕНИЯ

Изобретение относится к напитку на основе молока, имеющему низкий энергетический уровень, способу его получения с помощью различных способов фильтрации и напитку, содержащему напиток на основе молока в качестве по существу единственной жидкости.

ПРЕДВАРИТЕЛЬНО УПЛОТНЕННЫЕ КАЛЬЦИЙСОДЕРЖАЩИЕ КОМПОЗИЦИИ

Предварительно уплотненный материал, содержащий одно или несколько кальцийсодержащих соединений и один или несколько сахарных спиртов, где кальцийсодержащее соединение имеет поликристаллическую пористую структуру. Предварительно уплотненный материал предпочтительно получать валковым уплотнением, и он подходит для использования в дальнейшей переработке предварительно уплотненного материала в композицию, такую как, например, таблетки.

ПОКРЫТЫЕ ПЛЕНОЧНЫМ ПОКРЫТИЕМ И/ИЛИ ГРАНУЛИРОВАННЫЕ КАЛЬЦИЙСОДЕРЖАЩИЕ СОЕДИНЕНИЯ И ИХ ПРИМЕНЕНИЕ В ФАРМАЦЕВТИЧЕСКИХ КОМПОЗИЦИЯХ

Раскрываются кальцийсодержащие соединения, которые были, по крайней мере, частично покрыты пленочным покрытием и/или гранулированы водорастворимым веществом и водорастворимым полимерным веществом, и использование таких покрытых соединений в фармацевтических композициях. Оказалось, что, по крайней мере, частично покрытые пленочным покрытием и/или гранулированные кальцийсодержащие соединения являются подходящими для получения таблеток, имеющих очень высокую загрузку элементарного кальция и удобный маленький размер. Согласно изобретению получают таблетки с загрузкой лекарственного средства примерно 90% или более, и эти таблетки имеют достаточные механические и органолептические свойства.

СОСТАВ ДЛЯ АКТИВИЗАЦИИ ИММУННОЙ СИСТЕМЫ

Изобретение относится к области медицины и касается дозированной формы для перорального применения, которая предназначена для активации иммунной системы, и которая состоит из: (І) экстракта женьшеня обычного (Рanах ginseng); (II) витамина С и витамина Е; (III) селена; (IV) необязательно одного или более минералов, выбранных из меди и цинка; (V) необязательно аргинина и (VI) фармацевтически приемлемого носителя. Изобретение также касается применения указанной формы, изделия, которое ее содержит, и способа активации иммунной системы.

СПОСОБЫ И КОМПОЗИЦИИ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ КОСТЕЙ

Настоящее изобретение относится к способам и композициям для лечения заболеваний костей, в частности потери костной массы, такой как остеопороз. В частности, настоящее изобретение относится к питательным композициям на основе молока, в которые предпочтительно добавлены пребиотики и отдельный источник витамина K2, и способам применения таких питательных композиций для лечения или профилактики заболевания костей, в частности потери костной массы, такой как остеопороз. Композиция по настоящему изобретению включает одну или более фракций и/или компонентов молока; предпочтительно один или более пребиотиков; предпочтительно одну или более солей кальция и/или магния и витамин K2 (менахинон), включающий от 7 до 13 (от МК-7 до МК-13) изопропеноидных остатков.

ОБОГАЩЕННЫЙ БУЛЬОННЫЙ КУБИК

Бульонный кубик, включающий по отношению к массе бульонного кубика 30-70 мас.% NaCl, 10-45 мас.% глутамата натрия, дополнительно включающий по меньшей мере одно соединение железа из группы железа(III) натрия ЭДТА, восстановленного железа, железа(II) лактата, железа(III) цитрата, железа(III) пирофосфата, железа(II) сульфата моногидрата, железа(III) аммония цитрата коричневого, в таком количестве, что бульонный кубик включает количество Fe2+ и/или Fe3+, взятых вместе от по меньшей мере 0,01 мас.% и до менее 2 мас.%, предпочтительно от по меньшей мере 0,025 мас.% и до менее 1,6 мас.%, более предпочтительно от по меньшей мере 0,05 мас.% и до менее 1 мас.% по отношению к массе бульонного кубика.

КОМПОЗИЦИЯ, КОТОРАЯ СОДЕРЖИТ ЛАКТАТ И КАЛИЙ, И ЕЕ ПРИМЕНЕНИЕ

Изобретение касается фармацевтической композиции, которая содержит от 250 до 2400 миллимоль на литр молочной кислоты или лактата и от 2 до 10 миллимоль на литр калиевого катиона и необязательно от 2 до 5 миллимоль на литр кальциевого катиона. Изобретение также касается применения такой композиции в фармацевтике.

СОЛЕНЫЙ ПИЩЕВОЙ КОНЦЕНТРАТ, СОДЕРЖАЩИЙ ИСТОЧНИК ИОНОВ ЖЕЛЕЗА

Сухой соленый пищевой концентрат, содержащий: а) от 30 до 70 мас.% NaCl; b) от 0,05 до 2 мас.% ионов железа, выбранных из группы, состоящей из Fe2+ и Fe3+ и их смесей, где ионы железа получены из добавляемого соединения железа, которое является растворимым в водном растворе, с) от 0,35 до 7,0 мас.% кислотного соединения, выбранного из группы, состоящей из лимонной кислоты, аскорбиновой кислоты, яблочной кислоты, винной кислоты, молочной кислоты и их смесей, где все массовые проценты определяются по отношению к общей массе сухого соленого пищевого концентрата, в котором соотношение кислотных ионов к ионам железа на молекулярном уровне составляет между 1:1 и 10:1 и при этом концентрат является концентратом, выбранным из группы, состоящей из концентрата бульона, концентрата супа, концентрата соуса и концентрата подливы.

СПОСОБ ПРИГОТОВЛЕНИЯ И ПРИМЕНЕНИЯ КОМПОЗИЦИИ АДСОРБЕНТА ФОСФАТА, АДСОРБЕНТ ФОСФАТА, КОМПОЗИЦИЯ АДСОРБЕНТА ФОСФАТА

Данное изобретение относится к способу приготовления новой композиции и к применению данной композиции как адсорбента фосфата, в частности для лечения людей или животных.

ПРОЦЕСС ПОЛУЧЕНИЯ СЫПУЧЕГО ПОРОШКА, КОТОРЫЙ СОДЕРЖИТ РАСТВОРИМОЕ СОЕДИНЕНИЕ ЧЕТВЕРТИЧНОГО АММОНИЯ

Описанный процесс получения сыпучих порошков, свободных от носителей, из водных растворов растворимых соединений четвертичного аммония в двухэтапном процессе, который включает этап сушения, и этап смешивания порошков. Замечательных характеристик сыпучести и стабильности конечного продукта удалось достичь лишь тогда, когда среди других возможных добавок на этапе сушения к жидкой фазе прибавили по крайней мере одну соль жирной кислоты одновалентного металла и на этапе порошкового смешивания прибавили по крайней мере одну соль жирной кислоты поливалентного металла. Неожиданный синергический эффект наблюдался между этими добавками, когда их применили так, как описано в данном изобретении.

КАПСУЛЫ, КОТОРЫЕ СОДЕРЖАТ ПЕЛЕТЫ С ДЕЙСТВУЮЩИМИ ВЕЩЕСТВАМИ, КОТОРЫЕ ОТЛИЧАЮТСЯ МЕЖДУ СОБОЙ ПРОФИЛЕМ ВЫСВОБОЖДЕНИЯ ИЗ НИХ ДЕЙСТВУЮЩИХ ВЕЩЕСТВ

Изобретение касается капсулы, которая содержит пелеты по крайней мере трех групп с тем же профилем высвобождения действующих веществ в каждой из них с действующими веществами, которые отличаются между собой профилем высвобождения из них действующих веществ в желудочно-кишечном тракте и которые содержат по крайней мере два разных действующих вещества, выбранных из группы витаминов, минеральных веществ, микроэлементов, ненасыщенных жирных кислот, аминокислот и/или растительных экстрактов и веществ, при этом высвобождение соответствующих действующих веществ происходит на всем участке всасывания в желудочно-кишечном тракте (группа І), в двенадцатиперстной кишке или в двенадцатиперстной кишке и в пустой кишке (группа II), соответственно в пустой кишке, в пустой кишке и подвздошной кишке или в подвздошной кишке (группа III).

ПРИМЕНЕНИЕ КОМПОЗИЦИИ, КОТОРАЯ СОДЕРЖИТ ЭКСТРАКТЫ РАСТЕНИЙ PANAX GINSENG И PAULLINIA CUPANA

Изобретение относится к применению композиции, содержащей экстракты растений Panax ginseng (женьшень) и Paullinia cupana (гуарана) для изготовления пищевой добавки для улучшения когнитивных способностей субъекта. Также заявленная композиция дополнительно включает провитамин А, витамин В1, витамин В2, витамин В6, витамин В12, витамин С, витамин D3, d,l-альфа-токоферолацетат, фолиевую кислоту, биотин и витамин РР и медь, кальций, железо, цинк, селен, фосфор и магний. Кроме того, заявленная композиция заключена в капсулу с мягкой оболочкой или таблетку.

КОМПОЗИЦИЯ, КОТОРАЯ СОДЕРЖИТ ОМЕГА-3-ЖИРНЫЕ КИСЛОТЫ И ОМЕГА-6-ЖИРНЫЕ КИСЛОТЫ, ДЛЯ ЛЕЧЕНИЯ СИНДРОМА СУХОГО ГЛАЗА

Данное изобретение касается композиции, которая содержит омега-3-жирные кислоты и омега-6-жирные кислоты и соединение цинка для лечения синдрома сухого глаза.

СПОСІБ ІНГІБУВАННЯ КОНТРАКЦІЇ КЛІТИН ГЛАДКОЇ МУСКУЛАТУРИ

Даний винахід забезпечує спосіб застосування нутрицевтичної композиції, що містить екстракт зеленого чаю, аскорбінову кислоту, лізин, пролін, аргінін, магній, N-ацетилцистеїн, селен, мідь та марганець, для інгібування скорочення клітин гладких м'язів, і, таким чином, зниження кров'яного тиску.

ТВЕРДЫЙ ИЛИ ПОЛУТВЕРДЫЙ СОСТАВ ДЛЯ СНИЖЕНИЯ РАЗРУШЕНИЯ ЗУБОВ

... 1. Твердый или полутвердый состав для орального применения, содержащий соединение кальция и подкислитель, отличающийся тем, что кальций присутствует в диапазоне от 0,3 до 0,65 молей на моль кислоты, а соотношение кальция и подкислителя в составе выбрано таким, чтобы эффективное значение рН состава было от 3,5 до 4,5. 2. Состав по п.1, в котором кальций присутствует в диапазоне 0,3-0,55 моля на моль кислоты. 3. Состав по любому из пп.1-2, в котором кальций присутствует, по меньшей мере, в количестве 0,4 моля на моль кислоты. 4. Состав по любому из пп.1-3, в котором эффективное значение рН состава не превышает 4. 5. Состав по любому из пп.1-4, в котором эффективное значение рН состава находится в диапазоне от 3,7 до 3,9. 6. Состав по любому из пп.1-5, в котором кислота представляет собой лимонную кислоту, яблочную кислоту, молочную кислоту или их смеси. 7. Состав по любому из пп.1-6, в котором соединение кальция представляет собой карбонат кальция, гидроксид кальция, цитрат кальция, малат ...

ХАРЧОВА КОМПОЗИЦІЯ, ЩО МІСТИТЬ ПОЛІФЕНОЛИ, ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ЛІКУВАННІ РАКУ ТА ЗАПАЛЬНИХ ЗАХВОРЮВАНЬ

Винахід стосується харчової композиції, що містить аскорбінову кислоту, L-лізин, L-пролін і принаймні одну поліфенольну сполуку, що вибирають з групи, яка складається з галату епігалокатехіну, галату епікатехіну, епігалокатехіну, епікатехіну, катехіну, і використовується при лікуванні раку і запальних захворюваннь.

СПОСОБ ПОЛУЧЕНИЯ КАЛЬЦИЙСОДЕРЖАЩЕЙ БИОЛОГИЧЕСКИ АКТИВНОЙ ДОБАВКИ

Способ приготовления кальцийсодержащей биологически активной добавки включает смешивание карбоната кальция (CaCO3) с водой и лимонной кислотой. Воду предварительно обрабатывают постоянным магнитным полем, а при смешивании дополнительно добавляют углекислый магний и воздействуют на смесь инфракрасным излучением с длиной волны от 2 до 40 мкм. После приготовления смесь выдерживают при температуре 10-25°С не менее 20 ч.

КОМПОЗИЦИЯ ДЛЯ РЕГУЛИРОВАНИЯ МЕТАБОЛИЗМА ЛИПИДОВ

Настоящее изобретение относится к композиции для регулирования метаболизма липидов и способам, которые можно применять в пищевой промышленности, а также в нутрицевтической и терапевтической областях. В частности, настоящее изобретение относится к пищевым и питательным добавкам или добавкам, композиции, содержащей их, и их применению, в частности, для восстановления метаболизма субъекта, в частности метаболизма людей.

ПРИМЕНЕНИЕ КАЛЬЦИЙ-ПЕПТИДНОЙ КОМПОЗИЦИИ ДЛЯ ПРОФИЛАКТИКИ И/ИЛИ ЛЕЧЕНИЯ САХАРНОГО ДИАБЕТА II ТИПА

Изобретение относится к применению кальций-пептидной композиции, включающей по меньшей мере одну соль кальция, по меньшей мере один казеинфосфопептид (СРР) и по меньшей мере один гликомакропептид (ГМП), для изготовления средства для профилактики и/или лечения сахарного диабета II типа. При приеме указанной композиции удается существенно снизить вероятность возникновения сахарного диабета II типа (антидиабетогенное действие).

ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ЛАКТАТ, И ЕЕ ПРИМЕНЕНИЕ

Изобретение относится к фармацевтической композиции, содержащей 250-2400 ммоль/л L-молочной кислоты или L-лактата, 2-10 ммоль/л иона калия и, факультативно, 2-5 ммоль/л катиона кальция, и ее применению для лечения пациента во время хирургического вмешательства, для послеоперационного лечения пациента или для лечения острого гемодинамического дистресса.

ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ЛАКТАТ, И ЕЕ ПРИМЕНЕНИЕ

Изобретение относится к применению фармацевтической композиции, содержащей 250-2400 ммоль/л L-лактата или L-молочной кислоты, 2-10 ммоль/л катиона калия и, факультативно, 2-5 ммоль/л катиона кальция, в качестве ингредиента для производства фармацевтической композиции для лечения отека мозга, где отек мозга вызван травматическим или нетравматическим повреждением мозга, для лечения травматического повреждения мозга, где травматическое повреждение мозга является закрытой или открытой черепно-мозговой травмой, для лечения нетравматического повреждения мозга, где нетравматическое повреждение мозга является инсультом или повреждением, вызванным холодом.

СПОСОБЫ И КОМПОЗИЦИИ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ КОСТЕЙ

Настоящее изобретение относится к способам и композициям для лечения заболеваний костей, в частности потери костной массы, такой как остеопороз. В частности настоящее изобретение относится к питательным композициям на основе молока, в которые предпочтительно добавлены пребиотики и отдельный источник витамина K2, и способам применения таких питательных композиций для лечения или профилактики заболевания костей, в частности потери костной массы, такой как остеопороз. Композиция по настоящему изобретению включает одну или более фракцию и/или компонент молока; предпочтительно один или более пребиотик; предпочтительно одну или более соль кальция и/или магния и витамин K2 (менахинон), включающий от 7 до 13 (от MK-7 до MK-13) изопропеноидных остатков.

Nutritional products having improved organoleptic properties

Disclosed are nutritional products comprising pea protein hydrolysates as a primary or sole source of protein. The nutritional products include nutritional liquids, powders, bars, and other food products, wherein the resulting nutritional products are physically stable over shelf life and provide favorable organoleptic properties. These nutritional products may be used as a nutritional source for individuals who are intolerant and/or allergic to cow milk proteins and soy proteins and/or who have malabsorption, maldigestion, or other gastroinstestinal conditions.

Nutritional compositions

The invention relates to compositions comprising novel blends of nutritional ingredients and solid, semi-solid and beverage compositions comprising such blends. In particular, this invention relates to rehydration, energy and recovery beverages (e.g. sports drinks), compositions for support of weight management, as well as digestive, bone, cognitive and heart health.

Non-photosynthetic micro-organisms enriched with organic selenium from seleno-hydroxyacid compounds, and applications thereof in the fields of nutrition, cosmetics, and pharmaceuticals

The present invention relates to the enrichment of non-photosynthetic micro-organisms with organic selenium, and more particularly with selenomethionine, from a compound of the seleno-hydroxyacid type such as 2-hydroxy-4-methylseleno-butanoic acid in the (D, L) form or in the form of an enantioner, salt, ester, or amide derivative of said compound, and to the use of micro-organisms, particularly bacteria thus enriched in the fields of animal or human nutrition, cosmetics, or pharmaceuticals.

Calcium absorption enhancer

包含乙酸钙的厌食组合物

... 本发明提供了一种厌食组合物，包含适合口服并且在胃和小肠吸收形式的乙酸钙。该厌食组合物包括一种隐藏乙酸钙味道的风味剂，因此使该组合物适合口服并且在胃和小肠吸收。该厌食组合物还包括甜味剂和果胶。本发明还涉及一种治疗肥胖的方法，包括将所述厌食组合物给予需要它的人的步骤。优选该厌食组合物以饮料或食物的形式给予。该方法包括将足量的厌食组合物给予需要它的所述人每天至少两次的步骤，这样将3g-7g，优选5g有效量的乙酸钙给予所述人。 ...

Matrix-forming composition containing pectin

A liquid edible composition with a pH of more than 6, a viscosity below 600 mPas at a shear rate of 100s-1 and 20 DEG C., and a viscosity of at least 125% of the aforementioned viscosity at a pH below5 and a temperature of 37 DEG C., the composition comprising at least 0.05 wt. % of pectin having a degree of methoxylation between 2 and 50 and/or of alginate; at least 5 mg calcium per 100 ml; andatleast 0.1 wt. % indigestible oligosaccharide having a degree of polymerisation between 2 and 60. Another aspect of the invention relates to a method for the treatment or prevention of overweight orob esity in mammals, the method comprising the enteral administration to a mammal of an effective amount of the aforementioned composition.

Immune function-improving agent

Constitutional function-improving agents such as an immune function-improving agent, an antioxidative function-improving agent, a motility function-improving agent and a liver function-improving agenteach containing a d-amino acid, its derivative or its salt as the active ingredient.

碳水化合物改良剂和含该改良剂的饮料

... 本发明提供了一种组合物，它调节被施用该组合物的受试验者中的糖吸收和/或代谢的速率。所述组合物包含：活性可溶性纤维，一种或多种多酚化合物，以及一种氨基酸来源。所述组合物可呈干形式用于食料和饮料的配制中。在一个优选的实施方案中，所述组合物是成品饮料(例如，充气软饮料)的一种组分。 ...

Nutritional supplement which can be taken orally, intended for promoting the elimination of fats and the restoration of balanced nutritional behaviour

Complément nutritionnel absorbable, pour favoriser l'élimination des graisses et le rééquilibrage du comportement alimentaire, caractérisé en ce qu'il contient en association de la tyrosine, de la vitamine C, de la vitamine E, du magnésium et un excipient.

Nutritional supplement which can be taken orally to improve and optimise individuals' levels of physical and mental activity

Complément nutritionnel absorbable pour améliorer les niveaux d'activité physique et cérébrale, caractérisé en ce qu'il contient du magnésium, une association de vitamines C et B1 et un excipient.

BASED FOOD SUPPLEMENT OF B VITAMINS, [...]-CELL AND FATTY ACIDS W-3 AND/OR W-6 AND USE OF THE DIETARY SUPPLEMENT IN SIMULTANEOUS TREATMENT OF CELLULITE AND LOCALIZED SLACKENING OF THE SKIN

Melange nutritif destine a la personne agee

Melange nutritif complet, polymerique, sous forme d'emulsion fine, destine a la nutrition par voie orale ou enterale des personnes agees, melange caracterise en ce qu'il contient du calcium (>0,066 g/100 ml) associe a du fluor (1,5 a 2,26 mg/100 ml) et de la vitamine D (100 a 146,7 UI/100 ml), de l'acide folique (0,13 a 0,4 mg/100 ml), et du zinc (2,66 a 4,0 mg/100 ml).

NEW COMPOSITIONS HAS SYNERGISTIC EFFECT BETWEEN MICRONUTRIMENTS ETSUBSTANCES Of ALIVE ORIGIN

PRODUIT DESTINE A COMPLETER L'ALIMENTATION EN MICRO ET MACRO ELEMENT

L'invention concerne un produit destiné à compléter l'alimentation en micro et macro élément. Elle met en oeuvre les propriétés des lactoprotéines et peptides d'origine laitière pour transporter et fixer dans les cellules les oligo-éléments apportés dans la composition du produit.

FOOD COMPLEMENT INCLUDING/UNDERSTANDING an ASSOCIATION Of ANTIOXYDANT AGENTS AND CARNITINE, OBTAINED BY ENDOGENOUS OR EXOGENIC SYNTHESIS, LIKE HELPS WITH the FERTILITY AT the MAN AND the WOMAN

Food composition, useful to prevent/limit loss of muscle mass, loss of bone mineral density and cognitive decline, comprises pea/milk protein, potassium, calcium, selenium, vitamins D3, E, C, B2, B6, B9, and B12, choline and polyphenol

Composition alimentaire pour prévenir et limiter la perte de masse musculaire, la perte de densité minérale osseuse et le déclin cognitif, en particulier chez les personnes âgées de 50 ans et plus, caractérisée en ce que ladite composition comporte les constituants essentiels suivants exprimés en pourcentages en poids par rapport au poids sec de ladite composition : Protéines de pois ou de lait (lactosérum) 45 à 67 % Potassium 1,45 à 1,95 % Calcium 0,64 à 1 % Sélénium 0,000061 à 0,00013 % Vitamine D3 0,000011 à 0,000021 % Vitamine E 0,027 à 0,066 % Vitamine C 0,048 à 0,1 % Vitamine B2 0,0046 à 0,0066 % Vitamine B6 0,0048 à 0,011 % Vitamine B9 0,00037 % à 0,00086 % Vitamine B12 0,00008 % à 0,000013 % Choline 0,274 à 0,73 % Polyphénols 0,091 à 0,16 % ...

Food supplement or dietary product, useful e.g. as an antioxidant agent, antiasthenic agent, muscle tone, and anti-inflammatory agent, comprises an oil rich in omega-3 polyunsaturated fatty acids and a metal compound

Formulation à base d'huile(s) et de composés métalliques en prévention/complément de traitement anticancéreux, asthénie, état de convalescence et favorisant la tonicité musculaire. L'invention concerne une formulation lipidique liquide ou semi-solide et un composé métallique assimilable par l'organisme, et des agents auxiliaires classiques ou des additifs, favorable à la santé humaine ou animale. La formulation sous forme liquide ou semi-solide est contenue dans une gélule (3) dure ou molle, ou dans une ampoule en verre, ou en flacon buvable. La prise se fait par voie orale utilisée en complément alimentaire ou produit diététique. Par conséquent, la prise journalière de cette formulation pourrait être considérée comme la solution apportée en tant que complément et aux conséquences ou effets de ce type de traitements et états de santé du patient. La formulation apporte à l'organisme des oméga 3 (2) riches en EPA et DHA, et du cuivre (1), agissant sur l'ADN (4), favorisant la récupération ...

Compositions for the treatment of iron deficiency containing an iron salt, lactoferrin, and a fructo-oligosaccharide

L'objet de l'invention est une composition alimentaire ou médicamenteuse comprenant du fer ayant des caractéristiques améliorées d'assimilation par l'organisme humain en vue d'une lutte contre les carences en fer, caractérisée en ce qu'elle comprend en combinaison, au moins : - un produit transporteur du fer et ayant au moins un effet bifidogène, et - un sel de fer. L'invention couvre aussi des préparations adaptées.

NEW PHARMACEUTICAL AND/OR DIETETIC COMPOSITIONS AGAINST THE STRESS

La présente invention se rapporte au domaine de la chimie et plus particulièrement au domaine de la chimie thérapeutique. Elle a pour objet de nouvelles compositions pharmaceutiques et/ou diététiques caractérisées en ce qu'elles renferment un ou plusieurs sels de magnésium avec un acide organique, liposolubles, des aminoacides choisis parmi la Taurine et l'Arginine et une ou des vitamines du groupe B, associées ou en mélange avec un excipient ou un véhicule inerte, non-toxique, pharmaceutiquement-acceptable. Utilisation pour la réalisation de formulations destinées à l'alimentation, à la diététique, à la thérapeutique ainsi qu'aux compléments alimentaires afin de compenser les effets du stress.

Nutritional supplement for protection against premenstrual symptoms, menopausal problems, osteoporosis, and cancers comprises evening primrose and borage oils

La présente invention se rapporte au domaine de la diététique et plus particulièrement au domaine de la supplémentation alimentaire. Elle concerne une formulation renfermant une source végétale d'huiles apportant l'acide gamma linolénique, du lycopène de tomate. Elle peut être utilisée aussi bien par la femme pré ménopausée que par celle en période de ménopause afin d'éviter les troubles pré menstruels et d'apporter un confort et une prévention. Le complexe vitaminique C, B3 et B6 permet à l'organisme carencé de synthétiser facilement les prostaglandines à partir de l'acide gamma linolénique apporté par ce supplément. Enfin le lycopène de tomate est un actif protecteur contre les syndromes malins. L'addition de vitamine D, permet d'apporter une synergie et une action contre la prolifération des cellules malignes. Cette action est renforcée par la présence de curcuma. Emploi en supplémentation alimentaire sous diverses formes galéniques.

Food supplement containing rapeseed extract, green tea extract and zinc, used to treat or prevent androgenic alopecia, hyperseborrhea and acne

Complément alimentaire comportant un extrait de graines de colza, un extrait de thé vert, du zinc et/ou de la vitamine B6 et éventuellement un extrait de brocoli et l'utilisation du complément alimentaire pour la prévention ou la lutte contre les effets de l'alopécie androgénique, de l'hyperséborrhée et de l'acné.

COMPOSITION CONTAINING OF POLYPHENOLS OF GRENADE, THE VITAMIN D AND THE OLIGOELEMENTS.

METHOD FOR REALIZATION OF FOOD PRODUCTS CONTAINING FLOWERS OF PLANTS OF KIND HIBISCUS

APPLICATION Of an EXTRACT TITRATES IN ROSAVIN ASSOCIATES HAS a BIOLOGICAL PRINCIPLE OF the HYDRO TYPEVITAMINE AND SOLUBLE LIPO, TRACE ELEMENTS AND PARAVITAMINES

Use of water naturally rich in at least one mineral, from a plant, animal or microorganism raw material, to obtain an aqueous extract rich in at least one mineral, as food, food active agent, food supplements or cosmetics

L'objet de l'invention est un procédé de préparation d'un extrait aqueux à partir d'une matière première végétale, animale ou de microorganismes, comprenant au moins une étape d'extraction réalisée en présence d'au moins une eau naturellement riche en au moins un minéral. L'invention vise également les extraits aqueux obtenus, ainsi que leurs utilisations.

NUTRITIONAL COMPOSITION FOR PREGNANT WOMAN

La présente invention concerne une composition nutritionnelle pour femme enceinte permettant à la fois de répondre aux besoins nutritifs liés à l'état de grossesse et de soulager le phénomène de nausée. A cet effet, l'invention concerne une composition nutritive comprenant une fraction protéique, une fraction glucidique, une fraction lipidique comprenant au moins un acide gras du groupe des omégas 3, au moins un élément minéral dont le fer, au moins une vitamine dont la vitamine B6, ainsi que la combinaison d'une poudre de gingembre et d'un extrait d'artichaut.

Orally-absorbable nutritional supplement for daily admin. to females

Complément nutritionnel absorbable per-os à base de sels minéraux et de vitamines, pour assurer l'apport quotidien en micronutriments, caractérisé en ce qu'il comprend : - du glycérophosphate de magnésium ; - du carbonate de calcium ; - du citrate de zinc ; - du bétacarotène ; - un mélange de vitamines B1, B2, B5, B6, B8, B9, B12 et PP ; - de la vitamine C ; - de la vitamine E ; - et un excipient.

Food supplement which can relieve both menstrual and prostate disorders contains e.g. evening primrose and marrow seed oils and tomato lycopene

La présente invention se rapporte au domaine de la diététique et plus particulièrement au domaine de la supplémentation alimentaire. Elle concerne une formulation renfermant une source végétale d'huiles apportant l'acide gamma linolénique, du lycopène de tomate, de l'huile de graine de courge. Elle peut être utilisée aussi bien par la femme que par l'homme afin d'éviter aux uns les troubles menstruels et d'apporter un confort urinaire dû aux troubles de la prostate aux autres. Enfin le lycopène de tomate est un actif protecteur contre les syndromes malins. Il est bénéfique pour les deux sexes. Emploi en supplémentation alimentaire.

NОUVЕLLЕS СОМРОSIТIОNS А ЕFFЕТ SYNЕRGIQUЕ ЕNТRЕ МIСRОNUТRIМЕNТS ЕТ SUВSТАNСЕS D'ОRIGINЕ VIVАNТЕ

Composition comprising the extract of Loranthus yadoriki SIEB. having monoamine oxidase-inhibiting activity

CARBOHYDATE AND ELECTROLYTE REPLACEMENT COMPOSITION

The present invention discloses novel compositions and methods. These compositions and methods may be used to attenuate or reverse the effects of dehydration or other adverse effects of exercise, heat or other activity which causes bodily fluid loss. The novel compositions comprise carbohydrates, electrolytes and water along with flavoring agents. © KIPO & WIPO 2007 ...

COMPOSITION CONTAINING EGG WHTIE-CHALCANTHITE AND BAMBOO SALT FOR PREVENTING AND TREATING CANCER

PURPOSE: A composition containing egg white-chalcanthite for preventing and treating cancer is provided to remove toxicity and to ensure high anti-cancer activity. CONSTITUTION: A composition for preventing and treating cancer contains egg white-chalcanthite as an active ingredient. The composition additionally contains bamboo salt. The composition contains egg white-chalcanthite and bamboo salt in a weight ratio of 1:5-1:30. The egg white-chalcanthite is obtained by heating, dehydrating, and pulverizing chalcanthite and mixing with egg white. The composition additionally contains pharmaceutically acceptable carrier. A health food for preventing and treating cancer contains egg white-chalcanthite as an active ingredient. COPYRIGHT KIPO 2010 ...

CALCIUM PHOSPHATE DISPERSION COMPOSITION

COMPOSITIONS COMPRISING PROBIOTIC AND PREBIOTIC COMPONENTS AND MINERAL SALTS, WITH LACTOFERRIN

ELECTROLYTE PURGATIVES

PHOSPHATE BINDING MATERIALS AND THEIR USES

CEREAL-BASED FORTIFIIED FOOD PRODUCTS AND PROCESS FOR THEIR PREPARATION

A process for manufacturing a cereal-based fortified food product comprises the steps of (A) comminuting cereal raw material to obtain a comminuted cereal-based material; (B) hydrothermally-mechanically treating the comminuted cereal-based material until a cereal-based matrix material is obtained by at least partial gelatinization of the comminuted cereal-based material; (C) forming the at least partially gelatinized cereal-based matrix material by pressing and portioning in order to obtain cereal-based food articles; (D) drying the cereal-based food articles to obtain the final product in the form of reconstituted cereal-based food articles. At least one micronutrient is added to the comminuted cereal-based material during steps A) and/or B). Also, at least one further feature is added to the final product during any one of steps A) through D); said at least one further feature corresponding to the at least one micronutrient in the final product; and said at least one further feature being ...

COMPOSITIONS FOR MASKING THE FLAVOR OF NUTRIENTS AND METHODS FOR MAKING SAME

Nutritional compositions and methods of making and using the nutritional compositions are provided. In a general embodiment, the present disclosure provides nutritional compositions having whey protein micelles and leucine. The nutritional compositions provide a sufficient amount of leucine to improve protein synthesis in humans, while also maintaining a low-viscosity fluid matrix and acceptable organoleptic properties. 1. A nutritional composition comprising: whey protein powder comprising whey protein micelles and leucine , wherein the total amount of leucine in the composition is between about 20% and about 40% by weight dry matter.2. The composition according to claim 1 , wherein the whey protein powder comprises at least about 20% to at least about 80% whey protein micelles.3. The composition according to claim 1 , wherein the whey protein powder comprises at least about 50% whey protein micelles.4. The composition according to claim 1 , wherein the whey protein powder has a water binding capacity of at least about 50% to about 100%.5. The composition according to claim 1 , wherein the whey protein micelles and leucine are present in a weight ratio of about 30:1 to about 1:100.6. The composition according to claim 1 , wherein the dry weight ratio of added leucine to whey protein micelles is from about 1:2 to about 1:3.7. The composition according to claim 1 , wherein the whey protein powder is obtained by a process selected from the group consisting of spray-drying and freeze-drying claim 1 , that is performed with the whey protein micelles and leucine.8. The composition according to comprising at least one ingredient selected from the group consisting of antioxidants claim 1 , vitamins claim 1 , minerals claim 1 , phytonutrients claim 1 , prebiotics claim 1 , and probiotics.9. The composition according to claim 1 , wherein the composition is a liquid and the total amount of leucine in the composition is less than about 2.5 g per 100 g of the liquid claim 1 , ...

STABILIZED BIO-AVAILABLE SOLUBLE SILICATE SOLUTION

The present invention relates to dissolved silicate compositions in which the dissolved silicate is stabilized by at least two selected osmolytes and is therefore bioavailable. The composition and its dilutions are stable over a long period of time and are used in a wide field of applications for the benefit of living organisms such as plants, animals and humans. 1. A stable aqueous silicate composition comprising alkali metal silicate , characterised in that said composition comprisesat least a first osmolyte compound selected from urea and sugar alcohol and combinations thereof,at least a second osmolyte compound selected from an N-methylated compound,and further a third osmolyte compound selected from the group consisting of taurine, creatine, choline-o-sulphate, glycerophosphorylcholine, diglycerol-phosphate, sulfonio-analogs of trimethylglycine, dimethylsulfoniopropionate, ectoine, hydroxyl-ectoine, proline, valine, aspartic acid, isoleucine, glycine, alanine, glutamate, sucrose, myo-inositol, fructose, maltose, trehalose, putrescine, spermidine, spermine, cadaverine, and combinations thereof and salts thereof.2. The composition according to claim 1 , wherein said first osmolyte compound is selected from the group consisting of glycerol claim 1 , pinitol claim 1 , galactitol claim 1 , talitol claim 1 , erythritol claim 1 , threitol claim 1 , arabitol claim 1 , xylitol claim 1 , ribitol claim 1 , mannitol claim 1 , sorbitol claim 1 , dulcitol claim 1 , iditol claim 1 , maltitol claim 1 , lactitol claim 1 , polyglycitol claim 1 , and combinations thereof.3. The composition according to claim 1 , wherein said N-methylated compound is selected from the group consisting of trimethylglycine claim 1 , carnitine claim 1 , N-methyl alanine claim 1 , trimethylamino-butyric acid claim 1 , proline-betaine claim 1 , sarcosine claim 1 , N-methyl-glycine claim 1 , N claim 1 ,N-dimethylglycine claim 1 , N-methyl aspartic acid claim 1 , alanine-betaine claim 1 , histidine- ...

Calcium Carbonate Granulation

Highly compactable granulations and methods for preparing highly compactable granulations are disclosed. More particularly, highly compactable calcium carbonate granulations are disclosed. The granulations comprise powdered materials such as calcium carbonate that have small median particle sizes. The disclosed granulations are useful in pharmaceutical and nutraceutical tableting and provide smaller tablet sizes upon compression than previously available.

PRODUCTION OF LOW SODIUM SALT WITH BALANCED MINERAL CONTENT

A process is provided for preparing a salt product with reduced sodium content including the step of providing a concentrated brine, which is typically seawater, to which has been added potassium chloride. The mixture is transferred to a crystalliser unit where at least a portion of the mix is transferred to the crystalliser through a washing column. Liquid is evaporated from the crystalliser such that crystals form, crystals are passed from the crystalliser through said washing column to a separating unit such that in the passing through the washing column the crystals are rinsed with the brine portion being transferred as a counter current through the column. The inventive process is characterised by recycling of the brine from which the salt crystallises, thus all main ingredients of the mixed input brine reach a steady equilibrium concentration in the mother liquor in the crystalliser. These will then precipitate as crystals, as more of the respective substances gets added to the mother liquor through inflow of mixed input brine. None of the liquor is purged out of the system as in conventional salt crystallisers. All the components in the feed are substantially contained in the product from the crystalliser either as crystalline material or soluble ingredients. 1. A process for preparing a salt product derived from sea water , comprising trace minerals from sea water , comprising the steps of(a) providing a concentrated brine from sea water,(b) transferring the concentrated brine to a crystalliser unit,(c) building up and maintaining a mother liquor substantially saturated in main salt constituents, including sodium chloride, magnesium chloride, magnesium sulphate, potassium chloride and potassium sulphate,(d) evaporating liquid from said crystalliser such that crystals of different salts form into particles with substantially homogeneous composition including double salts,(e) transferring crystals from said crystalliser through a wash unit such that said ...

REDUCED SODIUM SALT

There is provided a process for preparing a reduced sodium salt composition, the process comprising the steps of mixing sodium chloride with one or more sodium chloride substitute complexes, heating the so-formed mixture to form a melt, and cooling the melt to form a solid. The so-formed solid is a fused granular matrix of sodium chloride and one or more sodium chloride substitute complexes. An alternative process is provided in which the sodium chloride and the sodium chloride substitute complex are heated to the liquid phase before they are combined. A reduced sodium salt composition is also provided, in particular a reduced sodium chloride salt obtained from these processes. 1. A process for preparing a reduced sodium salt composition , the process comprising the steps of: mixing sodium chloride with one or more sodium chloride substitute complexes; heating the so-formed mixture from the solid phase to the liquid phase to form a mixed melt; cooling the mixed melt from the liquid phase to the solid phase to form a solid.2. The process of wherein the process of solidification comprises a casting step.3. The process of comprising the further step of dispensing the mixed melt into a cast.4. The process of comprising the further step of crushing the so-formed solid to form a desired particle size.5. The process of comprising the further step of sieving the particles to isolate a particular range of particle sizes.6. The process of wherein the particle size is from about 1 mm to about 5 mm.7. The process of wherein the mixed melt is substantially homogeneous.8. The process of wherein the so-formed solid is substantially homogeneous.9. The process of wherein the so-formed solid is a fused granular matrix of sodium chloride and one or more sodium chloride substitute complexes.10. The process of wherein the sodium chloride substitute complex is a potassium complex.11. The process of wherein the sodium chloride substitute complex is a mixture of a potassium complex and a ...

HYDROGEN IODIDE-CONTAINING HEALTH FOOD AND HYDROGEN IODIDE-CONTAINING DRUG, AND METHOD FOR PRODUCING SAME

To propose a health food or a drug, which comprises an iodine compound as a substitute for organic iodine and can exert a similar effect as organic iodine. To propose a method for producing a liquid to be used as a starting material for the aforesaid health food or drug. A health food and a drug each containing hydrogen iodide as the active ingredient. A method for producing a hydrogen iodide-containing solution, which comprises: an alkaline ion water preparation step for preparing alkaline ion water containing hydrogen peroxide; a sodium hydroxide production step for adding sodium to the alkaline ion water and thus producing sodium hydroxide; and a hydrogen iodide production step for, after the sodium hydroxide production step, adding iodine to the alkaline ion water and thus producing hydrogen iodide. 1. A health food , comprising:hydrogen iodide as an active ingredient.2. A liquid health food , comprising:hydrogen iodide as an active ingredient.3. The liquid health food according to claim 2 ,wherein acid level of the health food indicates alkaline property.4. A pharmaceutical product claim 2 , comprising:hydrogen iodide as an active ingredient.5. A liquid pharmaceutical product claim 2 , comprising:hydrogen iodide as an active ingredient.6. The liquid pharmaceutical product according to claim 5 ,wherein acid level of the pharmaceutical product indicates alkaline property.7. A method for producing hydrogen iodide-containing solution claim 5 , comprising:preparing alkali ion water containing hydrogen peroxide;producing sodium hydroxide by adding sodium to the alkali ion water; andproducing hydrogen iodide by adding iodine to the alkali ion water after producing the sodium hydroxide. The present invention relates to health foods for promotion of health and pharmaceutical products for prevention and treatment of diseases.Conventionally, iodine has been used as an ingredient for antiseptic or hemostatic. However, iodine is a highly responsive substance, and when ...

Nanoparticles of Nutritional and Pharmaceutical Compounds

The invention relates to a composition in particle form having the structure: 2. A composition of claim 1 , wherein M is one or more of calcium claim 1 , magnesium claim 1 , zinc claim 1 , copper claim 1 , iron claim 1 , manganese.3. A composition of claim 1 , wherein M and M′ are the same nutritionally relevant divalent metal selected from the group consisting of copper claim 1 , zinc claim 1 , manganese claim 1 , iron claim 1 , magnesium claim 1 , and calcium.4. A composition of claim 1 , wherein M and M′ are different nutritionally relevant divalent metals claim 1 , each being selected from the group consisting of copper claim 1 , zinc claim 1 , manganese claim 1 , iron claim 1 , magnesium claim 1 , and calcium.5. The composition of claim 1 , wherein the particles are made according to a process that includes application of microwave hydrothermal energy.6. The composition of claim 5 , wherein the application of microwave hydrothermal energy occurs during synthesis of the compound.7. The composition of claim 6 , wherein the product resulting from the synthesis is subjected to ultrasonification to reduce the particle size.8. The composition of claim 1 , wherein the particles are made according to a process that includes ultrasonification.9. The composition of claim 1 , further comprising one or more pharmaceutically acceptable excipients.10. A method of improving the nutritional status of a warm-blooded animal claim 1 , the method comprising administering the composition of .11. The method according to claim 9 , wherein M and M′ are the same or different nutritionally relevant divalent metal selected from the group consisting of copper claim 9 , zinc claim 9 , manganese claim 9 , iron claim 9 , magnesium claim 9 , and calcium.12. The method of claim 9 , further comprising the preliminary step of formulating the composition into a tablet or capsule for oral delivery.13. The method of claim 13 , further comprising the preliminary step of formulating the composition ...

Process for the preparation of calcium salt suspensions

The current invention is related to a novel process for the production of aqueous suspensions of micro and nanoparticles of calcium salts smaller than 10 μm particle size, along with a method to enrich nutritional, nutraceutical, and pharmaceutical beverages with calcium salts. In the process, an aqueous suspension of calcium salt is subjected to pressurization with critical, subcritical, or supercritical carbon dioxide to increase the solubility of the calcium salt, which has a particle size greater than 30 μm. The resulting solution is expanded through a nozzle to generate a calcium salt suspension of micro and nanoparticles that is imperceptible to sight and taste.

MINERAL-PEPTIDE CHELATES

The present invention provides a mineral-peptide chelate comprising a peptide consisting of 2˜18 amino acids and a mineral chelated to the peptide, wherein the peptide can be a hydrolysate obtained by hydrolyzing soybean or other protein materials with proteases, or a product obtained by hydrolyzing soybean or other protein material with proteases and fermentation. The mineral-peptide chelate of the present invention may further comprise a carrier which covers the peptide and the mineral which is chelated to the peptide. 114-. (canceled)15Bacillus subtilisLactobacillus acidophilus,. A process for the preparation of a mineral-peptide chelate comprising a peptide consisting of 2˜18 amino acids and a mineral chelated to the peptide , and optionally a carrier , said process comprising hydrolyzing soybean or other protein materials with a protease which is obtained from YJ-1 , and fermenting the hydrolyzed protein material by using adding a mineral and optionally a carrier , and spray drying the resulting semi-product to obtain the final product.15. The process of claim 15 , wherein the other protein materials are rice or fish.16. The process of claim 15 , wherein the mineral is calcium claim 15 , zinc claim 15 , magnesium or iron.17. The process of claim 15 , which comprises a carrier which covers the peptide and the mineral chelated to the peptide.18. The process of claim 15 , wherein the carrier is a pharmaceutically acceptable carrier.19. The process of claim 15 , wherein the carrier is dextrin claim 15 , lactose claim 15 , arabinose claim 15 , polyethylene glycol claim 15 , sorbitol claim 15 , hydroxypropyl methylcellulose or microcrystalline cellulose. This application is a divisional application of pending U.S. patent application Ser. No. 12/659,241, filed Mar. 2, 2010, based on the priority document of TW 098129398 filed Sep. 1, 2009 (of which the entire disclosure of the pending, prior application is hereby incorporated by reference).The present invention ...

MINERAL COMPOSITION, AND PREPARATION METHOD THEREOF

Disclosed is a method for preparing a mineral composition by gathering deep sea water, dead sea water, underground salt water, sea water, aboveground salt water, mineral water, drinking water, fresh water, underground water, salt or seaweed which is rich in minerals. The present invention relates to a mineral composition, and a preparation method thereof, wherein the mineral composition is prepared by mixing 100 parts by weight of deep sea water, dead sea water, underground salt water, sea water, aboveground salt water, mineral water, drinking water, fresh water, underground water or water with salt dissolved therein, 1-15 parts by weight of sea weed, 0.1-10 parts of weight of a vegetable oil, 0.1-10 parts by weight of an animal oil, 0.1-10 parts by weight of a soap or saponificated product of a vegetable oil, 0.1-10 parts by weight of a soap or saponificated product of an animal oil, 0.1-5 parts by weight of glycerin, 0.1-5 parts by weight of an alcohol, 0.1-5 parts by weight of baking powder, and 0.1-10 parts by weight of one or more acids of glacial acetic acid, phytic acid, malic acid, erythorbic acid, tartaric acid, citric acid, succinic acid and L-aspartic acid. Therefore, the mineral composition can be used in food, cosmetics, medicine and for disease prevention, and is effective in supplementing minerals. 1. A mineral composition which is prepared in a manner that to 100 parts by weights of one or more selected from ocean deep sea water or deep sea water , dead sea water , maritime deep sea water , underground salt water , sea water , aboveground salt water , mineral water , drinking water , fresh water , underground water or salt-dissolved water is added 1-15 parts by weight of sea weed , 0.1-10 parts of weight of a vegetable oil , 0.1-10 parts by weight of an animal oil , 0.1-10 parts by weight of a soap or saponificated product of a vegetable oil , 0.1-10 parts by weight of a soap or saponificated product of an animal oil , 0.1-5 parts by weight of ...

NUTRITIONAL COMPOSITION MADE USING ISOLATED ORGANIC MATTER

Nutritional compositions, formulations, and intermediates are provided which may be utilized to formulate various sweeteners and other products. The formulations described herein are made from constituents found in soils or fossilized soils. 2. The composition of claim 1 , wherein said (SFSOM) has a second sterile profile (ii) of <10 cfu/gram coliform count measured according to AOAC 991.14.3. The composition of claim 2 , wherein said (SFSOM) has a third sterile profile (iii) of <10 cfu/gram yeast measured according to FDA-BAM claim 2 , 7ed.4. The composition of claim 2 , wherein said (SFSOM) has a third sterile profile (iii-a) of <10 cfu/gram yeast measured according to FDA-BAM claim 2 , 8ed.5. The composition of claim 3 , wherein said (SFSOM) optionally has a fourth sterile profile (iv) of <10 cfu/gram mold measured according to FDA-BAM claim 3 , 7Edition.6. The composition of claim 3 , wherein said (SFSOM) has a fourth sterile profile (iv-a) of <10 cfu/gram mold measured according to FDA-BAM claim 3 , 8Edition.7. The composition of claim 2 , wherein said (SFSOM) optionally has a fourth sterile profile (iv-b) of ≦10 cfu/gram mold measured according to FDA-BAM claim 2 , 7Edition.8. The composition of claim 2 , wherein said (SFSOM) has a fourth sterile profile (iv-c) of ≦10 cfu/gram mold measured according to FDA-BAM claim 2 , 8Edition.9. The composition of claim 3 , wherein the N-acetylglucosamine (NAG) is present in said (SFSOM) at a concentration of N-acetylglucosamine (NAG) to (SFSOM) from about 0.05 mg/1.0 gm to about 100 mg/1.0 gm.10. The composition of claim 4 , wherein the N-acetylglucosamine (NAG) is present in said (SFSOM) at a concentration of N-acetylglucosamine (NAG) to (SFSOM) from about 0.05 mg/1.0 gm to about 100 mg/1.0 gm.11. The composition of claim 1 , further comprising one or more amino acids claim 1 , or salts thereof claim 1 , selected from the group consisting of: arginine claim 1 , histidine claim 1 , isoleucine claim 1 , leucine claim 1 , ...

Calcium Fortifying Composition for Strength, a Hydration Supplement, and Process for Preparing the Same

The present invention provides nutrient fortifying composition for food products and water beverages. More particularly the present invention provides calcium fortifying composition comprising calcium lactate gluconate, copper ion source, acidity regulators and class II preservative (202). The invention further provides a hydration supplement and a fortified water beverage to supplement the deficiencies of calcium in humans.

Electrolyte Fortifying Composition for Recharge, a Hydrating Supplement, and Process for Preparing the Same

Nutrient fortifying composition for food products and electrolyte fortifying composition for recharge comprising calcium chloride, magnesium chloride, potassium bicarbonate, acidity regulator, copper sulphate; and class II preservative. A hydration supplement and a fortified water beverage to supplement the deficiencies of chromium and boron in humans. The hydrating supplement is such that the amount of the calcium chloride is 9.5% to 15.695% by weight, amount of Magnesium chloride is 2.2% to 10.31% by weight, amount of potassium bicarbonate is 10.2% to 15.99% by weight and amount of Copper sulfate is 32.14% to 55.7% by weight. The hydrating supplement is in liquid or semi I solid form, such as a beverage such as aerated drink or treated water. 2. The electrolyte fortifying composition for recharge as claimed in claim 1 , wherein acidity regulator is citric acid.3. The electrolyte fortifying composition as claimed in claim 1 , wherein the class II preservative (202) is potassium sorbate.5. The hydration supplement as claimed in claim 4 , wherein said supplement is liquid or semi solid selected from the group comprising of aerated drinks claim 4 , treated water claim 4 , juices claim 4 , etc.7. The water beverage as claimed in claim 6 , wherein said water beverage is neutral claim 6 , colourless claim 6 , odourless and requires no added flavor or sweeteners to mask ingredients.8. A process of preparing the water beverage fortified with tri-valent chromium and boron fortifying composition for health comprising the steps of:effective treatment and sterilization of source water;fortifying said treated water with the electrolyte fortifying composition for recharge.9. The hydration supplement of claim 4 , wherein the acidity regulator is citric acid.10. The hydration supplement of claim 4 , wherein the class II preservative (202) is potassium sorbate.11. The water beverage of claim 6 , wherein the acidity regulator is citric acid.12. The water beverage of claim 6 , ...

Zinc and Copper Fortifying Composition, a Hydrating Supplement, and Process for Preparing the Same

Electrolyte fortifying composition for recharge, a hydrating supplement, and process for preparing the same The present invention provides nutrient fortifying composition for food products. More particularly the present invention provides Electrolyte fortifying composition for recharge comprising calcium chloride, magnesium chloride, potassium bicarbonate, acidity regulator (330), copper sulphate; and class ii preservative (202). The invention further provides a hydration supplement and a fortified water beverage to supplement the deficiencies of chromium and boron in humans. 2. The zinc and copper fortifying composition for fortifying zinc as claimed in claim 1 , wherein the ratio of the elemental zinc to the elemental copper is maintained at 3:1.3. The zinc and copper fortifying composition as claimed in claim 1 , wherein the zinc lactate gluconate is present in an amount of 34.37% or 16.5 mg per liter.4. The zinc and copper fortifying composition as claimed in claim 1 , wherein the copper ion source is present in an amount of 44.79% or 21.5 mg per liter.5. The zinc and copper fortifying composition as claimed in claim 1 , wherein the class II preservative (202) is present in an amount of 20.83% or 10 mg per liter.6. The zinc and copper fortifying composition as claimed in claim 1 , wherein the copper ion source is copper sulphate.7. The zinc and copper fortifying composition as claimed in claim 1 , wherein the class II preservative (202) is potassium sorbate.9. The hydration supplement as claimed in claim 8 , wherein said supplement is liquid or semi solid or solid selected from the group comprising of aerated drinks claim 8 , treated water claim 8 , juices claim 8 , etc.11. The water beverage as claimed in claim 10 , wherein said water beverage comprises elemental zinc in an amount of about 0.3 mg/100 ml.12. The water beverage as claimed in claim 10 , wherein said water beverage comprises elemental copper in an amount of about 0.1 mg/100 ml.13. The water ...

Trivalent Chromium and Boron Fortifying Composition, a Hydration Supplement, and Process for Preparing the Same

The present invention provides nutrient fortifying composition for food products. More particularly the present invention provides chromium and boron fortifying composition comprising boron source, trivalent chromium source, copper ion source, class II preservative (202), and acidity regulator (330). The invention further provides a hydration supplement and a fortified water beverage to supplement the deficiencies of chromium and boron in humans. 2. The trivalent chromium & boron fortifying health composition as claimed in claim 1 , wherein the ratio of the elemental chromium to the elemental Copper is maintained at 1:100.3. The trivalent chromium & boron fortifying health composition as claimed in claim 1 , wherein the ratio of the elemental Boron to the elemental Copper is 67.5:1.4. The trivalent chromium & boron fortifying health composition as claimed in claim 1 , wherein trivalent chromium source is Chromium 454.5. The trivalent chromium & boron fortifying health composition as claimed in claim 1 , wherein boron source is calcium fructoborate.6. The trivalent chromium & boron fortifying health composition as claimed in claim 1 , wherein the copper ion source is copper sulphate.7. The trivalent chromium & boron fortifying health composition as claimed in claim 1 , wherein the class II preservative (202) is potassium sorbate.8. The trivalent chromium & boron fortifying health composition as claimed in claim 1 , wherein the acidity regulator is citric acid.9. The trivalent chromium & boron fortifying health composition as claimed in claim 5 , wherein the calcium fructoborate is present in an amount of 44.64% or 27.5 mg per liter.10. The trivalent chromium & boron fortifying health composition as claimed in claim 4 , wherein the Chromium 454™ is present in an amount of 0.17% or 0.105 mg per liter.11. The trivalent chromium & boron fortifying health composition as claimed in claim 1 , wherein the Copper Ion Source is present in an amount of 34.9% or 21.5 mg per ...

Composition for Improving Membrane Composition and Functioning of Cells

It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises: 2. The use according to claim 1 , characterized in that the composition further comprises a nucleotide fraction claim 1 , selected from the group consisting of nucleobases like uridine claim 1 , cytidine claim 1 , adenine claim 1 , guanidine claim 1 , thymidine claim 1 , their phosphorylated forms claim 1 , in particular the mono-phosphorylated forms such as uridine monophosphate claim 1 , but also adenosine and guanosine claim 1 , nucleotides and nucleosides.3. The use according to claim 1 , wherein the composition further comprises a digestible carbohydrate fraction claim 1 , preferably a source of galactose and/or ribose.4. The use according to claim 1 , wherein the composition comprises a lipid fraction from originating from a dairy product claim 1 , from eggs or from the endosperm of plant seeds or beans.5. The use according to claim 1 , wherein the lipid fraction comprises fat globules having a size of 0 claim 1 ,001-10 μm.6. The use according to claim 1 , characterized in that the composition comprises a protein fraction which provides cysteine and/or taurine and a lipid fraction claim 1 , and wherein the composition provides per daily dose:d) 400 to 3300 mg of DHA+DPA+EPA;e) a Uridine source which provides 0.08-3/324 Mol uridine,f) and wherein the product provides per 100 kJ 2-40 ug molybdenum and more than 0.0238 mg manganese.7. A composition for improving cognitive function in elderly subjects claim 1 , the composition having an energy content of 50-120 kcal claim 1 , a protein content of 1-10 g claim 1 , a lipids content of lipids 1-5 g claim 1 , and a content of digestible carbohydrates of 4-20 g claim 1 , which composition comprises:g) 1000-2000 mg DHA+DPA+EPAh) 30-280 mg cysteine or taurinei) 100-1000 mg phospholipidsj) 0.5-3 mg vitamin B6k) 50-500 ug folic acidl) 1- ...

Composition Comprising OPC and Omega-3 for Preventing and/or Inhibiting the Development of Diabetic Retinopathy

This invention relates to a composition comprising oligoproanthocyanidins (OPC) and omega-3 fatty acids, for use in preventing or stabilizing the development and/or the progression of a diabetes-related eye condition in a subject; this invention includes a functional food, a nutraceutical composition or a food or dietary supplement comprising said composition; this invention also relates to a pharmaceutical composition or a veterinarian product comprising oligoproanthocyanidins (OPC) and omega-3 fatty acids. 119.-. (canceled)21. The method of claim 20 , wherein the OPC and omega-3 fatty acid are comprised in a composition prior to administration.22. The method of claim 20 , further comprising administering at least one vitamin or inorganic compound to the subject.23. The method of claim 22 , further comprising administering at least one B vitamin to the subject.24. The method of claim 22 , further comprising administering at least one mineral to the subject.25. The method of claim 20 , further comprising administering at least one of vitamin B1 claim 20 , vitamin B6 claim 20 , chromium claim 20 , or magnesium to the subject.26. The method of claim 25 , wherein vitamin B1 is administered as at least one of thiamin or benfotiamin.27. The method of claim 25 , wherein vitamin B6 is administered as at least one of pyridoxamine claim 25 , pyridoxal claim 25 , or pyridoxine.28. The method of claim 25 , wherein chromium is administered as at least one of chromium picolinate claim 25 , chromium chloride claim 25 , chromium GTF® claim 25 , or chromium polynicotinate.29. The method of claim 25 , wherein magnesium is administered as at least one of magnesium gluconate claim 25 , magnesium citrate claim 25 , magnesium chloride claim 25 , magnesium malate claim 25 , magnesium orotate claim 25 , or magnesium from the sea.30. The method of claim 25 , further comprising administering OPC claim 25 , omega-3 fatty acids claim 25 , vitamin B1 claim 25 , vitamin B6 claim 25 , chromium ...

CHOLESTEROL LOWERING AGENT, NEUTRAL FAT LOWERING AGENT, BLOOD GLUCOSE LEVEL LOWERING AGENT, CHOLESTEROL ADSORBENT, ADSORBENT, NEUTRAL FAT ADSORBENT, HEALTHY FOOD, HEALTH SUPPLEMENT, FOOD WITH NUTRIENT FUNCTION CLAIMS, FOOD FOR SPECIFIED HEALTH USE, QUASI-DRUG, AND PHARMACEUTICAL DRUG

[Object] To provide a cholesterol lowering agent, a neutral fat lowering agent, a blood glucose level lowering agent, a cholesterol adsorbent, and a neutral fat adsorbent, which have high safety. 1. A cholesterol lowering agent , comprising:{'sup': 2', '3, 'a porous carbon material having a specific surface area value of 10 m/g or more and a pore volume of 0.1 cm/g or more, the specific surface area value measured by a nitrogen BET method, and the pore volume measured by at least one of a BJH method and an MP method.'}2. The cholesterol lowering agent according to claim 1 , whereina cholesterol lowering capacity is not affected by a coexistent protein.3. The cholesterol lowering agent according to claim 1 , whereina cholesterol lowering capacity is not affected by a coexistent sodium chloride.4. A neutral fat lowering agent claim 1 , comprising:{'sup': 2', '3, 'a porous carbon material having a specific surface area value of 10 m/g or more and a pore volume of 0.1 cm/g or more, the specific surface area value measured by a nitrogen BET method, and the pore volume measured by at least one of a BJH method and an MP method.'}5. A blood glucose level lowering agent claim 1 , comprising:{'sup': 2', '3, 'a porous carbon material having a specific surface area value of 10 m/g or more and a pore volume of 0.1 cm/g or more, the specific surface area value measured by a nitrogen BET method, and the pore volume measured by at least one of a BJH method and an MP method.'}6. A cholesterol adsorbent claim 1 , comprising:{'sup': 2', '3, 'a porous carbon material having a specific surface area value of 10 m/g or more and a pore volume of 0.1 cm/g or more, the specific surface area value measured by a nitrogen BET method, and the pore volume measured by at least one of a BJH method and an MP method.'}7. The cholesterol adsorbent according to claim 6 , whereinthe porous carbon material is subject to a chemical treatment or molecular modification.8. A neutral fat adsorbent claim 6 , ...

PROCESS FOR IRON SUPPLEMENTATION OF BEVERAGES

The present invention is directed to a new process for supplementation of beverages with soluble and bio available iron in the form of ferric pyrophosphate. This process allows iron supplementation of beverages at low cost, without affecting either the original taste or the colour of the beverages. It is also directed to a concentrate ferric pyrophosphate-citrate solution and its use in the preparation of an iron enriched beverage. The invention also relates to a beverage obtainable by this process. 1. Process for the preparation of an aqueous soluble ferric pyrophosphate concentrate , wherein said process comprising the steps of:(a) adding 0.1 to 5 weight/volume % ferric pyrophosphate to water,(b) adding 0.15 to 50 weight/volume % citrate salt to the dispersion from (a),(c) heating the resulting solution from (b) until complete dissolution of ferric pyrophosphate2. The process according to claim 1 , wherein the concentration of ferric pyrophosphate is comprised between 0.4 and 2 weight/volume %.3. The process according to claim 1 , wherein the concentration of citrate and/or derivative thereof is comprised between 4 and 20 weight/volume %.4. The process according to claim 1 , wherein the weight ratio of ferric pyrophosphate to citrate and/or derivative thereof claim 1 , is comprised between 0.01 and 1.5. The process according to claim 1 , wherein the weight ratio of ferric pyrophosphate to citrate and/or derivative thereof claim 1 , is comprised between 0.05 and 0.5.6. The Process according to claim 1 , wherein the citrate salt is selected from mono sodium citrate claim 1 , and tri sodium citrate.7. The Process according to claim 1 , wherein the heating step of step (c) is performed by heating the solution at a temperature comprised between 80 to 120° C. for 10 to 120 minutes.8. An aqueous soluble ferric pyrophosphate concentrate obtainable by the process of and comprising 0.25 to 12.5 g Fe/l.9. Use of an aqueous concentrate according to for the production of a ...

METHODS AND COMPOSITIONS FOR TREATMENT OF ADD/ADHD, DEPRESSION, MEMORY PROBLEMS AND OTHER CONDITIONS

Disclosed herein are compositions and methods for treating a variety of mood and behavioral disorders, including attention deficit hyperactivity disorder (ADHD), anxiety, depression, memory loss, as well as other conditions. Also disclosed herein are methods for diagnosing certain conditions, such as ADHD, using these compositions. 1. A method for treating attention deficit hyperactivity disorder , comprising orally administering to a human subject affected with said disorder a composition comprising 1 to 3 homeopathic pellets of Aconite wherein each pellet is of at least 3× strength.2. The method of claim 1 , wherein the composition comprises 3 homeopathic pellets of Aconite wherein each pellet is of at least 3× strength.3. The method of claim 2 , wherein the composition comprises 10 to 15 homeopathic pellets of Aconite wherein each pellet is of at least 3× strength.4. The method of claim 1 , wherein the composition further comprises one or more nutritional supplements.5. The method of claim 2 , wherein the composition further comprises one or more nutritional supplements.6. The method of claim 3 , wherein the composition further comprises one or more nutritional supplements.7. The method of claim 4 , wherein the composition further comprises one or more nutritional supplements selected from the group consisting of GABA claim 4 , pycnogenol claim 4 , L-tyrosine claim 4 , Ginko biloba claim 4 , DMAE claim 4 , Gotu kola claim 4 , Guarana claim 4 , L-5HTP claim 4 , magnesium claim 4 , and zinc.8. The method of claim 5 , wherein the composition further comprises one or more nutritional supplements selected from the group consisting of GABA claim 5 , pycnogenol claim 5 , L-tyrosine claim 5 , Ginko biloba claim 5 , DMAE claim 5 , Gotu kola claim 5 , Guarana claim 5 , L-5HTP claim 5 , magnesium claim 5 , and zinc.9. The method of claim 6 , wherein the composition further comprises one or more nutritional supplements selected from the group consisting of GABA claim 6 , ...

ORGANICALLY CHELATED MINERAL COMPOSITIONS AND METHODS THEREOF

Embodiments of the invention relate to a method of making a mineral product. The method includes contacting a carboxylic acid and an inorganic mineral compound sufficient to form a solution, reacting the solution over a period of time sufficient to provide a mineral chelated compound, transferring the mineral chelated compound to one or more molds prior to the compound substantially solidifying and reducing the size of the mineral chelated compound sufficient to provide a rapidly soluble mineral chelated product. 111.-. (canceled)12. A method of using a mineral product , comprising:applying a mineral product to a lawn, garden, pasture or field;wherein the mineral product includes a mineral lactate compound.13. The method of claim 12 , wherein the mineral product further comprises a carrier.14. The method of claim 12 , wherein the pasture or field comprises a harvested field claim 12 , bailed field claim 12 , or field or pasture with crops cut.15. The method of claim 12 , wherein the mineral lactate compound comprises one or more of a cobalt lactate compound claim 12 , zinc lactate compound claim 12 , copper lactate compound or manganese lactate compound.16. The method of claim 12 , wherein the carrier comprises diatomaceous earth.17. The method of claim 12 , wherein applying further comprises improving growth of plant life.18. A method of using a mineral product claim 12 , comprising:administering a mineral product to one or more living organisms;wherein the mineral product includes a mineral lactate compound.19. The method of claim 18 , wherein the one or more living organisms comprise monogastric mammals.20. The method of claim 18 , wherein the one or more living organisms comprise ruminant mammals.21. The method of claim 18 , wherein the mineral lactate compound comprises one or more of a cobalt lactate compound claim 18 , zinc lactate compound claim 18 , copper lactate compound or manganese lactate compound.22. The method of claim 18 , wherein the carrier ...

DIETARY SUPPLEMENT CONTAINING ALKALINE ELECTROLYTE BUFFERS

An improved dietary and/or therapeutic supplement composition comprising a quantity of a dietary and/or therapeutic supplement agent having a pH that upon ingestion with food or a beverage would limit the effectiveness of the agent and a sufficient amount of an alkaline electrolyte additive is provided in combination with the agent to raise the pH of the composition to a level of from about 8 to about 12.5 to increase the effectiveness and functional utilization of the agent while the composition is in the person's stomach. 1. A method of improving uptake of a dry dietary supplement comprising:a) providing the supplement;b) providing an alkaline electrolyte agent comprising electrolytes selected from the group consisting of magnesium, calcium, potassium, sodium electrolytes and mixes thereof;c) mixing the supplement and agent to from a mixture, wherein the agent is provided in sufficient amount such that the pH of the resulting mixture is in the range from 8.5 to 12.5, andd) feeding the mixture to a person.2. The method according to wherein the supplement is selected from the group consisting of Vitamins A claim 1 , B1 claim 1 , B2 claim 1 , B3 claim 1 , B5 claim 1 , B6 claim 1 , B12 claim 1 , D3 claim 1 , E claim 1 , folic acid claim 1 , biotin claim 1 , inositol claim 1 , phosphate claim 1 , zinc claim 1 , manganese claim 1 , copper claim 1 , selenium claim 1 , amino acids claim 1 , glucosamine claim 1 , choline claim 1 , chondroitin claim 1 , bioflavonoids claim 1 , MSM claim 1 , kelp claim 1 , ginseng claim 1 , gingko biloba extract claim 1 , fruit blends claim 1 , rose hips claim 1 , acerola and mixes thereof.3. The method according to wherein the supplement is selected from the group consisting of hawthorne berry extract claim 1 , astaxanthin extract claim 1 , coenzyme Q-10 claim 1 , borage extract claim 1 , DHA/EPA and mixes thereof.4. A dry mixture adapted for consumption by a person and having a pH in the range of 8.5 to 12.5 after consumption wherein the ...

NUTRITIONAL COMPOSITION

A nutritional composition is provided which has an effective prophylactic and/or improving effect for various symptoms of muscle mass decrease, decreased basal metabolism, low body temperature, suppression of obesity, suppression of visceral fat accumulation, hyperglycemia, hyperlipidemia and the like in elderly people. The nutritional composition can include n-3 fatty acid and one or more of free lysine, dipeptides containing lysine, and lysine salts, wherein the content of free lysine, dipeptides containing lysine, and/or lysine salts is 0.1 g-10.0 g per 100 kcal of the composition, and the content of the total amount of n-3 fatty acid is 0.17 g-5.00 g per 100 kcal of the composition. 1. A nutritional composition comprising:i) n-3 fatty acid, andii) an ingredient selected from the group consisting of free lysine, dipeptides containing lysine and lysine salts, and combinations thereof;wherein the ingredient is present in the composition in an amount of 0.1 g-10.0 g per 100 kcal of the composition, andwherein the n-3 fatty acid is present in the composition in an amount of 0.17 g-5.00 g per 100 kcal of the composition.2. The nutritional composition according to claim 1 , further comprising a branched chain amino acid selected from the group consisting of valine claim 1 , leucine claim 1 , isoleucine claim 1 , and combinations thereof.3. The nutritional composition according to claim 2 , wherein the branched chain amino acid is present in the composition in an amount of 1.0 g-20 g per 100 kcal of the composition.4. The nutritional composition according to claim 2 , wherein the branched chain amino acid in a free form is present in the composition in an amount of 0.1 g-15 g per 100 kcal of the composition.5. The nutritional composition according to claim 1 , wherein the n-3 fatty acid is selected from the group consisting of eicosapentaenoic acid claim 1 , docosapentaenoic acid claim 1 , docosahexaenoic acid claim 1 , and combinations thereof.6. The nutritional ...

Delivery of Active Agents Using a Chocolate Vehicle

This invention provides edible compositions comprising pharmaceutically or nutraceutically active agents in particulate form homogeneously dispersed in a fat matrix, such as chocolate or chocolate compound coating. 1. A chocolate composition comprising:a fat matrix comprising at least about 20% by weight cocoa butter, said fat matrix having a melting point between about 30° C. and about 49° C.; andat least about 20% by weight of one or more minerals in particulate form, having a median particle size between about 1 μm and about 25 μm, and being insoluble in said fat matrix, said one or more minerals being homogeneously dispersed throughout said fat matrix;wherein said chocolate composition has an apparent viscosity in the molten state within about ±50% of the apparent viscosity of said fat matrix in the absence of said one or more minerals, as measured under conditions of identical temperature and shear.2. The chocolate composition of wherein said median particle size of said one or more minerals is between about 8 μm and about 13 μm.3. The chocolate composition of wherein said median particle size of said one or more minerals is between about 10 μm and about 13 μm.4. A method of forming the chocolate composition of comprising:conching said fat matrix with said one or more minerals to substantially coat the particles with fat; andsubsequently allowing the mixture to solidify.5. The chocolate composition of wherein said one or more minerals include calcium carbonate. This application is a Continuation of U.S. patent application Ser. No. 13/324,231, filed Dec. 13, 2011 and currently pending, which is in turn a Continuation of U.S. patent application Ser. No. 12/908,568, filed Oct. 20, 2010 now U.S. Pat. No. 8,158,177, which is in turn a Continuation of U.S. patent application Ser. No. 11/437,371, filed May 19, 2006, now U.S. Pat. No. 7,820,221. The entire contents of all the above are hereby incorporated by reference.1. Field of the InventionThe present invention ...

FOOD COMPOSITION CONTAINING AMINO ACIDS AND COCOA

A food composition described herein contains a protein hydrolysate from a legume and cocoa. The food composition may be in a solid or powder composition, and it may also contain creatine, especially creatine monohydrate. The food composition may also contain at least one B vitamin and/or a zinc compound. 1. Food composition containing:a) a protein hydrolysate from a legume selected from peas, beans and lentils; andb) cocoa.2. Food composition according to claim 1 , which also contains creatine.3. Food composition according to or claim 1 , which also contains at least one B vitamin and/or a zinc compound.4. Food composition according to any one of the preceding claims claim 1 , wherein the protein hydrolysate from a legume is a pea protein hydrolysate.5. Food composition containing:a) hydrolysed pea protein; andb) cocoa.6. Food composition according to claim 5 , which also contains creatine.7. Food composition according to or claim 5 , which also contains at least one B vitamin and/or a zinc compound.8. Food composition claim 5 , especially a drink powder claim 5 , containing:a) 40-80% by weight hydrolysed pea protein;b) 20-50% by weight cocoa. The present invention relates to a food composition that contains a protein hydrolysate from a legume and cocoa.Preferably, the food composition according to the invention, especially when it is a solid or powder-form food composition, also contains creatine, especially creatine monohydrate, more especially Creapure©.More preferably, the food composition according to the invention contains at least one B vitamin and/or a zinc compound.More preferably, the food composition according to the invention contains all 20 standard amino acids in the form of the free amino acid and/or in the form of peptides.In the context of the present invention, the term legume relates to beans, lentils and peas, with preference being given to peas. In the context of the present invention, the term legume does not relate to soya or soybeans, that is ...

FOOD COMPOSITION

A food composition comprising astaxanthin (A), a powder (B) of a sucrose fatty acid ester that is powdery at 25° C. and has an HLB value of 10 or more, and an oil (C) that is a liquid at 25° C., wherein the powder (B) is dispersed in a dispersion medium comprising the oil (C). 1. A food composition comprising astaxanthin (A) , a powder (B) of a sucrose fatty acid ester that is powdery at 25° C. and has an HLB value of 10 or more , and an oil (C) that is a liquid at 25° C. ,wherein the powder (B) is dispersed in a dispersion medium comprising the oil (C).2. The food composition according to claim 1 , further comprising a polyoxyethylene sorbitan fatty ester (D) having an HLB value of 10 or more.3. The food composition according to claim 2 , wherein the polyoxyethylene sorbitan fatty ester (D) is polyoxyethylene sorbitan monolaurate.4. The food composition according to claim 1 , wherein the powder (B) is a powder of sucrose laurate.5. The food composition according to claim 2 , wherein the powder (B) is a powder of sucrose laurate.6. The food composition according to claim 3 , wherein the powder (B) is a powder of sucrose laurate.7. The food composition according to claim 1 , further comprising crocetin.8. The food composition according to claim 2 , further comprising crocetin.9. The food composition according to claim 3 , further comprising crocetin.10. The food composition according to claim 4 , further comprising crocetin.11. The food composition according to claim 1 , wherein a dosage form of the food composition is a soft capsule. This application is based on and claims priority under 35 USC 119 from Japanese Patent Application No. 2015-131090, filed on Jun. 30, 2015. The entire disclosure of the above application is incorporated herein by reference.Technical FieldThe present invention relates to a food composition.Related ArtAstaxanthin has attracted attention as a component having ‘anti-oxidant action’ for eliminating active oxygen. Astaxanthin is known to have ...

Calcium Carbonate Granulation

Highly compactable granulations and methods for preparing highly compactable granulations are disclosed. More particularly, highly compactable calcium carbonate granulations are disclosed. The granulations comprise powdered materials such as calcium carbonate that have small median particle sizes. The disclosed granulations are useful in pharmaceutical and nutraceutical tableting and provide smaller tablet sizes upon compression than previously available. 1. A dietary supplement tablet comprising an amount of calcium carbonate sufficient to provide about 600 mg of elemental calcium , said tablet being about 20% to about 35% smaller in volume than 1 cc.2. The tablet of claim 1 , wherein the tablet is about 20% smaller than 1 cc.3. The tablet of claim 1 , wherein said calcium carbonate is provided in compressed calcium carbonate granulations.4. The tablet of claim 3 , wherein said compressed calcium carbonate granulations comprise USP or food grade calcium carbonate powder having a median particle diameter of about 20 μm.5. The tablet of claim 3 , wherein said compressed calcium carbonate granulations comprise USP or food grade calcium carbonate powder having a median particle diameter from about 6 μm to about 12 μm.6. The tablet of claim 3 , wherein said compressed calcium carbonate granulations comprise USP or food grade calcium carbonate powder having a median particle diameter from about 6 μm to about 10 μm.7. The tablet of claim 3 , wherein said compressed calcium carbonate granulations comprise USP or food grade calcium carbonate powder having a median particle diameter of about 6 μm.8. The tablet of claim 3 , further comprising a binder in said compressed calcium carbonate granulations.9. The tablet of claim 8 , wherein the binder is maltodextrin.10. The tablet of claim 9 , wherein said maltodextrin has a dextrose equivalent (DE) of 10.11. The tablet of claim 10 , wherein said compressed calcium carbonate granulations comprise USP or food grade calcium ...

CALCIUM PHOSPHATE DISPERSION COMPOSITION

It is intended to provide a liquid oral composition and a liquid food composition in which calcium phosphate such as hydroxyapatite or tricalcium phosphate can be stably dispersed and prevented from being precipitated or separated out even in long-term storage. Calcium phosphate mixed with xanthan gum and polyglycerin fatty acid ester can be stably dispersed even in long-term storage and prevented from being precipitated or separated out even when used in liquid oral compositions such as mouthwashes, liquid dentifrices, and oral detergents or in liquid food compositions such as milk, soy milk, yoghurt, and refreshing beverages. In addition, calcium phosphate mixed with xanthan gum and polyglycerin fatty acid ester further supplemented with an amphoteric surfactant can be more effectively prevented from being precipitated or separated out in liquid oral compositions such as mouthwashes, liquid dentifrices, and oral detergents. 1. A calcium phosphate dispersion composition comprising calcium phosphate , xanthan gum , and polyglycerin fatty acid ester.2. The calcium phosphate dispersion composition according to claim 1 , wherein a content of the calcium phosphate is 0.01 to 20.0% by weight with respect to the total composition claim 1 , a content of the xanthan gum is 0.1 to 2.0% by weight with respect to the total composition claim 1 , and a content of the polyglycerin fatty acid ester is 0.01 to 2.5% by weight with respect to the total composition.3. The calcium phosphate dispersion composition according to claim 1 , wherein the calcium phosphate dispersion composition is obtained by adding the calcium phosphate into a solution in which the polyglycerin fatty acid ester is dissolved in an aqueous solvent claim 1 , stirring the mixture claim 1 , then adding the xanthan gum thereto claim 1 , and stirring the mixture.4. The calcium phosphate dispersion composition according to claim 1 , further comprising an amphoteric surfactant.5. The calcium phosphate dispersion ...

Roasted coffee with resveratrol

The present invention describes new compositions of matter comprising (1) roasted coffee beans in either whole bean form or in ground form to which a formulation containing resveratrol and glycerin and/or specified additional additives have been added, (2) liquid beverages extracted at a pressure of less than 2000 bar from said roasted coffee beans or grounds to which a formulation containing resveratrol and glycerin and/or specified additional additives have been added; and (3) so-called “instant coffee” or “soluble coffee” prepared from roasted coffee beans to which a formulation containing resveratrol and glycerin and/or specified additional additives have been added, but in which a pulverized coffee component is specifically excluded. The formulation including glycerin leads to increased solubility and bioavailability of resveratrol. By adding a formulation containing resveratrol and glycerin to roasted coffee beans and/or instant coffee, consumers enjoy the health benefits of resveratrol in their coffee without drinking red wine.

COMPOSITIONS FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASE, METHODS OF THEIR USE AND METHODS OF MAKING THE SAME

Provided herein are compositions useful for the treatment or prevention of -associated disease or -associated diarrhea in a subject in need thereof, and delivery systems and package systems comprising the same. Also provided are methods using the compositions, delivery systems, package systems and methods of making the same. 1Clostridium difficileClostridium difficile. A composition comprising 1 mg to 100 g smectite and at least one further agent that is effective to treat or prevent infection , associated disease , or a symptom thereof , in a subject in need thereof.2. The composition of claim 1 , wherein the smectite is selected from di-tri-octahedral smectite claim 1 , bentonite claim 1 , and combinations thereof.3Clostridium difficile. The composition of comprising a sufficient amount of smectite to treat or prevent associated disease claim 1 , or a symptom thereof claim 1 , in a subject in need thereof.4Clostridium difficile. The composition of comprising a sufficient amount of the at least one further agent to treat or prevent associated disease claim 1 , or a symptom thereof claim 1 , in a subject in need thereof.5. The composition of that comprises a synergistic amount of the at least one further agent.6. The composition of claim 1 , wherein the at least one further agent is selected from an amino acid claim 1 , a peptide claim 1 , a prebiotic claim 1 , a probiotic claim 1 , and combinations thereof.7Saccharomyces boulardii, Lactobacillus, Bifidobacteria, Bacillus. The composition of wherein the at least one further agent is selected from L-glutamine claim 6 , L-alanyl L-glutamine claim 6 , manna oligosaccharides claim 6 , claim 6 , and combinations thereof.8Saccharomyces boulardii. The composition of claim 7 , wherein the at least one further agent comprises and L-glutamine.9. The composition of claim 8 , wherein the smectite is di-tri-octahedral smectite.10. The composition of claim 1 , wherein the composition is a medical food claim 1 , nutritional ...

METHODS AND PRODUCTS TO PROVIDE ORAL NUTRITIONAL CARE TO SUBJECTS WITH DEMENTIA

The present invention provides food products, nutritional programs, and methods for meeting nutritional needs of subjects with dementia and related cognitive disorders. In one embodiment, the invention provides a food product comprising a reversibly sealed container and a soup, wherein the soup is in the container and comprises a total volume of 200-2000 mls, a vegetable or meat component, 300 to 2500 calories, a macronutrient caloric distribution comprising: 20-80% fat, 10-45% protein, and 10-65% carbohydrate, about 2% to about 40% medium chain triglycerides, omega 3 fatty acids in an amount of 100 to 2000 mg and less than 20 solid food particles having a volume greater than about 20 cm. Such food products, when administered to affected subjects, can positively impact (i) nutritional status; (ii) quality of life; (iii) disease course; (v) the demand for assistance from a care giver; (vi) subject compliance with a nutritional plan using the food product, and (vii) ease of monitoring compliance by the caregiver for verification. 1. A product comprising a reversibly closed container and a soup , wherein the soup is in the container and comprises:a. a total volume of 200 to 2000 ml;b. at least one of a vegetable component and a meat component;c. 300 to 2500 calories; i. 20% to 80% fat;', 'ii. 10% to 45% protein; and', 'iii. 10% to 65% carbohydrate; and', 'iv. about 2% to about 40% medium chain triglycerides,, 'd. a macronutrient caloric distribution comprisinge. optionally one or more antioxidants in a total amount of at least 100 mg equivalents of vitamin C by FRSA;f. optionally omega 3 fatty acids in an amount of at least 100 mg; andg. optionally a means for extending the stability of the product.2. The product of comprising omega 3 fatty acids in an amount of 100 to 2000 mg claim 1 , and comprising antioxidants in a total amount of 100 mg to 500 mg equivalents of vitamin C by FRSA.3. The product of wherein the product claim 1 , when provided daily to a subject with ...

Condensed iron (iii) phosphate

Method for producing condensed iron (III) phosphate, in which a) an aqueous solution containing Fe2+ ions is produced, in which oxidic iron (II), iron (III) or mixed iron (II, III) compounds selected from among hydroxides, oxides, oxide hydroxides, oxide hydrates, carbonates and hydroxide carbonates are introduced together with elementary iron into an aqueous medium containing phosphoric acid, wherein Fe2+ ions are dissolved and Fe3+ with elementary Fe (in a comproportionation reaction) is reacted to dissolved Fe2+, b) separating solid material from the phosphoric acid aqueous Fe2+ solution, c) adding an oxidizer to the phosphoric acid aqueous Fe2+ solution to oxidise iron (II) in the solution, d) adding polyphosphate in the form of polyphosphoric acid or salts thereof as solid material or aqueous solution after completion of the oxidation reaction to precipitate condensed iron (III) phosphate, and e) separating the precipitated condensed iron (III) phosphate solution and resulting product.

COMPOSITIONS OF NUTRITION SUPPLEMENTATION FOR NUTRITIONAL DEFICIENCIES AND METHOD OF USE THEREOF

A nutritional supplement composition for treating nutritional deficiencies caused by a medical condition in subjects is disclosed. The present application further discloses a method of using a nutritional supplements composition for treating a subject with complications resulting from sickle cell anemia. The method comprises administering to a subject an effective amount of the nutritional supplement. 127.-. (canceled)28. A method for treating conditions associated with abnormally slow energy metabolism or high energy requirement , comprising:administering to a subject in need of such treatment a daily nutritional supplement having total calories of about 700-980 kcal, wherein about 10-20% of the total calories are derived from protein, about 25-40% of the total calories are derived from fat, and about 45-65% of the total calories are derived from carbohydrate.29. The method of claim 28 , wherein the conditions associated with abnormally slow energy metabolism include malnutrition claim 28 , anorexia claim 28 , cancers claim 28 , AIDS and aging.30. The method of claim 28 , wherein the conditions associated with high energy requirement include sickle cell anemia claim 28 , pregnancy claim 28 , lactation claim 28 , growth claim 28 , exercise claim 28 , infectious diseases and recovery from surgical and other injuries.31. The method of claim 30 , wherein the condition associated with high energy requirement is sickle cell anemia.32. The method of claim 28 , wherein the nutritional supplement is administered orally in the form of a snack.33. The method of claim 32 , wherein the nutritional supplement is administered orally as the last snack before sleeping.34. The method of claim 32 , wherein the nutritional supplement is administered as snacks after each meal.35. A nutritional supplement to normal diet for treating conditions associated with abnormally slow energy metabolism or high energy requirement claim 32 , comprising:protein in an amount that provides about 10-20 ...

PHOSPHORUS-SPARING NUTRITIONAL COMPOSITION

A nutritional composition comprises (a) one to a plurality of physiologically acceptable calcium salts and/or chelates and (b) one or more phosphorus-containing components, such as phosphate salts, and/or phosphorus-rescuing components, such as phytase. The composition is useful for phosphorus-sparing calcium supplementation of the diet of a human subject, and for treatment of a low bone density condition in a human subject in need thereof.

PLANT-BASED EGG SUBSTITUTE COMPOSITIONS

An egg substitute composition includes a substantially egg-less dry mixture that includes a starch and/or lipid source and/or a protein source, and a hydrocolloid system. The hydrocolloid system includes a mixture of hydrocolloids and a crosslinking agent. The crosslinking agent is adapted to crosslink the mixture of hydrocolloids upon the introduction of a liquid. The mixture of hydrocolloids includes a lower-temperature gelling hydrocolloid and a higher-temperature gelling hydrocolloid. The compositions may further include a liquid activator, which may be added to the dry mix to hydrate the composition, and enable use of the composition in any application typically calling for raw eggs, e.g., scrambled eggs, omelets, frittatas, etc. The compositions (in dry or hydrated form) may also be used as egg-substitutes in various different applications, such as in emulsions (e.g., mayonnaise), and baking mixes. 1. A composition comprising: a starch and/or lipid source, and/or a protein source; and', 'a hydrocolloid system comprising a mixture of hydrocolloids and a crosslinking agent, the crosslinking agent being adapted to crosslink the mixture of hydrocolloids upon introduction of a liquid, and the mixture of hydrocolloids comprising a lower-temperature gelling hydrocolloid and a higher-temperature gelling hydrocolloid., 'a substantially egg-less dry mixture comprising2. The composition according to claim 1 , wherein the protein source comprises a plant-based protein source.3. The composition according to claim 1 , wherein the protein source comprises a protein derived from a vegetable claim 1 , a legume claim 1 , a seed claim 1 , a grain claim 1 , a tuber claim 1 , a root claim 1 , a fruit claim 1 , hemp claim 1 , a nut claim 1 , an algae claim 1 , and/or a seaweed.4. The composition according to claim 1 , wherein the protein source comprises a protein derived from an algae.5. The composition according to claim 1 , wherein the protein source comprises a protein derived ...

NUTRITIONAL SUPPLEMENT FOR GROWTH ENHANCEMENT

Provided are nutritional supplements designed for enhancing the growth, particularly the linear growth, of pre-pubertal children with a stature measure short compared to the norm. The nutritional composition includes an energy source, arginine and a combination of micronutrients. 1. A nutritional supplement in a powder form having per 100 g powder a total caloric content of from about 300 kcal to about 500 kcal comprising per 100 g powder arginine in an amount of from about 250 mg to about 1000 mg and a micronutrient combination comprising calcium in an amount of from about 250 mg to about 750 mg; vitamin C in an amount of from about 15 mg to about 350 mg; zinc in an amount of from about 2.0 mg to about 15 mg; iron in an amount of from about 2.0 mg to about 10 mg; vitamin A in an amount of from about 50 μg to about 350 μg; and vitamin D in an amount of from about 2 μg to about 10 μg.2. The nutritional supplement of claim 1 , wherein 40% to 70% of the total caloric content is carbohydrates.3. The nutritional supplement of claim 1 , wherein 10% to 40% of the total caloric content is lipids.4. The nutritional supplement of claim 1 , wherein 10% to 40% of the total caloric content is proteins.5. The nutritional supplement of claim 1 , said supplement comprises per 100 g powder arginine in an amount of from about 500 mg to about 1000 mg; calcium in an amount of from about 300 mg to about 400 mg; vitamin C in an amount of from about 15 mg to about 50 mg; zinc in an amount of from about 2.0 mg to about 5.0 mg; iron in an amount of from about 3.0 mg to about 5.0 mg; vitamin A in an amount of from about 50 μg to about 150 μg; and vitamin D in an amount of from about 2 μg to about 3.5 μg.6. The nutritional supplement of claim 1 , said composition having per 100 g powder a total caloric content of about 420 kcal; arginine in an amount of about 826-992 mg; calcium in an amount of about 413 mg; vitamin C in an amount of about 24-28 mg; zinc in an amount of from about 4 mg; iron ...

EDIBLE STICKER WITH NUTRIENT

An edible sticker including an edible paper, an edible ink, and an edible compound on at least a portion of the edible paper. The edible compound includes one selected from a nutrient, a supplement, a medicine, a mineral, a flavoring, a vitamin, and combinations thereof. A method of providing nutrients to a child using the edible sticker, a method of manufacturing the edible sticker, and a system for manufacturing the edible sticker have also been disclosed. 1. An edible sticker , comprising:an edible paper;an edible indicia on a first side of the edible paper; andan edible compound on at least a portion of the edible paper, the edible compound comprising one selected from the group consisting of a nutrient, a supplement, a medicine, a mineral, a flavoring, a vitamin, and combinations thereof.2. The edible sticker of claim 1 , wherein the edible compound comprises at least one of liquid multi-vitamin and mineral claim 1 , essential fatty acids claim 1 , colostrum with probiotics claim 1 , vitamin A claim 1 , vitamin C claim 1 , vitamin D claim 1 , vitamin E claim 1 , DHA claim 1 , calcium claim 1 , magnesium claim 1 , beta carotene claim 1 , iron or combinations thereof.4. The edible sticker of claim 1 , wherein the indicia comprises a customized design claim 1 , a picture claim 1 , text claim 1 , a cartoon character claim 1 , a bar code claim 1 , or combinations thereof.5. The edible sticker of claim 1 , further comprising:a protection layer over the edible compound.6. The edible sticker of claim 1 , further comprising:a paper backing on a second side of the edible paper opposite to the first side.7. The edible sticker of claim 6 , further comprising:an edible adhesive between the edible paper and the paper backing.8. The edible sticker of claim 7 , wherein the edible adhesive is selected from the group consisting of pressure sensitive adhesive claim 7 , heat activatable adhesive claim 7 , and water activatable adhesive.9. The edible sticker of claim 8 , wherein ...

Liquids rich in noble gas and methods of their preparation and use

Provided herein is a novel composition for oral administration and delivery of Noble gas, such as xenon or argon. Methods of treating and preventing neuronal or cardiovascular damage with such compositions are also provided. The present invention relates generally to the fields of molecular biology, medicine and nutraceuticals. More particularly, it concerns methods for oral delivery of inert gas compositions, such as Xenon or Argon, for the treatment and prevention of disease.

POWDERED DRINK MIX FOR RECOVERY

An oral product that includes an amino acid nitric oxide precursor and a compound capable of providing zinc ions. The product can be formulated as a powder and mixed with a liquid in preparation for consumption by a person. The powdered formulation may be mixed with water followed by a brief but necessary allotment of time for the powdered formulation to completely react in the water. The resulting beverage may then be consumed by a person or user to facilitate production of nitric oxide and creatine-phosphate that is usable by the person, especially to help recover and rejuvenate the person after physical exertion and reduce or relieve muscle soreness. 1. An oral dietary supplement comprising:an amino acid nitric oxide precursor; anda compound capable of providing zinc ions.2. The oral dietary supplement of claim 1 , wherein the amino acid precursor is arginine.3. The oral dietary supplement of claim 1 , wherein the compound capable of providing zinc ions is selected from the group consisting of zinc carbonate claim 1 , zinc chloride claim 1 , zinc oxide claim 1 , and zinc hydroxide.4. The oral dietary supplement of claim 1 , further comprising a creatine salt selected from the group consisting of creatine alphaketoglutarate claim 1 , creatine pyruvate claim 1 , and creatine.HO.5. The oral dietary supplement of claim 1 , further comprising at least one simple carbohydrate.6. The oral dietary supplement of claim 1 , further comprising at least two organic acids.7. The oral dietary supplement of claim 1 , further comprising at least one B vitamin.8. An oral dietary supplement for facilitating a user's recovery from physical exertion comprising:an amino acid selected from the group consisting of arginine and lysine;{'sub': '2', 'a creatine salt selected from the group consisting of creatine alphaketoglutarate, creatine pyruvate, and creatine.HO; and'}a compound capable of providing zinc ions selected from the group consisting of zinc carbonate, zinc chloride, zinc ...

DOUBLE FORTIFIED SALT COMPOSITION CONTAINING IRON AND IODINE AND PROCESS FOR THE PREPARATION THEREOF

The present invention relates to stable and white iron fortification and iron+iodine double fortification agents, their preparation and use in fortification of salt. These agents help overcome the normal difficulties encountered in iron and iodine fortification such as low iodine stability on storage, development of colour and odour, and use of unwanted additives to impart stability. In one of the invented products, both iron and iodine coexist in stable manner in the same matrix which allow for a more uniform distribution of iodine. The process of preparation is demonstrated to be scalable and utilizes commonly available raw materials which would enable the products to be synthesized in affordable manner. 1. A fortifying agent of general formula 1{'br': None, 'sub': 4.3±0.4', '10.6±0.8', '3', '0.486-0.5', '3', '0.00±0.002', '2, 'i': '.y', '[MgFe(III)(OH)][CO](IO)HO'}wherein y=3exhibiting magnetic moment in the range of 1.33 to 1.49 B.M and having 13-15% low spin Fe(III) (w/w) and 0.0-0.6% I (w/w) as iron and iodine source for fortification of edible salt.2. The fortifying agent as claimed in claim 1 , wherein representative compounds of general formula 1 comprising:{'br': None, 'sub': 4.3±0.4', '10.6±0.8', '3', '0.5', '2, '[MgFe(III)(OH)][CO].3HO;\u2003\u2003(1a)'}{'br': None, 'sub': 4.3±0.4', '10.6±0.8', '3', '0.486', '3', '0.016±0.002', '2, 'i': '.y', '[MgFe(III)(OH)](CO)(IO)HO;\u2003\u2003(1b).'}3. The fortifying agent as claimed in claim 2 , wherein compound of formula 1a is useful for iron fortification.4. The fortifying agent as claimed in claim 2 , wherein compound of formula 1b is useful as iron and iodine source for double fortification of edible salt.5. A process for the preparation of fortifying agent as claimed in and the said process comprising the steps of{'sub': 3', '2', '3, '(i) preparing a slurry by mixing aqueous FeClsolution into aqueous NaCOsolution at temperature in the range of 25 to 35° C.;'}{'sub': '2', '(ii) adding slurry as obtained in ...

SWEETENER COMPOSITIONS

A sweetener composition comprising xylose, a sugar alcohol and brown seaweed extract in solid form, preferably powdered or crystalline form. The sugar alcohol is preferably an erythritol and the brown seaweed extract is preferably obtained from Laminaria japonica. The sweetener composition can further comprise one or a combination of additional vitamins, minerals, probiotic cultures, and other plant-based extracts. 123-. (canceled)24. A sweetener composition consisting of: a xylose , an erythritol and a brown seaweed extract ,wherein the sweetener composition is provided in solid, crystalline and/or powdered form;wherein the sweetener composition is used for enhancing the flavor of foods; andwherein the relative amounts of the xylose, erythritol and brown seaweed extract are present in the sweetener composition to provide a mouth feel and taste like sucrose.25. A sweetener composition comprising: a xylose , an erythritol , and a brown seaweed extract ,wherein the sweetener composition is provided in solid, crystalline and/or powdered form;wherein the sweetener composition enhances the flavor of foods; andwherein the relative amounts of the xylose, erythritol and brown seaweed extract are present in the sweetener composition to provide a mouth feel and taste like sucrose.26. The sweetener composition of further comprising one or more vitamins selected from the group consisting of: vitamin A claim 25 , vitamin B claim 25 , vitamin B claim 25 , vitamin B claim 25 , vitamin B claim 25 , vitamin B claim 25 , vitamin B claim 25 , vitamin B claim 25 , vitamin B claim 25 , L-methyl folate claim 25 , inositol claim 25 , vitamin C claim 25 , vitamin D claim 25 , vitamin E claim 25 , vitamin K claim 25 , and CoQ10.27. The sweetener composition of claim 25 , further comprising one or more minerals selected from the group consisting of: calcium claim 25 , chromium claim 25 , copper claim 25 , iron claim 25 , magnesium claim 25 , manganese claim 25 , and zinc.28Bacillus coagulans ...

NUTRITIONAL COMPOSITIONS INCLUDING CALCIUM BETA-HYDROXY-BETA-METHYLBUTYRATE, CASEIN PHOSPHOPEPTIDE, AND PROTEIN

Nutritional compositions that include calcium ?-hydroxy-?-methylbutyrate and protein, and methods of using and making the nutritional compositions are provided. Casein phosphopeptide is utilized to sequester the calcium ?-hydroxy-?-methylbutyrate to reduce the interaction between the divalent calcium ions and protein in the nutritional composition to improve the overall stability, shelf life, and viscosity of the nutritional composition, while also facilitating the absorption of calcium. 1. A nutritional composition comprising:a calcium β-hydroxy-β-methylbutyrate-casein phosphopeptide complex in an amount sufficient to provide about 0.4 grams to about 4 grams of β-hydroxy-β-methylbutyrate per serving;about 5 grams to about 50 grams of protein per serving;potassium in a concentration of less than about 2500 ppm;sodium in a concentration of less than about 1600 ppm; andphosphorus in a concentration of less than about 3200 ppm.2. The nutritional composition according to claim 1 , further comprising about 0.1 grams to about 20 grams of fat per serving claim 1 , and about 0.1 grams to about 50 grams of carbohydrate per serving.3. The nutritional composition of claim 2 , wherein the fat is provided by at least one source selected from the group consisting of high oleic safflower oil claim 2 , high oleic sunflower oil claim 2 , canola oil claim 2 , soy oil claim 2 , and combinations thereof claim 2 , and the carbohydrate is provided by at least one source selected from the group consisting of maltodextrin claim 2 , sucrose claim 2 , fructose claim 2 , sucromalt claim 2 , and combinations thereof.4. The nutritional composition according to claim 2 , wherein the protein is provided from at least one source selected from the group consisting of calcium caseinate claim 2 , sodium caseinate claim 2 , milk protein concentrate claim 2 , milk protein isolate claim 2 , whey protein concentrate claim 2 , whey protein isolate claim 2 , whey protein hydrolysate claim 2 , soy protein ...

PREMIX FOR A FORTIFIED FOOD BLEND

The present invention relates to a vitamin, mineral and enzyme premix for a fortified food blend comprising an alpha-amylase and a glucoamylase to increase energy content, reduce viscosity, and improve taste of a porridge prepared from said fortified food blend. Furthermore, the invention relates to a high energy fortified food blend comprising a vitamin, mineral and enzyme premix from which a high energy, low viscosity and tasty porridge can be prepared. It also relates to a porridge prepared form the fortified food blend according to the present invention. 1. A fortified food blend for a porridge comprising a vitamin , mineral and enzyme premix , wherein the premix comprises at least an alpha-amylase and a glucoamylase having a ratio of alpha-amylase/glucoamylase enzyme units of between 1/2 and 1/75 , and wherein the porridge has an energy density of greater than 800 kcal/l , and a viscosity at 45° C. , as measured in a Bostwick test , of greater than 10 cm/30″.2. The fortified food blend according to claim 1 , wherein the fortified food blend is a corn soya blend or a wheat soya blend.3. The fortified food blend according to claim 2 , wherein the energy density of the porridge is greater than 1000 kcal/l claim 2 , and the viscosity at 45° C. claim 2 , as measured in a Bostwick test claim 2 , is greater than 10 cm/30″.4. The fortified food blend according to claim 1 , wherein the energy density of the porridge is greater than 1200 kcal/l claim 1 , and the viscosity at 45° claim 1 , as measured in a Bostwick test claim 1 , is greater than 10 cm/30″.5. The fortified food blend according to claim 1 , wherein the energy density of the porridge is greater than 1000 kcal/l claim 1 , and the viscosity at 45° C. claim 1 , as measured in a Bostwick test claim 1 , is greater than 12 cm/30″.6. A porridge prepared from a fortified food blend comprising a vitamin claim 1 , mineral and enzyme premix claim 1 , wherein the premix comprises at least an alpha-amylase and a ...

Composition comprising a multifunctional viscosity modifying agent

A nutritional composition comprising at least one protein, at least one macronutrient other than the at least one protein, and micronized calcium phosphate. The micronized calcium phosphate has a median particle size from about 0.20 to about 1.20 micrometers and may modify the viscosity of the nutritional composition. The micronization of the calcium phosphate may provide for increased bioavailability of calcium and phosphate and protein stability in the nutritional composition.

MINERAL FORTIFICATION SUBSTANCE FOR CLEAR BEVERAGES

The present invention relates to compositions comprising minerals which are soluble in water and juice. The compositions of the present invention dissolve in a beverage without any cloudiness or sedimentation. Methods of making said compositions are also provided. Said compositions are also suitable for tableting. 1. A process for producing a composition which may be used to mineral fortify clear beverages , comprising the steps of:(a) providing a compound containing a mineral portion wherein the mineral portion of said compound is selected from the group consisting of calcium, zinc, and magnesium and mixtures thereof; and(b) providing a phosphoric acid as an edible acid; and(c) combining at a constant rate over a period of about 30 minutes to 2 hours said mineral portion containing compound (a). and said edible acid (b). at ambient temperatures to produce a free flowing solid composition which comprises MCP-1 (mono-calcium phosphate monohydrate); and(d) adding water to the composition wherein the proportion of said mineral portion containing compound (a) to said edible acid (b) in said composition is such that a 1 wt % solution of said water added composition has a turbidity of less than 10 NTU and a pH of between about 2.8 to about 3.2.2. The process of claim 1 , wherein the phosphoric acid is 85% phosphoric acid.3. A process for producing a composition which may be used to mineral fortify juices claim 1 , comprising the steps of:(a) providing a compound containing a mineral portion wherein the mineral portion of said compound is selected from the group consisting of calcium, zinc, and magnesium and mixtures thereof; and(b) providing a phosphoric acid as an edible acid; and(c) combining at a constant rate over a period of about 30 minutes to 2 hours said mineral portion containing compound (a). and said edible acid (b). at ambient temperatures to produce a free flowing solid composition which comprises MCP-1 (mono-calcium phosphate monohydrate); and(d) adding ...

EFFERVESCENT MULTI-VITAMIN/MINERAL ADDITIVE FOR COFFEE AND TEA

A water soluble micronutrient composition that infuses vitamins and minerals into coffee and tea designed to maximize bio-absorption in consideration of pH levels, temperature and caffeine. The composition contains water-soluble and oil-soluble vitamins and minerals in bioavailable forms contained in a composition consisting of -% of a vitamin blend with -% of one or more minerals selected from the group consisting of calcium, magnesium, iron, zinc, copper and manganese, -% citric acid, -% of one or more alkali or alkaline earth metal bicarbonates or carbonates, -% flavoring agent, -% of a sweetening agent. When dissolved in liquid a specific amount of micronutrients are infused into the drink by way of a soluble, bioavailable form in the amount of approximately -% of the US RDA of multiple vitamins and trace minerals along with a desired flavor to enhance the coffee, tea or other liquid. 1. A water soluble micronutrient (vitamin and/or mineral) composition for direct use as an additive in coffee and tea , comprising:at least one of a vitamin additive, a literal additive and a flavor additive;at least one pH stabilizing agent that stabilizes a pH of the liquid into which the tablet is to be placed;at least one effervescence agent having sufficient effervescence to separate the tablet or powder upon placement in the coffee and tea; andat least one solubility agent that facilitates expeditious dissolution of the composition in the coffee and tea into which it is placed; wherein a percentage of components in the tablet are in a range of:Vitamin additive 1-5%;Mineral additive 5-15%;Flavor additive 10-20%;Base Reactor(s) 15-30% Acid Reactor(s) 10-30%;Binding Agent 10-30%;Lubricant(s) 5-10%.2. The effervescent vitamin and mineral composition of wherein the composition comprises a tablet and a dosage unit of said tablet is about two to six grams.3. The effervescent vitamin and mineral composition of wherein a dosage unit of said composition contains between about 25 and ...

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NATAL AND PRE-NATAL CONDITIONS WITH ALPHA-TOCOPHEROL

The present invention provides methods, compositions, and systems for preventing or reducing an allergic condition in an offspring by administering tocopherol to a mother pregnant or nursing the offspring, where the tocopherol in the composition is 98-100% unmodified natural d-alpha tocopherol, and less than 2% gamma tocopherol (e.g., undetectable levels of gamma tocopherol). In certain embodiments, a prenatal tablet or pill is provided composed of such tocopherol compositions in combination with folic acid, iron, and calcium. 1. A method of preventing , or reducing the severity of , a condition in a neonate , infant , or child comprising:administering a composition to a mother of a neonate, infant, or child: 1) prior to birth of said neonate, infant, or child, and/or 2) during a time period wherein said mother is breast feeding said neonate, infant, or child;wherein said composition comprises at least 5 international units (IU's) of tocopherol, wherein at least 98% of all of said tocopherol in said composition is unmodified natural d-alpha-tocopherol, and wherein less than 2% of all of said tocopherol in said composition is gamma-tocopherol, andwherein said administering prevents, or reduces the severity of, an inflammatory condition in said neonate, infant, or child.2. The method of claim 1 , wherein said condition premature fetal lung disease claim 1 , full term pulmonary distress claim 1 , childhood asthma claim 1 , or an allergic condition.3. The method of claim 1 , wherein said mother has at lease one type of allergy.4. The method of claim 3 , wherein said method further comprising claim 3 , prior to said administering claim 3 , testing said mother for at lease one type of allergy.5. The method of claim 1 , wherein at least 99% of all of said tocopherol in said composition is unmodified natural d-alpha-tocopherol claim 1 , and wherein less than 1% of all of said tocopherol in said composition is gamma-tocopherol.6. The method of claim 1 , wherein at least 99.9 ...

NUTRITIONAL SUPPLEMENT COMPRISING HERBAL GALACTAGOGUE

The present invention provides a single unit composition for lactation improvement comprising herbal galactagogue and a method for using the same. In one particular embodiment, the single unit composition of the invention comprises fenugreek and a mixture of essential minerals and vitamins. 1. A single unit nutritional supplement for breastfeeding female to enhance breast milk supply and/or lactation , said nutritional supplement comprising a postnatal vitamin , an essential mineral , and an effective amount of an herbal galactagogue.2. The single unit nutritional supplement of claim 1 , wherein said herbal galactagogue comprises fenugreek claim 1 , fennel seed claim 1 , or a combination thereof.3. The single unit nutritional supplement of claim 2 , wherein said nutritional supplement comprises at least 750 mg of effective fenugreek.4. The single unit nutritional supplement of claim 3 , wherein said nutritional supplement comprises at least 2 claim 3 ,000 mg of effective fenugreek.5. The single unit nutritional supplement of claim 1 , wherein said herbal galactagogue comprises fenugreek seed powder claim 1 , fenugreek extract claim 1 , or a combination thereof.6. The single unit nutritional supplement of claim 1 , wherein said single unit nutritional supplement comprises vitamin D claim 1 , vitamin B claim 1 , vitamin B claim 1 , chromium claim 1 , folic acid claim 1 , or a combination thereof.7. The single unit nutritional supplement of claim 6 , wherein said single unit nutritional supplement comprises vitamin D claim 6 , vitamin B claim 6 , vitamin B claim 6 , chromium claim 6 , folic acid claim 6 , fenugreek claim 6 , fennel seed claim 6 , and at least one of an additional ingredient selected from the group consisting of vitamin A claim 6 , vitamin C claim 6 , vitamin E claim 6 , vitamin K claim 6 , thiamin claim 6 , riboflavin claim 6 , niacin claim 6 , biotin claim 6 , pantothenic acid claim 6 , calcium claim 6 , iron claim 6 , iodine claim 6 , magnesium claim ...

Fermented nutrition high in lactose with increased iron bioavailability

The present invention relates to fermented nutritional compositions comprising high concentration of lactosem such as 6 grams per 100 ml, and optionally non-digestible oligosaccharides, such as galactooligosaccharides or fructooligosaccharides for improving the bioavailability of iron and preventing or treating of iron deficiency (anaemia), in particular for infants and young children or pregnant women. In another aspect of the invention, the nutritional composition are used for preventing cognitive disorders and/or socio-emotional disorders in an infant and/or young child.

COMPOSITIONS FOR USE IN STIMULATING BONE GROWTH

The present invention relates to use of a composition for maintenance of bone and/or cartilage health or prevention, alleviation and/or treatment of bone and/or cartilage disorders. 1. A method for potentiating the effects of one or more polyphenols on bone formation and/or cartilage anabolism comprising administering a composition comprising Vitamin D to an individual in need of same.2. Method according to wherein the polyphenols are one or more of oleuropein and hydroxytyrosol.3. A method for potentiating the stimulation of bone formation and/or cartilage anabolism by use of polyphenols comprising administering a composition comprising Vitamin D and one or more polyphenols to an individual in need of same.4. The method according to wherein the polyphenols comprise one or more of oleuropein and hydroxytyrosol.5. The method according to claim 3 , wherein the polyphenols comprise oleuropein and hydroxytyrosol.6. The method according to wherein the composition comprises from 800 to 1200 IU Vitamin D claim 5 , from 0.01 mg to 1 g oleuropein and from 0.01 mg to 1 g hydroxytyrosol.7. The method according to claim 1 , wherein the composition comprises one or more further bioactive molecules.8. The method according to claim 7 , wherein the composition comprises the mineral calcium and/or magnesium.9. The method according to claim 1 , wherein the individual is a member of an ageing population.10. The method according to claim 1 , wherein the use is in the treatment claim 1 , alleviation and/or prophylaxis of disorders linked to an imbalance in the relationship between bone formation and/or cartilage anabolism and bone resorption by potentiating the stimulation of bone formation and/or cartilage anabolism.11. The method according to claim 1 , wherein said-the use is to maintain and/or improve mobility.12. The method according to claim 1 , wherein the use is to improve bone strength.13. The method according to wherein the disorder is selected from the group consisting of ...

MUNG BEAN PROTEIN GEL COMPOSITION AND CHEESE-LIKE FOOD

The invention provides a gelled composition of mung bean protein comprising a mung bean protein and an alkali metal ion, wherein the gelled composition of mung bean protein comprises the alkali metal ion at 50 mM or greater based on the total amount of the gelled composition of mung bean protein. 1. A gelled composition of mung bean protein comprising a mung bean protein and an alkali metal ion , wherein the gelled composition of mung bean protein comprises the alkali metal ion at 50 mM or greater based on the total amount of the gelled composition of mung bean protein.2. The gelled composition of mung bean protein according to claim 1 , wherein the alkali metal ion is at least one of sodium ion and potassium ion.3. The gelled composition of mung bean protein according to claim 1 , further comprising no greater than 50 wt % of a fat or oil based on the total weight of the gelled composition of mung bean protein.4. A cheese-like food comprising the gelled composition of mung bean protein according to and a flavoring.5. The gelled composition of mung bean protein according to claim 2 , further comprising no greater than 50 wt % of a fat or oil based on the total weight of the gelled composition of mung bean protein.6. A cheese-like food comprising the gelled composition of mung bean protein according to and a flavoring.7. The gelled composition of mung bean protein according to claim 2 , wherein a sodium ion content is at least 50 mol % of a total alkali metal ion in the gelled composition of mung bean protein.8. The gelled composition of mung bean protein according to claim 1 , wherein a mung bean protein content is 8.3 to 15.0 wt % based on the total weight of the gelled composition of mung bean protein claim 1 , as crude protein calculated by the Kjeldahl method. The present invention relates to a gelled composition of mung bean protein and to a cheese-like food.Mung bean (seed) is a seed with a high level of physiological function that has been used in China as a ...

FERMENTED NUTRITION WITH NON-DIGESTIBLE OLIGOSACCHARIDES WITH INCREASED IRON BIOAVAILABILITY

The present invention relates to fermented nutritional compositions comprising non-digestible oligosaccharides for improving the bioavailability of iron and preventing or treating of iron deficiency, in particular for infants and young children or pregnant women. 120-. (canceled)21. A method for treating and/or preventing anaemia and/or treating and/or preventing iron deficiency in a human subject , comprising administering to the subject in need thereof a nutritional composition comprising:(a) a milk-derived product fermented by lactic acid producing bacteria, the fermented milk-derived product comprising lactic acid and/or lactate,(b) at least 0.2 g non-digestible oligosaccharides per 100 ml nutritional composition and/or at least 1.0 wt. % non-digestible oligosaccharides based on dry weight of the nutritional composition, wherein the non-digestible oligosaccharides are one or more selected from the group consisting of galactooligosaccharides, fructooligosaccharides, uronic acid oligosaccharides, glucooligosaccharides, xylooligosaccharides, mannanoligosaccharides, arabino-oligosaccharides, glucomannooligosaccharides, galactomannooligosaccharides, soy oligosaccharides, isomaltooligosaccharides, non-digestible dextrin, arabinogalactooligosaccharides, gentiooligosaccharides, nigerooligosaccharides, chitooligosaccharides, fucooligosaccharides, sialyloligosaccharides, and(c) iron.22. The method according to claim 21 , wherein the human subject is selected from the group consisting of human subjects with an age of 0 to 36 months and pregnant women.23. The method according to claim 21 , wherein the nutritional composition comprises iron in a concentration of 0.4 to 0.7 mg per 100 ml nutritional composition and/or of 0.03 to 0.055 mg per g dry weight of the nutritional composition.24. The method according to claim 21 , wherein the nutritional composition comprises 0.1 to 1.5 wt. % of the sum of lactic acid and lactate based on dry weight of the nutritional composition ...

FOOD SUPPLEMENT FOR PEOPLE WITH DOWN SYNDROME, AUTISM SPECTRUM DISORDER AND/OR ATTENTION DEFICIT DISORDER WITH OR WITHOUT HYPERACTIVITY

The present invention describes a food supplement comprising isomaltulose, milk serum protein concentrate, linseed, milk serum mineral complex, short chain fructooligosacharides, lactoferrin, and vitamin B6. This food supplement was developed for use as support in the nutritional therapy in people suffering from Trisomy 21, Autism Spectrum Disorders and/or Attention Deficit Disorder with or without Hyperactivity. 1. A food supplement characterized by comprising , by weight: a) from 62 to 75% isomaltulose; b) from 12 to 21% milk serum protein concentrate; c) from 2 to 8.4% linseed; d) from 1 to 4.4% milk serum mineral complex; e) from 1.6 to 6.7% short chain fructooligosacharides; f) from 0.03 to 0.09% lactoferrin; and , g) from 0.002 to 0.008% vitamin B6.2. A food supplement claim 1 , according to claim 1 , further comprising claim 1 , by weight: a) from 65 to 71% isomaltulose; b) from 14 to 17% milk serum protein concentrate; c) from 4 to 4.5% linseed; d) from 2 to 2.5% milk serum mineral complex; e) from 3 to 4% short chain fructooligosacharides; f) from 0.05 to 0.07% lactoferrin; and claim 1 , g) from 0.005 to 0.007% vitamin B6.3. A food supplement claim 1 , according to claim 1 , wherein the milk serum protein concentrate has a protein content of about 80%.4. A food supplement claim 1 , according to claim 1 , wherein the linseed has the following composition: about 41% fat claim 1 , about 28% dietetic fiber claim 1 , about 20% plant protein claim 1 , about 7% humidity claim 1 , and about 4% ashes.5. A food supplement claim 4 , according to claim 4 , wherein the linseed has a two parts of omega-6 fatty acids to three parts of omega-3 fatty acids ratio.6. A food supplement claim 5 , according to claim 5 , wherein the linseed employed is golden linseed.7. A food supplement claim 1 , according to claim 1 , wherein the milk serum mineral complex has the following composition: about 24% calcium claim 1 , about 12.50% phosphorous claim 1 , about 1.50% magnesium claim 1 ...

Preconception/Prenatal/Postnatal Optimal Nutrition System, Compositions and Kits for Use Therein, and Methods of Making and Using Same

A nutrition system for use during a preconception period, during pregnancy, during lactation, and/or during postnatal weight loss is disclosed herein. Also disclosed are compositions and kits for use therein, as well as methods of making and using same. Also disclosed are a range of preconception, prenatal, pregnancy, postnatal, and/or lactation food and/or beverage products, assemblies containing same, and methods of production and use thereof. 1. A composition , comprising at least two food and/or beverage product designed specifically for consumption during one or more periods spanning from preconception through postnatal lactation , the at least one food and/or beverage product comprising:a preconception/prenatal/postnatal fundamental nutrient bundle that comprises at least three preconception/prenatal/postnatal fundamental micronutrients;at least one macronutrient; andan metabolic health profile that includes one or more of: less than or equal to 20% calories from added sugar; less than 3 g fat; 0 g trans fat; less than 60 mg cholesterol; and less than 300 mg sodium;wherein each fundamental nutrient is present in the composition at a level in a range of from about 0.1% DV to about 100% DV; andwherein the at least one macronutrient is selected from the group consisting of protein, at least one amino acid, and carbohydrate.2. The composition of claim 1 , further defined as being sized and proportioned to serve as a complete meal claim 1 , as a meal replacement claim 1 , as an incomplete meal component claim 1 , and/or as a snack.3. The composition of claim 1 , wherein each of the at least three preconception/prenatal/postnatal fundamental micronutrients present in the preconception/prenatal/postnatal fundamental nutrient bundle is selected from the group consisting of docosahexaenoic acid (DHA) claim 1 , choline claim 1 , folic acid claim 1 , calcium claim 1 , vitamin C claim 1 , vitamin D claim 1 , vitamin E claim 1 , magnesium claim 1 , potassium claim 1 , ...

Calcium Carbonate Granulation

Highly compactable granulations and methods for preparing highly compactable granulations are disclosed. More particularly, highly compactable calcium carbonate granulations are disclosed. The granulations comprise powdered materials such as calcium carbonate that have small median particle sizes. The disclosed granulations are useful in pharmaceutical and nutraceutical tableting and provide smaller tablet sizes upon compression than previously available. 1. A dietary supplement tablet comprising an amount of calcium carbonate to provide an amount of elemental calcium , said tablet being about 20% to about 35% smaller in volume than a Caltrate® 600 mg tablet comprising the same amount of calcium carbonate , wherein said calcium carbonate is provided in compressed calcium carbonate granulations , wherein prior to compression into said tablet , said compressed calcium carbonate granulations are highly compactable and have a tap density between about 0.9 and about 2.0 g/cm.2. The tablet of claim 1 , wherein the tablet is about 20% smaller than said Caltrate® 600 mg tablet.3. The tablet of claim 1 , wherein said compressed calcium carbonate granulations comprise USP or food grade calcium carbonate powder having a median particle diameter of about 20 μm.4. The tablet of claim 1 , wherein said compressed calcium carbonate granulations comprise USP or food grade calcium carbonate powder having a median particle diameter from about 6 μm to about 12 μm.5. The tablet of claim 1 , wherein said compressed calcium carbonate granulations comprise USP or food grade calcium carbonate powder having a median particle diameter from about 6 μm to about 10 μm.6. The tablet of claim 1 , wherein said compressed calcium carbonate granulations comprise USP or food grade calcium carbonate powder having a median particle diameter of about 6 μm.7. The tablet of claim 1 , further comprising a binder in said compressed calcium carbonate granulations.8. The tablet of claim 7 , wherein the binder ...

NOVEL NOODLE DOUGH AND NOODLE PRODUCT USING THE SAME

A noodle product having a high magnesium content. 1. A noodle product made from wheat flour and/or buckwheat flour containing concentrated bittern.2. The noodle product according to claim 1 , wherein the concentrated bittern has a magnesium content of 6.0 wt % or more.3. The noodle product according to claim 1 , wherein the concentrated bittern has a sodium content of 1.0 wt % or less.4. The noodle product according to claim 1 , wherein the concentrated bittern contains magnesium in an amount of 60 to 100 mg based on 100 g of wheat flour and/or buckwheat flour.5. The noodle product according to claim 4 , wherein the magnesium content of the noodle product after boiling is 30 to 50 mg based on 100 g of the noodle product before boiling.6. The noodle product according to which alleviates the morning sickness of a pregnant woman.7. The noodle product according to which is a food with nutrient function.8. The noodle product according to which is wheat noodles claim 1 , fine noodles claim 1 , buckwheat noodles claim 1 , pasta claim 1 , Chinese noodles or noodles.9. The noodle product according to which is a dry noodle product.10. The noodle product according to claim 1 , wherein the concentrated bittern is naturally-concentrated bittern produced in Lake Deborah. The present invention relates to noodle dough having a high magnesium content produced by mixing wheat flour and/or buckwheat flour with concentrated bittern containing a large amount of magnesium and a noodle product thereof. That is, the noodle product of the present invention contains concentrated bittern having a high magnesium content in place of salt which is indispensable in the production of wheat noodles, thereby providing noodle dough containing a large amount of Mg as an essential mineral and a noodle product thereof.Noodles, for example, wheat noodles, fine noodles, buckwheat noodles, pasta, or noodles and Chinese noodles are eaten worldwide, and the process for producing noodle dough remains ...

UNIFORM FILMS FOR RAPID-DISSOLVE DOSAGE FORM INCORPORATING ANTI-TACKING COMPOSITIONS

The present invention relates to water-soluble films incorporating anti-tacking agents and methods of their preparation. Anti-tacking agents may improve the flow characteristics of the compositions and thereby reduce the problem of film adhering to a user's mouth or to other units of film. In particular, the present invention relates to edible water-soluble delivery systems in the form of a film composition including a water-soluble polymer, an active component selected from cosmetic agents, pharmaceutical agents, vitamins, bioactive agents and combinations thereof and at least one anti-tacking agent. 1. An edible film for delivery of an active comprising:an edible, water-soluble polymer;at least one anti-tacking agent selected from the group consisting of lubricants, antiadherants, glidants and combinations thereof; andan active component selected from the group consisting of cosmetic agents, pharmaceutical agents, vitamins, bioactive agents and combinations thereof,wherein said film is self-supporting.2. The film of claim 1 , wherein said anti-tacking agent comprises Vitamin E TPGS.3. The film of claim 1 , wherein said anti-tacking agent comprises magnesium stearate.4. The film of claim 3 , wherein said anti-tacking agent further comprises silica.5. The film of claim 1 , wherein said anti-tacking agent is present in amounts of about 0.01% to about 20% by weight of said delivery system.6. The film of claim 1 , wherein said anti-tacking agent comprises:magnesium stearate present in amounts of about 0.1% to about 2.5% by weight of said delivery system; andsilica present in amounts of about 0.1% to about 1.5% by weight of said delivery system.7. The film of claim 1 , wherein said water-soluble polymer comprises polyethylene oxide and a cellulosic polymer.8. The film of claim 7 , wherein said cellulosic polymer comprises hydroxypropyl cellulose.9. The film of claim 7 , wherein said cellulosic polymer comprises hydroxypropylmethyl cellulose.10. The film of claim 1 , ...

Food supplement to support brain function

The present invention relates to a food supplement to support brain function, including cognitive functions such as memory. The food supplement comprises one or more active ingredients selected from the group consisting of uridine, cytidine, glutamine, pantothenic acid, iron, colostrinin and caffeine.

Anti-Inflammatory Composition for Modulating the Cell Response of Neutrophils and Eosinophils

The present invention relates to an anti-inflammatory composition intended for humans and animals for modulating the cell response of the neutrophils and of eosinophils. 1Corturnix corturnix japonica. An anti-inflammatory composition intended for humans and animals for modulating a cell response of neutrophils and eosinophils , the anti-inflammatory composition comprising: an extract from eggs of a quail of a strain B-Mina comprising an ovomucoid and a quail egg ovo-inhibitor.2. The anti-inflammatory composition according to claim 1 , further comprising: at least one vitamin selected from a group consisting of A claim 1 , B claim 1 , C claim 1 , D claim 1 , E claim 1 , F claim 1 , K and P.3. The anti-inflammatory composition according to claim 1 , further comprising: at least one mineral selected from a group consisting of Al claim 1 , Bi claim 1 , Co claim 1 , Cu claim 1 , Fe claim 1 , F claim 1 , Li claim 1 , Mg claim 1 , Ni claim 1 , P claim 1 , K claim 1 , Se claim 1 , S and Zn.4. The anti-inflammatory composition according to claim 1 , further comprising: at least one amino acid taken from a group consisting of Ile claim 1 , Leu claim 1 , Lys claim 1 , Met claim 1 , Phe claim 1 , Thr claim 1 , Trp claim 1 , Val claim 1 , Glu and Gln.5. The anti-inflammatory composition according to claim 1 , further comprising: at least one plant extract selected from a group formed by plant extracts from roots claim 1 , stems claim 1 , leaves claim 1 , flowers and fruit.6. The anti-inflammatory composition according to claim 1 , further comprising: a pharmaceutically acceptable or food-compatible excipient.7. The anti-inflammatory composition according to claim 1 , wherein the anti-inflammatory composition is packaged as one of tablets claim 1 , globules claim 1 , gelatin capsules claim 1 , granules claim 1 , powders claim 1 , fluids claim 1 , liquids claim 1 , creams and sprays.8. The anti-inflammatory composition according to claim 3 , wherein Zn is protected Zn.9. The anti- ...

COMPOSITIONS OF NUTRITION SUPPLEMENTATION FOR NUTRITIONAL DEFICIENCIES AND METHOD OF USE THEREFORE

A nutritional supplement composition for treating nutritional deficiencies caused by a medical condition in subjects is disclosed. The present application further discloses a method of using a nutritional supplements composition for treating a subject with complications resulting from sickle cell anemia. The method comprises administering to a subject an effective amount of the nutritional supplement. 17-. (canceled)8. A nutritional supplement to normal diet for treating conditions associated with abnormally slow energy metabolism or high energy requirement , comprising:protein in an amount that provides about 10-20% of the total calories;fat in an amount that provides about 25-40% of the total calories; andcarbohydrate that provides about 45-65% of the total calories.9. The nutritional supplement of claim 8 , wherein the nutritional supplement comprises:protein in an amount that provides about 14% of the total calories;fat in an amount that provides about 32% of the total calories; andcarbohydrate that provides about 54% of the total calories.10. The nutritional supplement of claim 8 , wherein the nutritional supplement has a total calorie of about 700-980 kcal.11. The nutritional supplement of claim 10 , wherein the nutritional supplement comprises about 24-34 grams of protein; about 25-35 grams of fat; and about 96-135 grams of carbohydrate.12. The nutritional supplement of claim 8 , wherein the nutritional supplement further comprises at least one food grade amino acid selected from the group consisting of arginine claim 8 , histidine claim 8 , leucine claim 8 , valine claim 8 , cysteine and glutamine.13. The nutritional supplement of claim 12 , wherein the nutritional supplement comprises arginine claim 12 , histidine claim 12 , leucine claim 12 , valine claim 12 , cysteine and glutamine claim 12 , and wherein each amino acid is provided at a per diem dose range of 8-14 mg/kg body weight/day.14. The nutritional supplement of claim 12 , wherein the nutritional ...

FULVIC ACID AND DERIVATIVES AND METHODS OF PREPARATION AND USE

Disclosed are antioxidative, natural compounds, their salts, chelates and cleavage derivatives that exhibit a superior combination of properties. The compounds can be used for a variety of purposes, including stabilizing foods, cosmetics, beverages and nutritional supplements. The compounds can be prepared by hydrolyzing a fulvic acid of formula I or VIII to provide at least one antioxidant compounds of formula II, formula III, formula IV, formula V, formula VI, formula VII, salts, or chelates thereof. 2. The antioxidant compound of claim 1 , wherein at least one compound is formula II-VII claim 1 , a salt claim 1 , or chelate thereof.3. The antioxidant compound of claim 1 , wherein the compound is formula II claim 1 , a salt claim 1 , or chelate thereof.4. The antioxidant compound of claim 1 , wherein the compound is formula III claim 1 , a salt claim 1 , or chelate thereof.5. The antioxidant compound of claim 1 , wherein the compound is formula IV claim 1 , a salt claim 1 , or chelate thereof.6. The antioxidant compound of claim 1 , wherein the compound is formula V claim 1 , a salt claim 1 , or chelate thereof.7. The antioxidant compound of claim 1 , wherein the compound is formula VI claim 1 , a salt claim 1 , or chelate thereof.8. The antioxidant compound of claim 1 , wherein the compound is formula VII claim 1 , a salt claim 1 , or chelate thereof.9. The antioxidant compound of claim 1 , wherein the compound is formula VIII claim 1 , a salt claim 1 , or chelate thereof.10. The antioxidant compound of claim 1 , wherein the salt is selected from the group consisting of a lithium salt claim 1 , a sodium salt claim 1 , an ammonium salt claim 1 , a potassium salt claim 1 , a calcium salt claim 1 , a barium salt claim 1 , a magnesium salt claim 1 , a manganese salt claim 1 , a zinc salt claim 1 , an aluminum salt claim 1 , and an iron salt.11. The antioxidant compound of claim 1 , wherein the salt comprises sodium salt claim 1 , potassium salt claim 1 , calcium salt ...

Blood lactate range targets and nutritional formulations and protocols to support patients

Systems, techniques and methods for estimating the metabolic state or flux, e.g., the body energy state (“BES”) of a patient, are disclosed. The BES provides a deep insight into the nutritional needs of the patient, thus allowing for a sort of exquisite glycemic control with regard to the patient. The invention discloses systems and methods for estimating fractional gluconeogenesis. The invention also discloses systems and methods for estimating and targeting patient blood lactate concentration, both as a target itself and as an intermediate step to estimating and targeting patient fractional gluconeogenesis glucose production. Nutritional support methods and formulations are also disclosed. The invention is suitable for any sort of patient, including those who are injured, such as with traumatic brain injury, ill, or have other conditions that stress the metabolic system.

REDUCED-CALORIE AND DIGESTION-PROMOTING FOODS

The invention relates to reduced-calorie and digestion-promoting foods that have a calorific value-containing portion and are mixed with talc. Calorific value-containing components of the calorific value-containing portion are selected from the group consisting of carbohydrates, proteins and fats. Sugars are to be subsumed under carbohydrates. The invention relates to a food that has a calorific value-containing portion, wherein talc composes at least 15 wt % and no more than 40 wt % of the food relative to the total weight of the food. 1. A food having a calorific value-containing portion , characterized in that it contains talc in a portion of at least 15 wt % relative to the total weight of the food , wherein at least one calorific value-containing component of the calorific value-containing portion of the food is partially or completely replaced by talc.2. The food according to claim 1 , wherein the food contains talc in a portion of no more than 40 wt % relative to the total weight of the food.3. The food according to claim 1 , wherein at least two calorific value-containing components of the calorific value-containing portion of the food are partially or completely replaced by talc.4. The food according to claim 3 , wherein the calorific value-containing portion is selected from carbohydrates claim 3 , proteins or fats.5. The food according to claim 4 , wherein the calorific value-containing portion is at least 50 wt % relative to the whole food.6. The food according to claim 5 , wherein in the food at least 50 wt % of carbohydrates are present relative to the whole food.7. The food according to claim 6 , wherein in the food at least 30 wt % of fat are present relative to the whole food.8. The food according to claim 7 , wherein in the food at least 30 wt % of protein are present relative to the whole food.9. A method of reducing the calorific value of a food claim 7 , comprising replacing in total at least 15 wt % of a calorific value-containing portion of ...

Supplement for a Breastfeeding Woman

A daily intake formulated for breastfeeding women containing iron, vitamin B6, iodine, vitamin D, and herbs and galactogogues that support milk production. 1. A daily intake formulated for breastfeeding women comprising:a. less than about 18 mg per daily intake iron;b. greater than about 2 mg per daily intake vitamin B6;c. iodine;d. greater than about 600 IU per daily intake vitamin D; ande. herbs and galactogogues wherein the herbs and galactogogues support milk production.2. The daily intake of wherein the vitamin D is vitamin D3.3. The daily intake of wherein at least a portion of the iodine is from kelp.4. The daily intake of wherein the herbs and galactogogues are selected from the group consisting of oat claim 1 , lemon balm leaf claim 1 , chamomile flower claim 1 , lavender flower claim 1 , cardamom seed claim 1 , and combinations thereof.5. The daily intake of wherein the herbs and galactogogues are fermented.6. The daily intake of wherein the herbs and galactogogues are selected from the group consisting of kelp claim 1 , amla claim 1 , cumin seed claim 1 , turmeric claim 1 , and combinations thereof.7. The daily intake of further comprising vitamin B 1 claim 1 , vitamin B2 claim 1 , vitamin B3 claim 1 , vitamin B5 claim 1 , vitamin B7 claim 1 , and vitamin B9.8. The daily intake of further comprising from about 60 mg to about 120 mg vitamin C.9Lithothamnion calcareum.. The daily intake of further comprising calcium wherein at least a portion of the calcium is from10Lithothamnion calcareum.. The daily intake of further comprising greater than about 10 mg magnesium and wherein at least a portion of the magnesium is from11. The daily intake of further comprising from about 1 to about 3 mg manganese.12. A method of supporting the overall health and well-being of a breastfeeding woman by administering the composition of .13. A method of supporting the mood of a breastfeeding woman by administering the composition of .14. A method of supporting the digestion of ...

COMPOSITIONS AND METHODS FOR INCREASING IRON INTAKE IN A MAMMAL

Compositions containing iron and denatured protein have been prepared that are capable of increasing serum iron and other divalent metal cations in a subject. For example, edible microbeads have been prepared containing iron entrapped within a protein matrix that provides a gastroprotective effect and improves iron bioavailability relative to previously known vehicles for delivering iron to a subject. 1. A composition comprising:iron; anda carrier comprising denatured protein,wherein the composition releases less than 50 wt % of the total iron content as ferrous iron over the course of one hour in simulated gastric fluid at pH 1.6 andwherein the composition, when administered orally to a human, has a relative bioavailability of at least 120% that of an equimolar dose of an orally administered solution of ferrous sulfate in acidified water.2. The composition of claim 1 , wherein the iron:protein ratio claim 1 , by weight claim 1 , is 1:500 to 1:5.3. The composition of claim 1 , wherein the iron:protein ratio claim 1 , by weight claim 1 , is 1:100 to 1:5.4. The composition of claim 1 , wherein the composition is largely amorphous.5. The composition of claim 1 , where in the total iron content is 1%-2.5%.6. The composition of claim 1 , wherein the denatured protein is at least 50% claim 1 , 80% or 90% denatured.7. The composition of claim 1 , wherein the denatured protein contains at least 50% claim 1 , 80% or 90% denatured beta lactoglobulin.8. The composition of claim 1 , wherein the moisture content of the composition is less than 10% by weight.9. The composition of claim 1 , wherein the carrier comprises a core and a skin claim 1 , wherein skin comprises a denatured aggregated protein.1011-. (canceled)12. The composition of claim 1 , wherein the denatured protein contains claim 1 , excluding iron claim 1 , less than 1% divalent metal ions (w/v).13. The composition of claim 1 , wherein the denatured protein contains less than 1% calcium (w/w).14. The composition of ...

COMBINATION OF PETROSELINIC ACID AND TAURINE FOR ORAL ADMINISTRATION FOR HAIR AGING CONTROL

The invention relates to the cosmetic use, by oral administration, of a combination of active agents including petroselinic acid and taurine, for improving hair quality and for preventing and controlling the microinflammation of hair follicles, in particular for controlling hair aging in men over the age of 30 or in women. 117-. (canceled)18. A cosmetic method for improving the quality of the head of hair , comprising at least a step consisting in an oral administration of a combination of active agents comprising petroselinic acid and taurine , wherein the improvement in the quality of the hair fiber comprises improving the tensile strength of the hair , and/or the resistance to styling and/or shaping of the hair , and/or preventing and/or combating limp and/or breakable and/or dull and/or split and/or embrittled and/or sensitized and/or dry hair , and/or improving the softness and/or vigor of the hair fibers.19. The method as claimed in claim 18 , for preventing and/or combating aging of the hair in the case of men over 30 years old or in the case of women.20. The method as claimed in claim 18 , for preventing and/or combating low-noise microinflammation of the hair follicles.21Geranium sanguineum. The method as claimed in claim 18 , wherein petroselinic acid is used in the form of umbellifera plant oil or oil.22. The method as claimed in claim 18 , wherein petroselinic acid is used in the form of coriander claim 18 , chervil claim 18 , carrot claim 18 , celery claim 18 , cumin claim 18 , caraway claim 18 , parsley or dill oil.23. The method as claimed in claim 18 , wherein petroselinic acid is used in the form of an oil of coriander seeds.24. The method as claimed in claim 18 , wherein the combination of active agents also comprises zinc gluconate.25. The method as claimed in claim 18 , wherein the combination of active agents also contains vitamin D3.26. The method as claimed in claim 18 , wherein the combination of active agents is used in the form of a food ...

DIETARY SUPPLEMENT COMPOSITIONS

This document provides dietary supplement compositions as well as methods for using dietary supplement compositions to control glucose levels. For example, a dietary supplement composition including chromium (e.g., Chromium Oligofructose Complex), a sweet potato extract, and one or more of a mulberry extract, a green tea extract, a cinnamon extract, or a ginseng extract (e.g., Korean Red Ginseng extract) are provided. 1. A dietary supplement composition , comprising:a sweet potato extract;a chromium; andone or more ingredients selected from the group consisting of a mulberry extract, a green tea extract, a cinnamon extract, and a ginseng extract.2. The dietary supplement composition of claim 1 , wherein the dietary supplement composition comprises a mulberry extract claim 1 , a green tea extract claim 1 , a cinnamon extract claim 1 , and a ginseng extract.3. The dietary supplement composition of claim 1 , wherein the dietary supplement composition is in the form of a dry powder.4. The dietary supplement composition of claim 3 , wherein the dry powder dietary supplement composition is suitable for blending with a liquid to form a beverage comprising a solution claim 3 , aqueous slurry claim 3 , or combination thereof.5. The dietary supplement composition of claim 3 , wherein the dietary supplement composition comprises between 0.1 weight percent and 2.0 weight percent of one or more sweet potato extracts.6. The dietary supplement composition of claim 3 , wherein the dietary supplement composition comprises between 0.01 weight percent and 0.1 weight percent of a chromium containing compound.7. The dietary supplement composition of claim 3 , wherein the dietary supplement composition comprises between 0.5 weight percent and 10 weight percent one or more mulberry extracts.8. The dietary supplement composition of claim 3 , wherein the dietary supplement composition comprises between 0.1 weight percent and 5 weight percent one or more ginseng extracts.9. The dietary ...

Hemp-Based Infant Formula and Methods of Making Same

The present invention pertains to the field of nutrition and in particular a food product formulation based on protein and other nutrients extracted from oil seeds, such as hemp, for a plurality of uses, including, but not limited to an infant or toddler formula, a beverage, baked goods or a protein supplement. Suitable oil seeds include, but are not limited to hemp, flax, chia, pea and spirulina. Accordingly, the present invention provides a food product formulation for human consumption that can provide a complete source of dietary protein and other nutrients through oil seed protein. The formulation may be prepared in a variety of product forms, including but not limited to, a ready-to-serve liquid form, or a powder form that can be reconstituted prior to human consumption into liquid form, or a powder form that can be added to oilier ingredients to produce a baked product for human consumption, or a protein supplement. 1. An infant formula composition comprising protein , carbohydrates and lipids effective to supply , per 100 calories , between about 1.8 and 4.5 g of protein , between about 3.3 and 6 g of lipids , and between about 9 and 14 g of carbohydrates , the formulation also comprising between about 1 and 100% of a daily recommended intake of vitamins and minerals , wherein said formulation comprises hemp or a hemp derivative as at least one source of protein , carbohydrate , lipids , vitamins or minerals , or a combination thereof.2. The composition of claim 1 , wherein said hemp or a hemp derivative comprises hulled or dehulled hemp seed claim 1 , hemp concentrate claim 1 , hemp protein powder claim 1 , hemp isolate claim 1 , hemp oil claim 1 , hemp liquid or a combination thereof.3aphanizomenflos aquaequinoa. The composition of claim 1 , wherein said composition comprises a protein source in addition to said hemp or a hemp derivative selected from the group consisting of: hemp protein claim 1 , hemp protein isolate claim 1 , hemp milk claim 1 , whey ...

FORMULATION FOR IRON SUPPLEMENTS

An iron supplement nutritional formulation for infants and adults is provided using a non-nutritive sweetener including an extract from monk fruit () in combination with a polysaccharide iron complex. The formulation improves the taste and palatability of the supplement, thereby increasing the dosage accuracy within children and infants who tend to spit out or regurgitate other forms of polysaccharide iron complexes. 1. An iron nutritional supplement comprising:an aqueous composition comprising a mixture of monk fruit extract and a polysaccharide iron complex.2. The composition according to wherein the amount of monk fruit is present at a percentage by weight of between about 0.09% to about 0.8%.3. An iron nutritional supplement comprising a mixture of monk fruit extract and a polysaccharide iron complex where the ratio of monk fruit extract to polysaccharide iron complex ranges from about 1:30 parts by weight to about 1:60 parts by weight. This application claims the benefit of U.S. application Ser. No. 61/715,545 filed on Oct. 18, 2012 and which is incorporated herein by reference.This invention is directed towards iron preparations suitable for pharmaceutical and OTC formulations and processes for the preparation thereof. An iron preparation of the invention comprises non-nutritive and dietically sugar free flavoring agents which improve the ingestion rate of iron supplements in infants and young children and improves the flavor and reduces unpleasant aftertaste associated with traditional iron nutritional supplements.This invention relates to improvements in iron nutritional supplements.Iron deficiency is the most common micronutrient deficiency in the world, affecting 1.3 billion people (24% of the world's population). Severe iron deficiency, i.e., iron deficiency anemia, is particularly debilitating, since iron has several vital physiological functions, including: (1) carriage of oxygen from lung to tissues; (2) electron transport within cells; and (3) ...

TOXIN DECONTAMINANT FOOD PRODUCT AND METHOD OF TREATING DISORDERS OF THE GASTROINTESTINAL TRACT

The invention encompasses antidotal food products containing activated charcoal for ingestion into the gastrointestinal tract of a user for treating various gastrointestinal disorders. The antidotal food product is orally administered having the visual appearance and physical properties which enables the desire on the part of young children to chew and ingest the food product. 1. A method of treating or preventing a gastrointestinal disorder comprising administering to a subject in need thereof an edible toxin-decontaminant product comprising a plurality of ingredients said plurality comprising an effective amount of activated charcoal.2. The method of claim 1 , wherein the gastrointestinal disorder is diarrhea claim 1 , intestinal gas claim 1 , abdominal/enteric sepsis claim 1 , peptic ulcer disease claim 1 , gastritis claim 1 , reflux esophagitis claim 1 , food poisoning claim 1 , bad breath claim 1 , gingivitis claim 1 , or ostomy odor.3. The method of claim 1 , wherein one or more of ingredients comprises a dough.4. The method of claim 3 , wherein the dough comprises one or more flavoring agents.5. The method of claim 3 , wherein the dough comprises one or more complexing or thickening agents or mixtures thereof.6. The method of claim 3 , wherein the dough comprises one or more emulsifying agents or mixtures thereof.7. The method of claim 3 , wherein the dough comprises an agent to improve porosity and texture.8. The method of claim 1 , wherein said activated charcoal is characterized by an internal surface area of from about 800 m/g to about 3 claim 1 ,000 m/g.9. The method of claim 1 , wherein said activated charcoal is characterized by an internal surface area of about 2 claim 1 ,000 m/g.10. The method of claim 1 , wherein the product includes the activated charcoal in the approximate weight range of from about 20% to about 70% thereof.11. The method of claim 1 , wherein the product includes the activated charcoal in the approximate weight range of from about ...

FOOD COMPOSITION

Disclosed is a food supplement including at least the amino acids leucine, isoleucine, valine, threonine and lysine and Chromium. Also disclosed are food compositions including the food supplement as well as uses of both. 110-. (canceled)11. A food supplement consisting of leucine , isoleucine , valine , threonine , lysine and chromium.12. The food supplement according to claim 11 , consisting of tryptophan and/or taurine.13. The food supplement of wherein the chromium is present in a form selected from chromium picolinate claim 11 , chromium nicotinate claim 11 , chromium polynicotinate claim 11 , chromium propionate claim 11 , chromium acetylacetonate claim 11 , chromium-citrate claim 11 , chromium nicotinate claim 11 , chromium dinicocysteinate claim 11 , niacin-bound chromium claim 11 , amino acid chelates with chromium claim 11 , chromium chelavite claim 11 , or combinations thereof.14. The food supplement according to claim 11 , wherein leucine is present in an amount of 10-50% claim 11 , isoleucine is present in an amount of 5-35% claim 11 , valine is present in an amount of 10-25% claim 11 , threonine is present in an amount of 10-35% and lysine is present in an amount of 10-25% wherein the percent is calculated on the total amount of the amino acids in the food supplement.15. The food supplement according to claim 11 , wherein leucine is present in an amount of 15-45% claim 11 , isoleucine is present in an amount of 5-35% claim 11 , valine is present in an amount of 10-20% claim 11 , threonine is present in an amount of 17-27% and lysine is present in an amount of 13-23% wherein the percent is calculated on the total amount of the amino acids in the food supplement.16. The food supplement according to further comprising magnesium and/or calcium.17. The food supplement according to further comprising ascorbic acid.18. The food supplement according to further comprising at least one probiotic bacteria.19. A food composition comprising the food supplement ...

Calcium Formate for Use as a Dietary Supplement

A calcium formate composition for oral administration to an individual for the purpose of supplementary dietary calcium is disclosed.

POLARISCOPE TOY AND ORNAMENT WITH ACCOMPANYING PHOTOELASTIC AND/OR PHOTOPLASTIC DEVICES

A variety of toy polariscopes are simpler in design and less costly than precision instruments used in scientific research and stress analysis of materials and structures. The toy polariscopes are designed for a variety of objects that may exhibit photoelastic properties such as glass, plastic, Plexiglas, gel candle material and other gels, and even edible photoelastic objects. They are specially designed for objects of various sizes with a variety of purposes such as objects to enhance learning in a variety of conditions and experiences. Special objects are designed to go with the toy polariscopes such as edible and inedible photoelastic objects, photoelastic candle material, a variety of photoelastic/photoplastic stands capable of a variety of displays in interaction with other designed photoelastic objects capable of a variety of interaction and displays. Other optical phenomena may also be observed. 1. A method of forming edible photoelastic material comprising:mixing a gelling agent with a liquid to form a first mixture;heating the first mixture with microwave radiation until a foam head is produced and the mixture reaches a temperature of 150° F. to 220° F.;adding a sugar and/or other sweetener to the heated first mixture to form a second mixture; andallowing the second mixture to set for at least 30 minutes;wherein the set second mixture is optically transparent to a thickness of at least ¼ in, has a melting point of at least 95° F., can be held in a human hand and manipulated by the fingers for at least 3 minutes without degradation, and exhibits multi-colored photoelastic fringes visible to the naked eye under polarized light under stress.2. The method of claim 1 , wherein the set second mixture can endure compressive force of at least 2 N/inwithout structural damage.3. The method of claim 1 , wherein the liquid is water in a temperature range of 32° F.-42° F.4. The method of claim 1 , further comprising allowing the gelling agent to bloom in the liquid for ...

PRE-PACKAGED MEAL OF FORTIFIED MACARONI AND CHEESE, AND FORTIFIED RICE AND BEANS

A prepackaged, fortified meal provides a substantial portion of the daily recommended requirements, which can be adjusted depending upon the intended consumers for the meals. In a first embodiment, the meal contains macaroni, powdered cheese, soy, vitamins, and minerals. The cheese, vitamins and minerals are contained in a small package, and is added to a larger bag with the macaroni and soy. In a second embodiment, the meal contains rice, beans, soy, dehydrated vegetables, vitamins, minerals and seasoning. The vitamins, minerals and seasoning are contained in a small package, which is added to a larger bag with the rice, beans, soy and vegetables. The meals are cooked in boiling water before consumption. 1. A method of preparing a pre-packaged , fortified meal:opening a first package containing macaroni, soy protein and a second package, wherein the second package contains powdered cheese, vitamins and minerals;boiling the macaroni and soy protein in water to cook the macaroni; and thenafter the macaroni is cooked, adding the contents of the second bag to the cooked macaroni and soy protein.2. The method of wherein the soy protein is selected from a group consisting of textured soy and granulated soy.3. The method of wherein the vitamins are selected from a group consisting of Vitamin A claim 1 , Vitamin B6 claim 1 , Vitamin B12 claim 1 , Vitamin C claim 1 , Vitamin D and Vitamin E claim 1 , biotin claim 1 , folic acid claim 1 , pantothenic acid claim 1 , niacin claim 1 , thiamine claim 1 , and riboflavin.4. The method of wherein the minerals are selected from a group consisting of phosphorus claim 1 , iodine claim 1 , magnesium claim 1 , copper claim 1 , zinc and manganese.5. The method of further comprising retaining the water with the macaroni and soy protein for consumption.6. The method of where in the water is not drained prior to consumption of the macaroni and soy protein.7. A method of preparing a meal of fortified macaroni and cheese claim 1 , comprising: ...

COMPOSITIONS AND METHODS FOR TREATING CARDIOMETABOLIC DISEASES AND DISORDERS

Described herein are combinations useful for treating or preventing a cardiometabolic disease or disorder, or which can be used for appetite suppression, for improvement of endothelial function, for controlling weight, or a combination of one or more thereof. The combinations comprise Berberine, alpha lipoic acid (LA), and apocynin, or an isomer, derivative, pharmaceutically acceptable salt or ester of one or more thereof. Methods of treatment using the combinations, as well as compositions and re lated medical uses are also described. 1. A combination for treating or preventing a cardiometabolic disease or disorder , for appetite suppression , for improvement of endothelial function , for controlling weight , or for one or more thereof in a subject , said combination comprising:Berberine, an isomer, derivative, pharmaceutically acceptable salt or ester thereof,alpha lipoic acid (LA), an isomer, derivative, pharmaceutically acceptable salt or ester thereof,and a source of apocynin, an isomer, derivative, pharmaceutically acceptable salt or ester thereof.2Picrorhiza. The combination of claim 1 , wherein the source of apocynin is sp.3Picrorhiza. The combination of claim 2 , wherein said combination is formulated in a dosage form effective for administering from 100 mg to 400 mg Berberine claim 2 , from 75 mg to 300 mg LA and from 50 mg to 200 mg per dose claim 2 , up to 3 times daily.4Picrorhiza.. The combination of claim 3 , wherein said combination is formulated in a dosage form effective for administering 200 mg Berberine claim 3 , 150 mg LA claim 3 , and 100 mg5. The combination of claim 4 , wherein said combination is for administration 3 times a day claim 4 , before breakfast claim 4 , lunch and dinner.6. The combination of claim 4 , wherein said combination is for administration 3 times a day claim 4 , about 30 minutes before meals.7. The combination of claim 1 , formulated as an oral supplement claim 1 , or as a food/feed additive.8. The combination of claim 1 ...

NUTRITIONAL COMPOSITION AND METHOD OF MANUFACTURE

A nutritional composition, and method of making it, that includes a carbohydrate, an insulin potentiator, an amino acid, a muscle growth stimulator, an energy increaser, at least one natural supplement for weight loss, reduction of cholesterol levels, and/or increased resistance to stress, and at least one flavoring ingredient. The composition may be provided in dry form for addition to a fluid or in liquid forms. The composition is ingested to improve endurance and muscle tissue repair after exercise. In an embodiment the composition includes vanadyl sulfate, gamma oryzanol, American ginseng, sucralose, and rhodiola rosea. In another embodiment the composition includes vanadyl sulfate, gamma oryzanol, stevia, garcinia cambogia, and diarginine malate. 1. A nutritional composition comprising:a carbohydrate;an insulin potentiator;an amino acid;a muscle growth stimulator;at least one energy increaser;at least one natural supplement selected from the group consisting of: garcinia cambogia,rhodiola rosea, and royal jelly; andat least one flavoring ingredient.2. The nutritional composition of wherein the carbohydrate is dextrose.3. The nutritional composition of wherein the insulin potentiator is vanadyl sulfate.4. The nutritional composition of wherein the amino acid is provided as at least one of diarginine malate claim 1 , dicreatine malate claim 1 , taurine and n-acetyl glutamine.5. The nutritional composition of wherein the muscle growth stimulator is gamma oryzanol.6. The nutritional composition of further comprising at least one of guanidinopropionic acid claim 5 , glycocyamine and diarginine malate.7. The nutritional composition of wherein the energy increaser is one of American ginseng and caffeine.8. The nutritional composition of wherein the flavoring ingredient is citric acid.9. The nutritional composition of further comprising a non-sugar sweetener.10. The nutritional composition of wherein the non-sugar sweetener is selected from the group consisting of: ...

FOOD-GRADE ENCAPSULATE AND PROCESS FOR THE PRODUCTION THEREOF

A food-grade encapsulate which comprises gelled proteins associated with a micronutrient, preferably a dietary mineral, as well as a process for producing the encapsulates are disclosed, with low micronutrient leakage during storage. 1. A food-grade encapsulate comprising gelled protein aggregates embedded in a continuous polysaccharide phase , the gelled protein aggregates comprise a micronutrient , and the encapsulate has a size of from 1 micron to 5 mm.2. The encapsulate according to claim 1 , wherein the micronutrient is a dietary mineral selected from the group consisting of potassium claim 1 , calcium claim 1 , magnesium claim 1 , iron claim 1 , trace elements claim 1 , and mixtures thereof claim 1 , the micronutrients being provided as a food-grade mineral claim 1 , organic salt claim 1 , or ions.3. The encapsulate according to claim 1 , wherein the proteins comprise globular proteins.4. The encapsulate according to claim 1 , wherein the proteins are selected from the group consisting of micellar caseins claim 1 , acid caseins claim 1 , caseinates claim 1 , and mixtures thereof.5. The encapsulate according to claim 1 , wherein the polysaccharide component is selected from the group consisting of highly branched pectins claim 1 , arabinogalactans claim 1 , arabinogalactan-protein complexes claim 1 , cereal arabinoxylans claim 1 , high molecular weight polysaccharides claim 1 , gelling polysaccharides and mixtures thereof.6. The encapsulate according to claim 1 , which has a pH ranging from 3.5 to 7.0.7. A process for producing a food-grade encapsulate claim 1 , comprising the steps of:a) mixing a micronutrient with a protein solution;b) gelling the protein solution; andc) before or after step b), adding a polysaccharide component to the protein solution.8. The process according to claim 7 , wherein step b) comprises at least one step selected from the group consisting of:heating the protein solution to a temperature from 70° C. to 150° C., for a period of from ...

Liquid Dietary Supplement Formulation Compositions

This invention relates to liquid dietary supplement formulation compositions that provide dietary minerals and additional optional ingredients beneficial for health; methods of design and manufacture of such compositions; and methods to enable convenient oral ingestion of the formulation ingredients, by adding the formulations to drinking water, beverages, foods, or meals. The formulation compositions of this invention generally include water, water-soluble calcium compound(s), water-soluble magnesium compound(s), and additional optional ingredients, wherein the sum of the concentrations of the calcium and magnesium compounds is most preferably 2 molar or more, up to the point of saturation. The formulations of this invention possess inherent resistance to microbial growth. The formulations of this invention and variations thereof can be used as dietary supplements to increase intake of beneficial minerals, to mineralize water, to fortify foods or beverages, and can also be used to prepare a variety of additional liquid formulations by varying the calcium and magnesium compounds, and/or by adding one or more compatible ingredient(s). 2. The composition of claim 1 , wherein the sum of the concentrations of the dissolved calcium compound(s) and dissolved magnesium compound(s) is in the range of about 1.5 molar to the point of saturation.3. The composition of claim 1 , wherein the sum of the concentrations of the dissolved calcium compound(s) and dissolved magnesium compound(s) is in the range of about 2 molar to the point of saturation.4. The composition of claim 1 , wherein the sum of the concentrations of the dissolved calcium compound(s) and dissolved magnesium compound(s) is in the range of about 1 molar to about 4.2 molar.5. The composition of claim 1 , wherein the sum of the concentrations of the dissolved calcium compound(s) and dissolved magnesium compound(s) is in the range of about 1.5 molar to about 4.2 molar.6. The composition of claim 1 , wherein the sum ...

MICRO-COLLOIDAL SILICIC ACID / BORIC ACID COMPOSITION AND A METHOD OF PREPARING A BIOENHANCING SOLUTION AND POWDER

The present invention provides a composition comprising an acidified aqueous solution of (1) micro colloidal silicic acid, (2) boric acid, and (3) a water absorbing additive, having a pH value of equal to or less than 1, wherein the micro colloidal silicic acid has particle sizes in the range of 1-8 nm, especially in the range of 1.5-6 nm. The invention also provides a particulate product obtainable by the method according to claim 18, wherein the particles comprise (1) silicic acid, (2) boric acid, and (3) the water absorbing additive, and wherein at least 90% of the particles in the particulate product have particle sizes in the range of 0.3-5 μm. 1. An acidified aqueous solution composition having a pH less than 1 , comprising:(i) micro colloidal silicic acid particles ranging in size from 3.5 nm to 8 nm,(ii) one or more nutrients selected from the group consisting of zinc, copper, molybdenum, selenium, a humic acid, a fulvic acid, an amino acid, and(iii) a water absorbing additive for at least 30% V/V of the composition.2. The composition according to claim 1 , wherein the micro colloidal silicic acid has particle sizes in the range of about 3.5 nm to about 6 nm.3. The composition according to claim 1 , wherein the water absorbing additive comprises a humectant selected from the group consisting of a polysorbate claim 1 , a vegetable gum claim 1 , a substituted cellulose claim 1 , a polyglycerol ester of a fatty acid claim 1 , a polyethylene glycol claim 1 , a polydextrose claim 1 , a propylene glycol claim 1 , a propylene glycol alginate claim 1 , a polyoxy ethylene glycol ester claim 1 , a pectine or amidated pectine claim 1 , a sucrose ester of a fatty acid claim 1 , an acetylated or hydroxypropyl starch claim 1 , a starch phosphate claim 1 , urea claim 1 , sorbitol claim 1 , malitol claim 1 , a vitamins claim 1 , and a mixture of two or more of such humectants.4. The composition according to claim 1 , wherein the water absorbing additive concentration is in ...

COMPOSITION FOR ENHANCING IMMUNITY

The invention relates to preparations for dietary, food supplement or medical purposes and more specifically to a safe and natural preparation or a composition useful in immunity regulation and/or stimulation and in particular in the building, reinforcement, efficiency, maintenance and regeneration of natural immune defences in a subject. The preparations comprise magnesium, zinc and/or iron, blackcurrent seed oil and/or palm oil, two plant extracts selected from thyme, chickpea and lentil, as well as algae (fucus, wakame, nori), mushroom (shiitake, maitake) and at least one hydrosoluble vitamin and/or vitamin E. 1. A composition for immunity regulation and/or stimulation , per 100 g or 100 ml , comprising the combination of:10 μg to 1000 μg of positively charged minerals consisting of magnesium,10 μg to 1000 μg of metals selected from zinc and iron{'i': Ribes nigrum Oleum Acini', 'Elaeis guineensis Oleum, '7 μg to 700 μg of at least one plant oil selected from (blackcurrant seed oil) and (palm oil),'}{'i': Thymus vulgaris', 'Cicer arietinum', 'Ervum lens, '6 μg to 600 μg of at least two plant extracts selected from (thyme), (chickpea), and (lentil),'}{'i': Fucus vesiculosus', 'Undaria pinnatfida', 'Palmaria palmata', 'Porphyra umbilicalis, '6 μg to 600 μg of at least one alga chosen among (Fucus), (Wakame), (Dulse), and (Nori),'}{'i': Lentinula edodes', 'Grifola frondosa, '7 μg to 700 μg of at least one mushroom chosen among (Shiitake) and (Maitake),'}8 μg to 800 μg of at least one vitamin chosen among vitamins A, B1, B2, B5, B6, B9, C, E, PP(B3);optionally with a suitable excipient.2. The composition for immunity regulation and/or stimulation of claim 1 , wherein vitamin A is between 15% and 100% of the GDA (Guideline Daily Amounts).3. The composition for immunity regulation and/or stimulation of claim 2 , wherein the input weight of vitamin A represents from 120 to 800 μg/100 g of said composition.4. The composition for immunity regulation and/or stimulation of ...

HUNGER MINIMIZED JUICE FASTING SYSTEM

The hunger minimized fasting system relies on providing a blood glucose level at all times in the range of 5 to 10 mM, satisfying glucose needs of the brain and metabolizing blood glucose through anaerobic glycolysis to release ATP at the extramitocontrial portion of the cell. Consuming only solid free nutrient liquids eliminates brain hunger response. Liquids consumed during fasting include solid filtered vegetable soup and clear fruit juices of 8 to 12 ounces taken every 2 to 4 hours having calorie deficiency of 600 to 1400 as compared to minimal daily calorie requirements for an adult. Fat released from storage is metabolized by ATP produced by glycolysis at the extramitocontrial location and enters the interior of the mitochondria, enabling the TCA cycle. Weight loss observed during fasting is about one half to one pound per day. 1) A hunger minimized fasting system , comprising:a) preparing a fasting person for 3 to 5 days prior entering a fasting phase;b) providing liquefied vitamin and mineral supplement on a daily basis enabling production of numerous enzymes for use in glycolysis, the process of conversion blood glucose to pyruvic acid and adenosine triphosphate (ATP) as well as beta oxidation of fats in the TCA (Kreb) cycle;c) providing on a daily basis juices, clear solid free vegetable soup of 8 to 12 ounces every 2 to 4 hours during waking hours representing a caloric intake of only 800 to 1200 calories representing a deficit of 600 to 1400 calories, maintaining blood glucose levels in the range of 5 to 10 mM (90 to 180 mg/dL), preventing the onset of hunger sensing mechanism present in the brain hypothalamus and brain stem preventing or minimizing the hunger sensation of the fasting person;d) said clear solid free vegetable soup formed by lightly cooking vegetables in water at a temperature of about 80° C. to 95° C. to extract vitamins and minerals and micro nutrients and filtering out all solid material;e) the blood glucose entering anaerobic ...

PETROSELINIC ACID OR A COMBINATION OF ACTIVE INGREDIENTS COMPRISING AT LEAST PETROSELINIC ACID FOR PROMOTING WEIGHT LOSS AND/OR WEIGHT MAINTENANCE

The present invention relates to the field of weight management and obesity. It concerns petroselinic acid or a combination of active ingredients including at least petroselinic acid and at least one compound chosen from zinc, taurine, one of the salts of same, lycopene and the mixtures thereof, and preferably at least taurine or zinc gluconate and, more preferably still, at least taurine and zinc gluconate, as a drug for oral administration or as a functional food intended to promote weight loss and/or weight maintenance in a human being and/or animal, or indeed intended to fight obesity. 113-. (canceled)14. Method for promoting weight loss and/or weight maintenance in man and/or animals in need thereof , comprising an oral administration step of petroselinic acid or a combination of active agents comprising at least petroselinic acid and at least one compound chosen from zinc , taurine , a salt thereof , lycopene , and mixtures thereof , wherein petroselinic acid or said combination is a medicament or a functional food.15. The method as claimed in claim 14 , wherein the medicament or the functional food is intended for reducing the weight of fat mass of a human and/or an animal.16. The method as claimed in claim 14 , wherein the medicament or the functional food is intended for reducing the total weight of a human and/or an animal.17. The Method as claimed in claim 14 , wherein the petroselinic acid is combined with at least taurine or zinc gluconate.18. The Method as claimed in claim 14 , wherein the petroselinic acid is combined with at least taurine and zinc gluconate.19. Method for combating obesity claim 14 , comprising an oral administration step of petroselinic acid or a combination of active agents comprising at least petroselinic acid and at least one compound chosen from zinc claim 14 , taurine claim 14 , a salt thereof claim 14 , lycopene claim 14 , and mixtures thereof claim 14 , wherein petroselinic acid or said combination is a medicament or a ...

Compositions comprising plant proteins and methods for prevention of metabolic and cardiovascular pathologies in patient with cardiometabolic risk, including hyperglycemia

A composition for oral administration in humans comprising at least one plant protein chosen from pea proteins, rice proteins or a mixture thereof, and: at least one protein of animal origin chosen from calcium caseinate, lactoserum proteins, or a mixture thereof, and/or at least one free amino acid chosen from leucine, glutamine, isoleucine, valine, tryptophan or plant 5HTP, lysine, threonine, arginine and taurine, or any mixture thereof, and/or at least one micronutrient chosen from vitamin D, vitamin B6, vitamin B9, vitamin E, milk calcium, marine magnesium, zinc and chromium, or any mixture thereof, and/or at least one anti-inflammatory and/or antioxidant compound of plant origin chosen from ALA omega-3 fatty acid, purified EPA, protectin in PD1 or PDX form, and curcumin, or any mixture thereof. Methods with these compositions for preventing cardiometabolic risk are also provided.

BRINE AND METHOD FOR THE MANUFACTURE THEREOF

The present invention relates to a method for manufacturing a brine with improved features for use in food as a condiment and for the preservation and treatment of fish and shellfish, improving the organoleptic and nutritional properties of the foods treated and/or cooked with it. The brine with improved features obtained according to the method of the present invention can furthermore be used as raw material for manufacturing intensely hydrating and mineralizing isotonic beverages for human consumption, as well as any food product requiring water in the manufacturing process, improving the nutritional properties thereof. It can also be used as raw material for manufacturing products with a high nutritional value in agriculture and stock raising, in the food industry, in other industries and in health treatments. 1. A brine obtained from seawater , characterized in that it maintains the mineral composition of the seawater in its natural state , with a boron content less than 1 mg/l , free of organic components , bacteria and macromolecules of a size greater than 0.1 μ and with a pH greater than 8.2.2. The brine according to claim 1 , characterized in that it is vitalized claim 1 , maintaining the angle in the molecular structure of the bonds of the hydrogen atoms with the oxygen atom of highly pure natural spring water.3. A method for obtaining a brine according to claim 1 , comprising the following steps:a) Seawater extraction,b) Purity analysis,c) First microfiltration,d) Deboronation treatment,e) Increase in pH,f) Vitalization treatment,g) Second microfiltration,h) Microbiological analysis,i) Packaging.4. The method according to claim 3 , characterized in that the microfiltration step c) is performed with membrane filters with a pore size of 1 μ and 0.22 μ.5. The method according to claim 3 , characterized in that the deboronation step d) is performed with a boron-selective ion exchange demineralization system.6. The method according to claim 3 , characterized in ...

COMPOSITIONS COMPRISING DEHYDRATED MICRO-ORGANISMS, METHOD OF PREPARATION THEREOF, AND USES THEREOF

The invention relates to a composition comprising revivable dehydrated micro-organisms. The invention is characterised in that it further comprises particles at least 50% of which have a mean diameter greater than 250 μm. The invention is applicable, in particular, to human or veterinary pharmaceuticals, to dietetics or to food products. 113-. (canceled)14. A method of preparing a food or medicinal composition , wherein the method comprises:{'i': Lactobacillus plantarum', 'Streptococcus infantarius, 'dehydrating uncoated, revivable micro-organisms, wherein the micro-organisms are a mixture of and ; and'}mixing the dehydrated uncoated, revivable micro-organisms with particles,wherein (i) each of said particles has a mean diameter, (ii) the mean diameters of said particles are distributed almost exclusively in a range of from 50 to 1,000 μm, (iii) about 65% of said particles have a mean diameter greater than 250 μm, and (iv) about 35% of said particles have a mean diameter of at most 250 μm,so as to form a composition comprising about 33% w/w revivable dehydrated micro-organisms, and further comprising about 67% w/w particles, wherein the micro-organisms are mixed with the particles in the composition,wherein the particles are granules comprising an aggregated and granulated mixture of (i) vitamins, trace elements, amino acids, sugars, and minerals or the salts thereof, and (ii) at least one carrier, and wherein the granules are substantially devoid of micro-organisms,wherein the composition has a water activity lower than 0.3, andwherein the micro-organisms in the composition have a revivability such that, after being kept moisture-free and at room temperature for 18 months, the composition comprises at least 20% revivable micro-organisms from amongst 100% revivable micro-organisms initially present in said composition.15. The method of claim 14 , being carried out under controlled moisture conditions ensuring a water activity lower than 0.2 in the composition ...

COATED CALCIUM PARTICULATES FOR USE IN BEVERAGE PRODUCTS

Coated particulate material used to enable the incorporation of calcium materials in a beverage product (especially those having a low pH) preserved with sodium hexametaphosphate (SHMP) are disclosed. The particulates are made up of a substrate material, such as a calcium salt, such as calcium phosphate. The substrate material can, in preferred embodiments, be incorporated into a prill which utilizes a sterol as the prilling material. The substrate material, preferably in the form of a prill, is then coated with a phospholipid coating, such as hydrogenated phosphatidyl choline, such that the final coated particulate product includes from about 70% to about 200% (by weight of the substrate) of the phospholipid coating. Beverage compositions which include these coated particulates are also disclosed. 1. A coated particulate , having a particle size of from about 4 μm to about 10 μm , comprising a substrate consisting essentially of a material selected from calcium salts , iron salts , and alkali earth metal salts , oxidative labile vitamins , and combinations thereof; and from about 70% to about 200% (by weight of the substrate) of a phospholipid coating.2. The particulate according to wherein the substrate is in the form of a prill consisting essentially of a sterol and the substrate material selected from calcium salts claim 1 , iron salts and alkali earth metal salts claim 1 , oxidative labile vitamins and combination thereof.3. The particulate according to wherein the sterol material is hydrogenated.4. The particulate according to wherein the prill consists essentially of from about 50% to about 70% sterol and from about 30% to about 50% of the substrate material.5. The particulate according to wherein the substrate material is a calcium salt.6. The particulate according to wherein the sterol is non-polar and is soluble in the prilling solvent.7. The particulate according to wherein the calcium salt is selected from calcium phosphate claim 6 , calcium chloride ...

Micro-colloidal silicic acid / boric acid composition and a method of preparing a bioenhancing solution and powder

The present invention provides a composition comprising an acidified aqueous solution of (1) micro colloidal silicic acid, (2) boric acid, and (3) a water absorbing additive, having a pH value of equal to or less than 1, wherein the micro colloidal silicic acid has particle sizes in the range of 1-8 nm, especially in the range of 1.5-6 nm. The invention also provides a particulate product obtainable by the method according to claim 18 , wherein the particles comprise (1) silicic acid, (2) boric acid, and (3) the water absorbing additive, and wherein at least 90% of the particles in the particulate product have particle sizes in the range of 0.3-5 μm.

COMPOSITIONS AND METHODS FOR PRODUCING STABLE NEGATIVE OXIDATION REDUCTION POTENTIAL IN CONSUMABLE MATERIALS

Compositions of reducing agents and carriers for producing a stable negative oxidation reduction potential in consumable materials are disclosed and claimed. Compositions of the invention find use in enhancing the hydration and anti-oxidant value of consumable materials such as foods, beverages and cosmetics, for example. Compositions of the invention also find use in water treatment, agricultural and scientific research applications. Methods for using and making the compositions are also within the scope of the invention. 1. An additive for producing negative oxidation reduction potential in a consumable material , wherein the additive comprises a mixture of:a. at least one reducing agent; andb. at least one carrier,c. wherein the additive produces a negative oxidation reduction potential of between about −200 and −800 mV in the consumable material.2. The mixture of claim 1 , wherein the at least one reducing agent is selected from an inorganic reducing agent claim 1 , an organic reducing agent claim 1 , and combinations thereof.3. The mixture of claim 2 , wherein the at least one carrier is selected from a base claim 2 , a saccharide claim 2 , ascorbate analog claim 2 , EDTA analog claim 2 , and combinations thereof.4. The mixture of claim 3 , wherein the inorganic reducing agent comprises particles of an elemental metal selected from magnesium claim 3 , calcium claim 3 , zinc claim 3 , iron claim 3 , copper claim 3 , manganese claim 3 , cobalt and combinations thereof5. The mixture of claim 3 , wherein the organic reducing agent is selected from amino-guanidine claim 3 , dihydro-pyrrol derivatives claim 3 , dihydro-furan derivatives claim 3 , dihydro-pyridine derivatives claim 3 , and combinations thereof.6. The mixture of claim 4 , wherein the base is selected from the group consisting of sodium bicarbonate claim 4 , potassium bicarbonate claim 4 , sodium carbonate claim 4 , potassium carbonate claim 4 , magnesium carbonate claim 4 , magnesium oxide claim 4 , ...

ANTI-FATIGUE COMPOSITION AND USE THEREOF

Disclosed is a composition with a sustainable anti-fatigue function and which helps the body to restore the level of high-energy phosphate materials and increases energy, wherein the active ingredients thereof are ribose and caffeine. The composition comprises components with the following weight parts: 1-99.9 parts ribose and 0.1-99 parts coffee or 1-99.99 parts ribose and 0.01-99 parts caffeine. 1. A composition containing ribose and caffeine as effective ingredients , which has a sustainable anti-fatigue effect and helps the body restore the level of high-energy phosphate substances and increase energy.2. The composition according to claim 1 , further comprising the following components in parts by weight: 1-99.9 ribose and 0.1-99 coffee claim 1 , or 1-99.99 ribose and 0.01-99 caffeine.3. The composition according to claim 1 , further comprising one or more selected from the group consisting of: milk powder or fresh milk claim 1 , amino acids claim 1 , sugars claim 1 , sugar alcohols claim 1 , cereals claim 1 , cocoa claim 1 , chocolate claim 1 , non-saccharide and sugar alcohols sweeteners claim 1 , pectin claim 1 , soluble dietary fibers claim 1 , salts claim 1 , other carbohydrates claim 1 , vitamins claim 1 , minerals claim 1 , carbon dioxide or other food additives; wherein claim 1 ,the amino acids comprise one or more of taurine, pyruvic acid, ketoglutaric acid, arginine and citrulline;the sugars comprise one or more of glucose, sucrose or fructose;{'i': 'Momordica grosvenori', 'the non-saccharide and sugar alcohols sweeteners comprise one or more of stevia, aspartame, sucralose, , glycyrrhizin, beet sweetener or saccharin sodium;'}the sugar alcohols comprise one or more of xylitol, erythritol, maltitol, isomalt orsorbitol;the minerals comprise one or more elements of calcium, magnesium, iron and zinc; the salts comprise one or more salts of sodium, potassium and phosphate; said other carbohydrates comprise wheat flour, inulin, oligosaccharides, starch and/ ...

DIETARY SUPPLEMENTS FOR PROMOTION OF GROWTH, REPAIR, AND MAINTENANCE OF BONE AND JOINTS

The present invention provides a dietary supplement that promote the growth, repair, and maintenance of mammalian bone and joint connective tissue. In particular, the dietary supplement comprises a combination of at least one metal chelate and at least one chondroprotective agent. 1. A dietary supplement comprising at least one chondroprotective agent and at least one metal chelate; the metal chelate comprising at least one metal ion and at least one ligand.2. The dietary supplement of claim 1 , further comprising at least one ingredient selected from the group consisting of vitamin claim 1 , mineral claim 1 , amino acid claim 1 , antioxidant claim 1 , yeast culture claim 1 , anti-inflammatory agent claim 1 , and essential fatty acid.3. The dietary supplement of claim 1 , wherein the average ligand to metal ion ratio is from about 1:1 to about 3:1.4. The dietary supplement of claim 1 , wherein the metal ion is selected from the group consisting of zinc ions claim 1 , copper ions claim 1 , manganese ions claim 1 , magnesium ions claim 1 , iron ions claim 1 , chromium ions claim 1 , calcium ions claim 1 , and combinations thereof.5. The dietary supplement of claim 3 , wherein the metal ions are manganese ions claim 3 , zinc ions claim 3 , and copper ions.6. The dietary supplement of claim 1 , wherein the chondroprotective agent is selected from the group consisting of glucosamine claim 1 , chondriotin claim 1 , hyaluronic acid claim 1 , collagen claim 1 , concentrated eggshell membrane claim 1 , and green-lipped mussel.7. The dietary supplement of claim 1 , wherein the ligand is selected from alanine claim 1 , arginine claim 1 , asparagine claim 1 , aspartic acid claim 1 , cysteine claim 1 , glutamine claim 1 , glutamic acid claim 1 , glycine claim 1 , histidine claim 1 , isoleucine claim 1 , leucine claim 1 , lysine claim 1 , methionine claim 1 , phenylalanine claim 1 , proline claim 1 , serine claim 1 , threonine claim 1 , tryptophan claim 1 , tyrosine claim 1 , ...

NUTRITIONAL SUPPLEMENT SYSTEM

A multi-part nutritional supplement system supplies nutrients to a user at advantageous locations in the digestive tract. One type of dosage unit is formulated to release vitamin B12 in the stomach and intestines of the upper GI tract, advantageously in an amount that is greater than or at multiple levels of the DV (Daily Value) of vitamin B12. 1. A nutritional supplement system for human subjects , a daily dose of the nutritional supplement system comprising phosphorus , magnesium , zinc , manganese , boron , copper , chromium , molybdenum , nickel , tin , vanadium , selenium , silicon , calcium , iodine , vitamin A , vitamin B1 , vitamin B2 , vitamin B3 , vitamin B5 , vitamin B6 , vitamin B12 , vitamin C , vitamin D , vitamin E , folic acid , biotin , lutein , lycopene , one or more omega-3 fatty acids , and one or more tocopherols , the daily dose of the nutritional supplement system consisting essentially of four nutritional supplement dosage units , wherein:a first nutritional supplement dosage unit comprises one or more nutrients being selected from phosphorus, magnesium, vitamin C, zinc, vitamin E, manganese, vitamin B3, boron, copper, vitamin A, beta carotene, vitamin B5, chromium, molybdenum, nickel, tin, vanadium, iron, selenium, vitamin K, N-acetyl cysteine, silicon, vitamin B6, vitamin B1, vitamin B2, vitamin B12, vitamin D, folate, folic acid, biotin, iodine and any combination thereof, the first dosage unit being in the form of at least one first dosage element formulated to release one or more nutrients in the stomach of a human subject;a second nutritional supplement dosage unit comprises one or more nutrients being selected from lutein, lycopene, vitamin D, vitamin E, omega-3 fatty acids, gamma tocopherol, beta tocopherol, delta tocopherol, and any combination thereof, the second dosage unit being in the form of at least one second dosage element formulated to release one or more nutrients in the upper intestinal tract of the subject;a third ...

METHOD FOR PRODUCING LIQUID FOOD COMPOSITION

A liquid food composition that can be conveniently ingested or given with a tube and contains reduced aggregates in the composition is provided. A liquid food composition that shows fluidity in the neutral region, but solidifies in the stomach environment is further provided. According to the production method of the present invention, generation of fine particles in the production process of a liquid food composition containing a divalent metal salt, a protein, and water-soluble dietary fibers is reduced. Therefore, emulsification stability of the composition is improved, clogging of aggregates in strainer disposed in the production line etc. are eliminated, and thus the composition can be efficiently produced. Furthermore, since the composition obtained by the production method shows fluidity in the neutral region, but solidifies in the stomach environment, it can be conveniently ingested or given with a tube, and can effectively reduce the risks for developing gastroesophageal reflux disease, aspiration pneumonia, diarrhea, etc. 1. A method for producing a liquid food composition , comprising:mixing a divalent metal salt with a solvent to obtain a first mixture;mixing the first mixture with at least one of a phosphoric acid salt and an organic acid salt to obtain a second mixture;performing mixing such that the second mixture has a pH of 6.2 to 9.5;mixing the second mixture having a pH of 6.2 to 9.5 with a protein to obtain a third mixture; and(c) mixing water-soluble dietary fibers with the third mixture such that a liquid food composition including the divalent metal salt, at least one of the phosphoric acid salt and the organic acid salt, the protein, and the water-soluble dietary fibers is obtained.2. The method according to claim 1 , wherein the protein is mixed with the second mixture having a temperature in a range of from 30 to 80° C.3. The method according to claim 1 , wherein the liquid food composition includes i) phosphate ions and/or organic acid ...

LIQUID FOOD COMPOSITION

A liquid food composition that can be conveniently ingested or given by tube feeding, and can prevent gastroesophageal reflux disease, vomiting, esophagitis, pneumonia, asphyxiation, diarrhea, etc., and can increase feeling of fullness through improvement in the solidification ratio of the composition under the endogastric condition is provided. Since the liquid food composition of the present invention shows superior solidification ratio under the endogastric acidic condition, it can more effectively reduce the risks for developing gastroesophageal reflux disease, vomiting, esophagitis, pneumonia, asphyxiation, diarrhea, etc., and it does not require labor for separately adding a gelling agent etc. at the time of ingestion, and since it is liquid, it can be easily ingested by tube feeding. 1. A liquid food composition , comprising:at least one substance selected from the group consisting of alginic acid, a salt thereof, and pectin;a divalent metal salt; anda vegetable protein having a relative mobility, Rf value, of larger than 0.6 at a cumulative value of pixel intensity frequency of 50% in SDS-PAGE densitometry analysis,wherein the liquid food composition has fluidity at pH 5.5 to 10.0, and thickens and/or solidifies at a pH of lower than 5.5.2. The liquid food composition according to claim 1 , wherein the vegetable protein includes a 7S globulin at a content of not lower than 0.01% by weight and lower than 21% by weight claim 1 , and the vegetable protein includes a 11S globulin at a content of not lower than 0.01% by weight and lower than 41% by weight.3. The liquid food composition according to claim 2 , wherein a content ratio of the 11S globulin with respect to the 7S globulin is larger than 0.0005 and smaller than 4100.4. The liquid food composition according to claim 1 , wherein a content ratio of the at least one substance with respect to the vegetable protein is from 0.05 to 4.0.5. The liquid food composition according to claim 2 , wherein a content ...

QUICK DISSOLVE NUTRITIONAL POWDER

The present disclosure provides a rapidly disintegrating orally administrable powder. The powder may include an active ingredient such as a dietary supplement. Methods of using the same are also provided herein. 1. A composition comprising a powder including:at least one bulking agent;at least one sweetening ingredient; andat least one active ingredient selected from the group consisting of Vitamin A, Vitamin C, Vitamin D, Vitamin E, Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Selenium, Zinc, Boron, omega-3 fatty acids, coenzyme Q10, calcium, probiotics, and combinations thereof,wherein the powder dissolves in the mouth upon contact with saliva.2. The composition of claim 1 , the powder further comprising a flow agent selected from the group consisting of sodium bicarbonate claim 1 , sodium ferrocyanide claim 1 , postassium ferrocyanide claim 1 , calcium ferrocyanide claim 1 , bone phosphate claim 1 , sodium silicate claim 1 , silicon dioxide claim 1 , calcium silicate claim 1 , magnesium trisilicate claim 1 , talcum powder claim 1 , sodium aluminosilicate claim 1 , potassium aluminum silicate claim 1 , calcium aluminosilicate claim 1 , bentonite claim 1 , aluminum silicate claim 1 , stearic acid claim 1 , polydimethylsiloxane claim 1 , and combinations thereof.3. The composition of claim 1 , wherein the at least one bulking agent is selected from the group consisting of polyols claim 1 , sucrose claim 1 , maltodextrin claim 1 , and combinations thereof.4. The composition of claim 3 , wherein the polyol is selected from the group consisting of mannitol claim 3 , xylitol claim 3 , sorbitol claim 3 , maltitol claim 3 , erythritol claim 3 , isomalt claim 3 , lactitol claim 3 , polyglycitol claim 3 , and combinations thereof.5. The composition of claim 1 , wherein the sweetening ingredient is selected from the group consisting of stevia claim 1 , sucralose claim 1 , ...

MINERAL SUPPLEMENTATION OF BEVERAGES

The present invention is directed to metal supplementation of beverages. More particularly, it is directed to a metal containing complex coacervate core micelle comprising a negatively charged chelating agent, a low molecular weight natural food-grade polymeric cation, and water. It is also directed to a process to produce said metal containing complex coacervate core micelle, and to the use of said metal containing complex coacervate core micelle to supplement beverages with a source of highly bioavailable metal. It is also related to a beverage comprising said metal containing complex coacervate core micelle. 1. A metal containing complex coacervate core micelle comprising80 to 99 wt.-% of a negatively charged chelating agent,0.2 to 10 wt.-% of a low molecular weight natural food-grade polymeric cation,0.5 to 10 wt.-% of a metal cation, and water, wherein wt.-% means dry weight percent based on the total weight of the complex coacervate core micelle,and wherein the average particle size as measured by dynamic light scattering is between 10 and 150 nm.2. The metal containing complex coacervate core micelle according to claim 1 , wherein the metal is iron in the form Fe+.3. The metal containing complex coacervate core micelle according to claim 1 , wherein the negatively charged chelating agent is sodium hexametaphosphate.4. The metal containing complex coacervate core micelle according to claim 1 , wherein the low molecular weight natural food-grade polymeric cation is chitosan with a polymerisation degree between 5 and 100.5. The metal containing complex coacervate core micelle according to claim 1 , wherein the low molecular weight natural food-grade polymeric cation is chitosan with a polymerisation degree between 10 and 20.6. The metal containing complex coacervate core micelle according to further comprising a water soluble food flavouring agent and/or vitamin claim 1 , or a fat soluble food flavouring agent and/or vitamin in the shell of the micelle.7. The ...

Lactate powder and method for the preparation thereof

The present invention relates to a lactate powder, more particularly a lactate powder having a lactate content of at least 20 wt. % and a water content of less than 3.5 wt. %, said powder comprising calcium cations as well as sodium cations. According to the invention, a calcium lactate powder combining high stability with excellent water dissolution properties can be obtained even though anhydrous calcium lactate represents the bulk of the powder if the powder additionally contains a certain amount of sodium lactate. The inventors have found that the presence of sodium lactate greatly improves the dissolution behavior of the anhydrous calcium lactate while maintaining the storage stability of the powder. The present inventors also established that the dissolution behavior of the powder can be further improved by the addition of a fast-dissolving carbohydrate material.

ANTI-GLYCATION METHODS AND COMPOSITIONS

The present invention comprises compositions that provide anti-glycation activity comprising a mineral extract composition or a mogroside/mineral extract composition or a mogroside composition. Such compositions are useful for methods of preventing, treating and inhibiting the effects of glycation in the body. The methods of the present invention comprise use of anti-glycation composition for the treatment and prevention of glycation related conditions including diabetes, atherosclerosis, arthritis, mental conditions and vision impairment. 120-. (canceled)21. A method of treating glycation-related conditions , comprising , administering to a human or animal an effective amount of an extracted mineral element composition wherein said extracted mineral element composition is prepared by a method consisting of:one acid treatment step, a settling step, a separating step, and a concentration step,wherein the one acid treatment step consists of admixing a clay soil, a mixture of clay soils, or a mixture of clay soils and leonardite with water in an amount at least two times the weight of the soil and an acid to produce a water-acid-soil slurry, wherein the amount of acid is 0.25% to 7.5% of the weight of the water;wherein the settling step consists of allowing solids from the water-acid-soil slurry to settle;wherein the separating step consists of separating the liquid of the water-acid-soil slurry from the settled solids wherein the solids comprise substantially all of the silica and aluminum from the clay soil, mixture of clay soils, or a mixture of clay soils and leonardite;wherein the concentrating step consists of concentrating the separated liquid to form a liquid extracted mineral element composition comprising (i) calcium, chlorine, magnesium, manganese, phosphorous, potassium, silicon, and sodium, and (ii) a lower amount of silica and aluminum than the clay soil, a mixture of clay soils, or a mixture of clay soils and leonardite; andwherein the amount is ...

EDIBLE COMPOSITION

The present invention relates to edible compositions for the maintenance of normal liver function comprising zinc, 1-deoxynojirimycinand α-lipoic acid. 1. An edible composition comprising 0.1 to 40 mg zinc , 0.5 to 1000 mg 1-deoxynojirimycin and 5 to 2000 mg α-lipoic acid.2. A composition as claimed in wherein the composition comprises 0.5 to 30 mg of zinc claim 1 , preferably 1 to 20 mg.3. A composition as claimed in - wherein the composition comprises 1 to 800 mg of 1-deoxynojirimycin claim 1 , preferably 5 to 500 mg.4. A composition as claimed in wherein the composition comprises 15 to 1500 mg of α-lipoic acid claim 1 , preferably 40 to 800 mg.5. A composition as claimed in wherein the molar ratio of zinc to 1-deoxynojirimycin is 10:1 to 1:50 claim 1 , preferably 5:1 to 1:20 claim 1 , more preferably 2:1 to 1:10.6. A composition as claimed in wherein the molar ratio of zinc to α-lipoic acid is 10:1 to 1:50 claim 1 , preferably 5:1 to 1:20 claim 1 , more preferably 2:1 to 1:10.7. A composition as claimed in wherein the molar ratio of 1-deoxynojirimycin to α-lipoic acid is 20:1 to 1:20 claim 1 , preferably 10:1 to 1:10 claim 1 , more preferably 5:1 to 1:5.8. A composition as claimed in claim 1 , wherein the composition is a food or beverage product.9. A composition as claimed in wherein the composition is packaged.10. A composition comprising 0.1 to 40 mg zinc claim 1 , 0.5 to 1000 mg 1-deoxynojirimycin and 5 to 2000 mg α-lipoic acid for use as a medicament.11. A composition comprising 0.1 to 40 mg zinc claim 1 , 0.5 to 1000 mg 1-deoxynojirimycin and 5 to 2000 mg α-lipoic acid for use in the treatment and/or prevention of hepatic steatosis.12. A composition comprising 0.1 to 40 mg zinc claim 1 , 0.5 to 1000 mg 1-deoxynojirimycin and 5 to 2000 mg α-lipoic acid for use in the treatment and/or prevention of steatohepatitis.13. A composition according to wherein the composition comprises 0.5 to 30 mg of zinc claim 10 , preferably 1 to 20 mg.14. A composition according ...

Whey Protein Composition with a Reduced Astringency

The invention relates to a sterilized liquid or semi-solid acid enteral composition comprising per 100 ml 9 to 20 g of non-hydrolysed globular proteins, fat and at least 100 mg of divalent metal cations and having a pH ranging between 3 and 5. 1. A sterilized liquid or semi-solid acid enteral nutritional composition comprising per 100 ml of said composition 9 to 20 g of non-hydrolysed globular protein , fat , and at least 100 mg of divalent metal cations and having a pH ranging between 3 and 5.2. The nutritional composition according to claim 1 , wherein the pH ranges between 3.7 and 4.3.3. The nutritional composition according to claim 1 , further comprising a stabilizing polysaccharide selected from the group consisting of (high) methoxy pectin and carboxymethyl cellulose and combinations thereof.4. The nutritional composition according to claim 1 , wherein the amount of divalent metal cations ranges between 100 and 600 mg per 100 ml.5. The nutritional composition according to claim 1 , wherein the amount of non-hydrolysed globular protein ranges between 9 and 16 g.6. The nutritional composition according to claim 1 , wherein the divalent metal cation is selected from the group consisting of Ca and Mg and any mixture thereof.7. The nutritional composition according to claim 6 , wherein the globular protein is selected from the group consisting of whey protein claim 6 , pea protein claim 6 , soy protein claim 6 , and any mixture thereof.8. The nutritional composition according to claim 1 , wherein the globular protein comprises whey protein and the source of whey protein is selected from the group consisting of whey protein concentrate (WPC) claim 1 , whey protein isolate (WPI) claim 1 , and any mixture thereof.9. The nutritional composition according to claim 1 , wherein the amount of non-hydrolysed globular protein is at least 85 weight % of the total proteinaceous matter in the composition.10. The nutritional composition according to claim 1 , further comprising ...

COMPOSITIONS AND METHODS COMPRISING MEDIUM CHAIN TRIGLYCERIDES FOR TREATMENT OF EPILEPSY

The invention provides compositions and methods for treatment of epilepsy in an animal. In one embodiment, a dietary regime suitable for enhancing the effect of an anti-epileptic drug (AED) in an animal can comprise a food composition comprising a medium chain triglyceride (MCT) and the AED, wherein the MCT is present in the food composition in an effective amount for enhancing the effect of the AED when the food composition and the AED are administered to the animal. 1. A dietary regime suitable for enhancing the effect of an anti-epileptic drug (AED) in an animal comprising the AED and a food composition comprising a medium chain triglyceride (MCT) , wherein the MCT is present in the food composition in an effective amount for enhancing the effect of the AED when the food composition and the AED are administered to the animal.2. The dietary regime of claim 1 , wherein the animal is a human or companion animal.3. The dietary regime of claim 1 , wherein the animal is a canine or a feline.5. The dietary regime of claim 5 , wherein greater than about 95% of the R′ claim 5 , R″ claim 5 , and R′″ are 8 carbons in length.6. The dietary regime of claim 6 , wherein the remaining R′ claim 6 , R″ claim 6 , and R′″ are 6-carbon or 10-carbon fatty acids.7. The dietary regime of claim 1 , wherein the food composition comprises from about 1% to about 15% of the MCT.8. The dietary regime of claim 1 , wherein the AED is selected from the group consisting of acetazolamide claim 1 , carbamazepine claim 1 , chlorazepate claim 1 , clobazam claim 1 , clonazepam claim 1 , diazepam claim 1 , eslicarbazepine acetate claim 1 , ethisyxunudem claim 1 , ethosuximide claim 1 , felbamate claim 1 , gabapentin claim 1 , imepitoin claim 1 , keppra claim 1 , lacosamide claim 1 , lamotrigine claim 1 , levetiracetam claim 1 , methylphenobarbitone claim 1 , nitrazepam claim 1 , oxcarbazepine claim 1 , perampanel claim 1 , piracetam claim 1 , phenobarbital claim 1 , phenytoin claim 1 , potassium ...